Motif 140 (n=235)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0C4DFX4 | None | S1682 | ochoa | Snf2 related CREBBP activator protein | None |
A4FU01 | MTMR11 | S175 | ochoa | Myotubularin-related protein 11 (Cisplatin resistance-associated protein) (hCRA) (Inactive phosphatidylinositol 3-phosphatase 11) | None |
E9PAV3 | NACA | S915 | ochoa | Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC) | Cardiac- and muscle-specific transcription factor. May act to regulate the expression of genes involved in the development of myotubes. Plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration. Involved in the organized assembly of thick and thin filaments of myofibril sarcomeres (By similarity). {ECO:0000250|UniProtKB:P70670}. |
E9PAV3 | NACA | S917 | ochoa | Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC) | Cardiac- and muscle-specific transcription factor. May act to regulate the expression of genes involved in the development of myotubes. Plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration. Involved in the organized assembly of thick and thin filaments of myofibril sarcomeres (By similarity). {ECO:0000250|UniProtKB:P70670}. |
E9PAV3 | NACA | S1487 | ochoa | Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC) | Cardiac- and muscle-specific transcription factor. May act to regulate the expression of genes involved in the development of myotubes. Plays a critical role in ventricular cardiomyocyte expansion and regulates postnatal skeletal muscle growth and regeneration. Involved in the organized assembly of thick and thin filaments of myofibril sarcomeres (By similarity). {ECO:0000250|UniProtKB:P70670}. |
O00512 | BCL9 | T315 | ochoa | B-cell CLL/lymphoma 9 protein (B-cell lymphoma 9 protein) (Bcl-9) (Protein legless homolog) | Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity (By similarity). {ECO:0000250, ECO:0000269|PubMed:11955446}. |
O14497 | ARID1A | S1602 | ochoa | AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD) | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). {ECO:0000250|UniProtKB:A2BH40, ECO:0000303|PubMed:12672490, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
O14686 | KMT2D | S477 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O14686 | KMT2D | S618 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O14686 | KMT2D | S654 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O14686 | KMT2D | S4321 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O14686 | KMT2D | S4325 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O14686 | KMT2D | S4327 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O14828 | SCAMP3 | S32 | ochoa | Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3) | Functions in post-Golgi recycling pathways. Acts as a recycling carrier to the cell surface. |
O15069 | NACAD | S1121 | ochoa | NAC-alpha domain-containing protein 1 | May prevent inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). May bind to nascent polypeptide chains as they emerge from the ribosome and block their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. May also reduce the inherent affinity of ribosomes for protein translocation sites in the ER membrane (M sites) (By similarity). {ECO:0000250}. |
O15156 | ZBTB7B | S172 | ochoa | Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox) (hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog) (Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK) | Transcription regulator that acts as a key regulator of lineage commitment of immature T-cell precursors. Exerts distinct biological functions in the mammary epithelial cells and T cells in a tissue-specific manner. Necessary and sufficient for commitment of CD4 lineage, while its absence causes CD8 commitment. Development of immature T-cell precursors (thymocytes) to either the CD4 helper or CD8 killer T-cell lineages correlates precisely with their T-cell receptor specificity for major histocompatibility complex class II or class I molecules, respectively. Cross-antagonism between ZBTB7B and CBF complexes are determinative to CD4 versus CD8 cell fate decision. Suppresses RUNX3 expression and imposes CD4+ lineage fate by inducing the SOCS suppressors of cytokine signaling. induces, as a transcriptional activator, SOCS genes expression which represses RUNX3 expression and promotes the CD4+ lineage fate. During CD4 lineage commitment, associates with multiple sites at the CD8 locus, acting as a negative regulator of the CD8 promoter and enhancers by epigenetic silencing through the recruitment of class II histone deacetylases, such as HDAC4 and HDAC5, to these loci. Regulates the development of IL17-producing CD1d-restricted naural killer (NK) T cells. Also functions as an important metabolic regulator in the lactating mammary glands. Critical feed-forward regulator of insulin signaling in mammary gland lactation, directly regulates expression of insulin receptor substrate-1 (IRS-1) and insulin-induced Akt-mTOR-SREBP signaling (By similarity). Transcriptional repressor of the collagen COL1A1 and COL1A2 genes. May also function as a repressor of fibronectin and possibly other extracellular matrix genes (PubMed:9370309). Potent driver of brown fat development, thermogenesis and cold-induced beige fat formation. Recruits the brown fat lncRNA 1 (Blnc1):HNRNPU ribonucleoprotein complex to activate thermogenic gene expression in brown and beige adipocytes (By similarity). {ECO:0000250|UniProtKB:Q64321, ECO:0000269|PubMed:9370309}. |
O15417 | TNRC18 | S2375 | ochoa | Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein) | None |
O43281 | EFS | S323 | ochoa | Embryonal Fyn-associated substrate (hEFS) (Cas scaffolding protein family member 3) | Docking protein which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion. May serve as an activator of SRC and a downstream effector. Interacts with the SH3 domain of FYN and with CRK, SRC, and YES (By similarity). {ECO:0000250}. |
O43312 | MTSS1 | S594 | ochoa | Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein) | May be related to cancer progression or tumor metastasis in a variety of organ sites, most likely through an interaction with the actin cytoskeleton. |
O43379 | WDR62 | S995 | ochoa | WD repeat-containing protein 62 | Required for cerebral cortical development. Plays a role in neuronal proliferation and migration (PubMed:20729831, PubMed:20890278). Plays a role in mother-centriole-dependent centriole duplication; the function also seems to involve CEP152, CDK5RAP2 and CEP63 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication (PubMed:26297806). {ECO:0000269|PubMed:20729831, ECO:0000269|PubMed:20890278, ECO:0000269|PubMed:26297806}. |
O43439 | CBFA2T2 | S270 | ochoa | Protein CBFA2T2 (ETO homologous on chromosome 20) (MTG8-like protein) (MTG8-related protein 1) (Myeloid translocation-related protein 1) (p85) | Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes (PubMed:12559562, PubMed:15203199). Via association with PRDM14 is involved in regulation of embryonic stem cell (ESC) pluripotency (PubMed:27281218). Involved in primordial germ cell (PCG) formation. Stabilizes PRDM14 and OCT4 on chromatin in a homooligomerization-dependent manner (By similarity). Can repress the expression of MMP7 in a ZBTB33-dependent manner (PubMed:23251453). May function as a complex with the chimeric protein RUNX1/AML1-CBFA2T1/MTG8 (AML1-MTG8/ETO fusion protein) which is produced in acute myeloid leukemia with the chromosomal translocation t(8;21). May thus be involved in the repression of AML1-dependent transcription and the induction of G-CSF/CSF3-dependent cell growth. May be a tumor suppressor gene candidate involved in myeloid tumors with the deletion of the 20q11 region. Through heteromerization with CBFA2T3/MTG16 may be involved in regulation of the proliferation and the differentiation of erythroid progenitors by repressing the expression of TAL1 target genes (By similarity). Required for the maintenance of the secretory cell lineage in the small intestine. Can inhibit Notch signaling probably by association with RBPJ and may be involved in GFI1-mediated Paneth cell differentiation (By similarity). {ECO:0000250|UniProtKB:O70374, ECO:0000269|PubMed:23251453, ECO:0000303|PubMed:12559562, ECO:0000303|PubMed:15203199}. |
O43516 | WIPF1 | S154 | ochoa|psp | WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein) (WASP-interacting protein) | Plays a role in the reorganization of the actin cytoskeleton. Contributes with NCK1 and GRB2 in the recruitment and activation of WASL. May participate in regulating the subcellular localization of WASL, resulting in the disassembly of stress fibers in favor of filopodia formation. Plays a role in the formation of cell ruffles (By similarity). Plays an important role in the intracellular motility of vaccinia virus by functioning as an adapter for recruiting WASL to vaccinia virus. {ECO:0000250, ECO:0000269|PubMed:10878810, ECO:0000269|PubMed:19910490, ECO:0000269|PubMed:9405671}. |
O43516 | WIPF1 | S203 | ochoa | WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein) (WASP-interacting protein) | Plays a role in the reorganization of the actin cytoskeleton. Contributes with NCK1 and GRB2 in the recruitment and activation of WASL. May participate in regulating the subcellular localization of WASL, resulting in the disassembly of stress fibers in favor of filopodia formation. Plays a role in the formation of cell ruffles (By similarity). Plays an important role in the intracellular motility of vaccinia virus by functioning as an adapter for recruiting WASL to vaccinia virus. {ECO:0000250, ECO:0000269|PubMed:10878810, ECO:0000269|PubMed:19910490, ECO:0000269|PubMed:9405671}. |
O43516 | WIPF1 | S234 | ochoa | WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein) (WASP-interacting protein) | Plays a role in the reorganization of the actin cytoskeleton. Contributes with NCK1 and GRB2 in the recruitment and activation of WASL. May participate in regulating the subcellular localization of WASL, resulting in the disassembly of stress fibers in favor of filopodia formation. Plays a role in the formation of cell ruffles (By similarity). Plays an important role in the intracellular motility of vaccinia virus by functioning as an adapter for recruiting WASL to vaccinia virus. {ECO:0000250, ECO:0000269|PubMed:10878810, ECO:0000269|PubMed:19910490, ECO:0000269|PubMed:9405671}. |
O43516 | WIPF1 | S276 | ochoa | WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein) (WASP-interacting protein) | Plays a role in the reorganization of the actin cytoskeleton. Contributes with NCK1 and GRB2 in the recruitment and activation of WASL. May participate in regulating the subcellular localization of WASL, resulting in the disassembly of stress fibers in favor of filopodia formation. Plays a role in the formation of cell ruffles (By similarity). Plays an important role in the intracellular motility of vaccinia virus by functioning as an adapter for recruiting WASL to vaccinia virus. {ECO:0000250, ECO:0000269|PubMed:10878810, ECO:0000269|PubMed:19910490, ECO:0000269|PubMed:9405671}. |
O43516 | WIPF1 | S412 | ochoa | WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein) (WASP-interacting protein) | Plays a role in the reorganization of the actin cytoskeleton. Contributes with NCK1 and GRB2 in the recruitment and activation of WASL. May participate in regulating the subcellular localization of WASL, resulting in the disassembly of stress fibers in favor of filopodia formation. Plays a role in the formation of cell ruffles (By similarity). Plays an important role in the intracellular motility of vaccinia virus by functioning as an adapter for recruiting WASL to vaccinia virus. {ECO:0000250, ECO:0000269|PubMed:10878810, ECO:0000269|PubMed:19910490, ECO:0000269|PubMed:9405671}. |
O43896 | KIF1C | S983 | ochoa | Kinesin-like protein KIF1C | Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end-directed motility. {ECO:0000269|PubMed:9685376}. |
O60216 | RAD21 | S454 | ochoa|psp | Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product) (65-kDa carboxy-terminal product)] | [Double-strand-break repair protein rad21 homolog]: As a member of the cohesin complex, involved in sister chromatid cohesion from the time of DNA replication in S phase to their segregation in mitosis, a function that is essential for proper chromosome segregation, post-replicative DNA repair, and the prevention of inappropriate recombination between repetitive regions (PubMed:11509732). The cohesin complex may also play a role in spindle pole assembly during mitosis (PubMed:11590136). In interphase, cohesins may function in the control of gene expression by binding to numerous sites within the genome (By similarity). May control RUNX1 gene expression (Probable). Binds to and represses APOB gene promoter (PubMed:25575569). May play a role in embryonic gut development, possibly through the regulation of enteric neuron development (By similarity). {ECO:0000250|UniProtKB:Q61550, ECO:0000250|UniProtKB:Q6TEL1, ECO:0000269|PubMed:11509732, ECO:0000269|PubMed:11590136, ECO:0000269|PubMed:25575569, ECO:0000305|PubMed:25575569}.; FUNCTION: [64-kDa C-terminal product]: May promote apoptosis. {ECO:0000269|PubMed:11875078, ECO:0000269|PubMed:12417729}. |
O60292 | SIPA1L3 | S1382 | ochoa | Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3) | Plays a critical role in epithelial cell morphogenesis, polarity, adhesion and cytoskeletal organization in the lens (PubMed:26231217). {ECO:0000269|PubMed:26231217}. |
O60307 | MAST3 | S1182 | ochoa | Microtubule-associated serine/threonine-protein kinase 3 (EC 2.7.11.1) | None |
O75128 | COBL | S287 | ochoa | Protein cordon-bleu | Plays an important role in the reorganization of the actin cytoskeleton. Regulates neuron morphogenesis and increases branching of axons and dendrites. Regulates dendrite branching in Purkinje cells (By similarity). Binds to and sequesters actin monomers (G actin). Nucleates actin polymerization by assembling three actin monomers in cross-filament orientation and thereby promotes growth of actin filaments at the barbed end. Can also mediate actin depolymerization at barbed ends and severing of actin filaments. Promotes formation of cell ruffles. {ECO:0000250, ECO:0000269|PubMed:21816349}. |
O75128 | COBL | S321 | ochoa | Protein cordon-bleu | Plays an important role in the reorganization of the actin cytoskeleton. Regulates neuron morphogenesis and increases branching of axons and dendrites. Regulates dendrite branching in Purkinje cells (By similarity). Binds to and sequesters actin monomers (G actin). Nucleates actin polymerization by assembling three actin monomers in cross-filament orientation and thereby promotes growth of actin filaments at the barbed end. Can also mediate actin depolymerization at barbed ends and severing of actin filaments. Promotes formation of cell ruffles. {ECO:0000250, ECO:0000269|PubMed:21816349}. |
O75128 | COBL | S324 | ochoa | Protein cordon-bleu | Plays an important role in the reorganization of the actin cytoskeleton. Regulates neuron morphogenesis and increases branching of axons and dendrites. Regulates dendrite branching in Purkinje cells (By similarity). Binds to and sequesters actin monomers (G actin). Nucleates actin polymerization by assembling three actin monomers in cross-filament orientation and thereby promotes growth of actin filaments at the barbed end. Can also mediate actin depolymerization at barbed ends and severing of actin filaments. Promotes formation of cell ruffles. {ECO:0000250, ECO:0000269|PubMed:21816349}. |
O75970 | MPDZ | S1283 | ochoa | Multiple PDZ domain protein (Multi-PDZ domain protein 1) | Member of the NMDAR signaling complex that may play a role in control of AMPAR potentiation and synaptic plasticity in excitatory synapses (PubMed:11150294, PubMed:15312654). Promotes clustering of HT2RC at the cell surface (By similarity). {ECO:0000250|UniProtKB:O55164, ECO:0000269|PubMed:11150294, ECO:0000269|PubMed:15312654}. |
O94823 | ATP10B | S1371 | ochoa | Phospholipid-transporting ATPase VB (EC 7.6.2.1) (ATPase class V type 10B) (P4-ATPase flippase complex alpha subunit ATP10B) | Catalytic component of a P4-ATPase flippase complex, which catalyzes the hydrolysis of ATP coupled to the transport of glucosylceramide (GlcCer) from the outer to the inner leaflet of lysosome membranes. Plays an important role in the maintenance of lysosome membrane integrity and function in cortical neurons. {ECO:0000269|PubMed:32172343}. |
O94973 | AP2A2 | S658 | ochoa | AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9) (HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit) | Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. During long-term potentiation in hippocampal neurons, AP-2 is responsible for the endocytosis of ADAM10 (PubMed:23676497). The AP-2 alpha subunit binds polyphosphoinositide-containing lipids, positioning AP-2 on the membrane. The AP-2 alpha subunit acts via its C-terminal appendage domain as a scaffolding platform for endocytic accessory proteins. The AP-2 alpha and AP-2 sigma subunits are thought to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif (By similarity). {ECO:0000250, ECO:0000269|PubMed:12960147, ECO:0000269|PubMed:14745134, ECO:0000269|PubMed:15473838, ECO:0000269|PubMed:19033387, ECO:0000269|PubMed:23676497}. |
O95104 | SCAF4 | S139 | ochoa | SR-related and CTD-associated factor 4 (CTD-binding SR-like protein RA4) (Splicing factor, arginine/serine-rich 15) | Anti-terminator protein required to prevent early mRNA termination during transcription (PubMed:31104839). Together with SCAF8, acts by suppressing the use of early, alternative poly(A) sites, thereby preventing the accumulation of non-functional truncated proteins (PubMed:31104839). Mechanistically, associates with the phosphorylated C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit (POLR2A), and subsequently binds nascent RNA upstream of early polyadenylation sites to prevent premature mRNA transcript cleavage and polyadenylation (PubMed:31104839). Independently of SCAF8, also acts as a suppressor of transcriptional readthrough (PubMed:31104839). {ECO:0000269|PubMed:31104839}. |
O95359 | TACC2 | S1949 | ochoa | Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1) | Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). May play a role in organizing centrosomal microtubules. May act as a tumor suppressor protein. May represent a tumor progression marker. {ECO:0000250, ECO:0000269|PubMed:10749935}. |
O95835 | LATS1 | S221 | ochoa | Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts) | Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:10518011, PubMed:10831611, PubMed:18158288, PubMed:26437443, PubMed:28068668). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:18158288, PubMed:26437443, PubMed:28068668). Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:18158288, PubMed:26437443, PubMed:28068668). Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint (PubMed:15122335, PubMed:19927127). Negatively regulates G2/M transition by down-regulating CDK1 kinase activity (PubMed:9988268). Involved in the control of p53 expression (PubMed:15122335). Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1 (PubMed:15220930). May also play a role in endocrine function. Plays a role in mammary gland epithelial cell differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 (PubMed:28068668). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:10831611, ECO:0000269|PubMed:15122335, ECO:0000269|PubMed:15220930, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:28068668, ECO:0000269|PubMed:39173637, ECO:0000269|PubMed:9988268}. |
O96013 | PAK4 | S267 | ochoa | Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) | Serine/threonine-protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell adhesion turnover, cell migration, growth, proliferation or cell survival (PubMed:26598620). Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Promotes kinase-independent stabilization of RHOU, thereby contributing to focal adhesion disassembly during cell migration (PubMed:26598620). {ECO:0000269|PubMed:11278822, ECO:0000269|PubMed:11313478, ECO:0000269|PubMed:14560027, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:20507994, ECO:0000269|PubMed:20631255, ECO:0000269|PubMed:20805321, ECO:0000269|PubMed:26598620, ECO:0000269|PubMed:26607847}. |
P08235 | NR3C2 | S459 | psp | Mineralocorticoid receptor (MR) (Nuclear receptor subfamily 3 group C member 2) | Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels. {ECO:0000269|PubMed:3037703}. |
P08621 | SNRNP70 | Y38 | ochoa | U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70) | Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome (PubMed:19325628, PubMed:25555158). SNRNP70 binds to the loop I region of U1-snRNA (PubMed:19325628, PubMed:2467746, PubMed:25555158). {ECO:0000269|PubMed:19325628, ECO:0000269|PubMed:2467746, ECO:0000269|PubMed:25555158}.; FUNCTION: [Isoform 3]: Truncated isoforms that lack the RRM domain cannot bind U1-snRNA. {ECO:0000269|PubMed:2467746}.; FUNCTION: [Isoform 4]: Truncated isoforms that lack the RRM domain cannot bind U1-snRNA. {ECO:0000269|PubMed:2467746}. |
P11137 | MAP2 | S1634 | ochoa | Microtubule-associated protein 2 (MAP-2) | The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules. |
P13631 | RARG | S390 | psp | Retinoic acid receptor gamma (RAR-gamma) (Nuclear receptor subfamily 1 group B member 3) | Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, acts mainly as an activator of gene expression due to weak binding to corepressors. Required for limb bud development. In concert with RARA or RARB, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). {ECO:0000250}. |
P16989 | YBX3 | S346 | ochoa | Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB) | Binds to the GM-CSF promoter. Seems to act as a repressor. Also binds to full-length mRNA and to short RNA sequences containing the consensus site 5'-UCCAUCA-3'. May have a role in translation repression (By similarity). {ECO:0000250}. |
P22681 | CBL | S668 | ochoa | E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL) | E3 ubiquitin-protein ligase that acts as a negative regulator of many signaling pathways by mediating ubiquitination of cell surface receptors (PubMed:10514377, PubMed:11896602, PubMed:14661060, PubMed:14739300, PubMed:15190072, PubMed:17509076, PubMed:18374639, PubMed:19689429, PubMed:21596750, PubMed:28381567). Accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome (PubMed:10514377, PubMed:14661060, PubMed:14739300, PubMed:17094949, PubMed:17509076, PubMed:17974561). Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, CSF1R, EPHA8 and KDR and mediates their ubiquitination to terminate signaling (PubMed:15190072, PubMed:18374639, PubMed:21596750). Recognizes membrane-bound HCK, SRC and other kinases of the SRC family and mediates their ubiquitination and degradation (PubMed:11896602). Ubiquitinates EGFR and SPRY2 (PubMed:17094949, PubMed:17974561). Ubiquitinates NECTIN1 following association between NECTIN1 and herpes simplex virus 1/HHV-1 envelope glycoprotein D, leading to NECTIN1 removal from cell surface (PubMed:28381567). Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis (PubMed:15190072, PubMed:18374639). Essential for osteoclastic bone resorption (PubMed:14739300). The 'Tyr-731' phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function (PubMed:14739300). May be functionally coupled with the E2 ubiquitin-protein ligase UB2D3. In association with CBLB, required for proper feedback inhibition of ciliary platelet-derived growth factor receptor-alpha (PDGFRA) signaling pathway via ubiquitination and internalization of PDGFRA (By similarity). {ECO:0000250|UniProtKB:P22682, ECO:0000269|PubMed:10514377, ECO:0000269|PubMed:11896602, ECO:0000269|PubMed:14661060, ECO:0000269|PubMed:14739300, ECO:0000269|PubMed:15190072, ECO:0000269|PubMed:17094949, ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:17974561, ECO:0000269|PubMed:18374639, ECO:0000269|PubMed:19689429, ECO:0000269|PubMed:21596750, ECO:0000269|PubMed:28381567}. |
P29536 | LMOD1 | S520 | ochoa | Leiomodin-1 (64 kDa autoantigen 1D) (64 kDa autoantigen 1D3) (64 kDa autoantigen D1) (Leiomodin, muscle form) (Smooth muscle leiomodin) (SM-Lmod) (Thyroid-associated ophthalmopathy autoantigen) | Required for proper contractility of visceral smooth muscle cells (PubMed:28292896). Mediates nucleation of actin filaments. {ECO:0000269|PubMed:26370058, ECO:0000269|PubMed:28292896}. |
P42684 | ABL2 | S969 | ochoa | Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) | Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 also acts as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Positively regulates chemokine-mediated T-cell migration, polarization, and homing to lymph nodes and immune-challenged tissues, potentially via activation of NEDD9/HEF1 and RAP1 (By similarity). {ECO:0000250|UniProtKB:Q4JIM5, ECO:0000269|PubMed:15735735, ECO:0000269|PubMed:15886098, ECO:0000269|PubMed:16678104, ECO:0000269|PubMed:17306540, ECO:0000269|PubMed:18945674}. |
P47974 | ZFP36L2 | S430 | ochoa | mRNA decay activator protein ZFP36L2 (Butyrate response factor 2) (EGF-response factor 2) (ERF-2) (TPA-induced sequence 11d) (Zinc finger protein 36, C3H1 type-like 2) (ZFP36-like 2) | Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (PubMed:14981510, PubMed:25106868, PubMed:34611029). Acts as a 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery (PubMed:25106868). Functions by recruiting the CCR4-NOT deadenylase complex and probably other components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs, and hence promotes ARE-mediated mRNA deadenylation and decay processes (PubMed:25106868). Binds to 3'-UTR ARE of numerous mRNAs (PubMed:14981510, PubMed:20506496, PubMed:25106868). Promotes ARE-containing mRNA decay of the low-density lipoprotein (LDL) receptor (LDLR) mRNA in response to phorbol 12-myristate 13-acetate (PMA) treatment in a p38 MAPK-dependent manner (PubMed:25106868). Positively regulates early adipogenesis by promoting ARE-mediated mRNA decay of immediate early genes (IEGs). Plays a role in mature peripheral neuron integrity by promoting ARE-containing mRNA decay of the transcriptional repressor REST mRNA. Plays a role in ovulation and oocyte meiotic maturation by promoting ARE-mediated mRNA decay of the luteinizing hormone receptor LHCGR mRNA. Acts as a negative regulator of erythroid cell differentiation: promotes glucocorticoid-induced self-renewal of erythroid cells by binding mRNAs that are induced or highly expressed during terminal erythroid differentiation and promotes their degradation, preventing erythroid cell differentiation. In association with ZFP36L1 maintains quiescence on developing B lymphocytes by promoting ARE-mediated decay of several mRNAs encoding cell cycle regulators that help B cells progress through the cell cycle, and hence ensuring accurate variable-diversity-joining (VDJ) recombination process and functional immune cell formation. Together with ZFP36L1 is also necessary for thymocyte development and prevention of T-cell acute lymphoblastic leukemia (T-ALL) transformation by promoting ARE-mediated mRNA decay of the oncogenic transcription factor NOTCH1 mRNA. {ECO:0000250|UniProtKB:P23949, ECO:0000269|PubMed:14981510, ECO:0000269|PubMed:20506496, ECO:0000269|PubMed:25106868, ECO:0000269|PubMed:34611029}. |
P48634 | PRRC2A | S1691 | ochoa | Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2) | May play a role in the regulation of pre-mRNA splicing. {ECO:0000269|PubMed:14667819}. |
P49418 | AMPH | S285 | ochoa|psp | Amphiphysin | May participate in mechanisms of regulated exocytosis in synapses and certain endocrine cell types. May control the properties of the membrane associated cytoskeleton. |
P49848 | TAF6 | S639 | ochoa | Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80) | The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription (PubMed:33795473). TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) (PubMed:33795473). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (PubMed:33795473). The TFIID complex structure can be divided into 3 modules TFIID-A, TFIID-B, and TFIID-C (PubMed:33795473). TAF6 homodimer connects TFIID modules, forming a rigid core (PubMed:33795473). {ECO:0000269|PubMed:33795473}.; FUNCTION: [Isoform 4]: Transcriptional regulator which acts primarily as a positive regulator of transcription (PubMed:20096117, PubMed:29358700). Recruited to the promoters of a number of genes including GADD45A and CDKN1A/p21, leading to transcriptional up-regulation and subsequent induction of apoptosis (PubMed:11583621). Also up-regulates expression of other genes including GCNA/ACRC, HES1 and IFFO1 (PubMed:18628956). In contrast, down-regulates transcription of MDM2 (PubMed:11583621). Acts as a transcriptional coactivator to enhance transcription of TP53/p53-responsive genes such as DUSP1 (PubMed:20096117). Can also activate transcription and apoptosis independently of TP53 (PubMed:18628956). Drives apoptosis via the intrinsic apoptotic pathway by up-regulating apoptosis effectors such as BCL2L11/BIM and PMAIP1/NOXA (PubMed:29358700). {ECO:0000269|PubMed:11583621, ECO:0000269|PubMed:18628956, ECO:0000269|PubMed:20096117, ECO:0000269|PubMed:29358700}. |
P50570 | DNM2 | S761 | ochoa | Dynamin-2 (EC 3.6.5.5) (Dynamin 2) (Dynamin II) | Catalyzes the hydrolysis of GTP and utilizes this energy to mediate vesicle scission at plasma membrane during endocytosis and filament remodeling at many actin structures during organization of the actin cytoskeleton (PubMed:15731758, PubMed:19605363, PubMed:19623537, PubMed:33713620, PubMed:34744632). Plays an important role in vesicular trafficking processes, namely clathrin-mediated endocytosis (CME), exocytic and clathrin-coated vesicle from the trans-Golgi network, and PDGF stimulated macropinocytosis (PubMed:15731758, PubMed:19623537, PubMed:33713620). During vesicular trafficking process, associates to the membrane, through lipid binding, and self-assembles into ring-like structure through oligomerization to form a helical polymer around the vesicle membrane and leading to vesicle scission (PubMed:17636067, PubMed:34744632, PubMed:36445308). Plays a role in organization of the actin cytoskeleton by mediating arrangement of stress fibers and actin bundles in podocytes (By similarity). During organization of the actin cytoskeleton, self-assembles into ring-like structure that directly bundles actin filaments to form typical membrane tubules decorated with dynamin spiral polymers (By similarity). Self-assembly increases GTPase activity and the GTP hydrolysis causes the rapid depolymerization of dynamin spiral polymers, and results in dispersion of actin bundles (By similarity). Remodels, through its interaction with CTTN, bundled actin filaments in a GTPase-dependent manner and plays a role in orchestrating the global actomyosin cytoskeleton (PubMed:19605363). The interaction with CTTN stabilizes the interaction of DNM2 and actin filaments and stimulates the intrinsic GTPase activity that results in actin filament-barbed ends and increases the sensitivity of filaments in bundles to the actin depolymerizing factor, CFL1 (By similarity). Plays a role in the autophagy process, by participating in the formation of ATG9A vesicles destined for the autophagosomes through its interaction with SNX18 (PubMed:29437695), by mediating recycling endosome scission leading to autophagosome release through MAP1LC3B interaction (PubMed:29437695, PubMed:32315611). Also regulates maturation of apoptotic cell corpse-containing phagosomes by recruiting PIK3C3 to the phagosome membrane (By similarity). Also plays a role in cytokinesis (By similarity). May participate in centrosome cohesion through its interaction with TUBG1 (By similarity). Plays a role in the regulation of neuron morphology, axon growth and formation of neuronal growth cones (By similarity). Involved in membrane tubulation (PubMed:24135484). {ECO:0000250|UniProtKB:P39052, ECO:0000250|UniProtKB:P39054, ECO:0000269|PubMed:15731758, ECO:0000269|PubMed:17636067, ECO:0000269|PubMed:19605363, ECO:0000269|PubMed:19623537, ECO:0000269|PubMed:24135484, ECO:0000269|PubMed:29437695, ECO:0000269|PubMed:32315611, ECO:0000269|PubMed:33713620, ECO:0000269|PubMed:34744632, ECO:0000269|PubMed:36445308}. |
P50570 | DNM2 | S762 | ochoa | Dynamin-2 (EC 3.6.5.5) (Dynamin 2) (Dynamin II) | Catalyzes the hydrolysis of GTP and utilizes this energy to mediate vesicle scission at plasma membrane during endocytosis and filament remodeling at many actin structures during organization of the actin cytoskeleton (PubMed:15731758, PubMed:19605363, PubMed:19623537, PubMed:33713620, PubMed:34744632). Plays an important role in vesicular trafficking processes, namely clathrin-mediated endocytosis (CME), exocytic and clathrin-coated vesicle from the trans-Golgi network, and PDGF stimulated macropinocytosis (PubMed:15731758, PubMed:19623537, PubMed:33713620). During vesicular trafficking process, associates to the membrane, through lipid binding, and self-assembles into ring-like structure through oligomerization to form a helical polymer around the vesicle membrane and leading to vesicle scission (PubMed:17636067, PubMed:34744632, PubMed:36445308). Plays a role in organization of the actin cytoskeleton by mediating arrangement of stress fibers and actin bundles in podocytes (By similarity). During organization of the actin cytoskeleton, self-assembles into ring-like structure that directly bundles actin filaments to form typical membrane tubules decorated with dynamin spiral polymers (By similarity). Self-assembly increases GTPase activity and the GTP hydrolysis causes the rapid depolymerization of dynamin spiral polymers, and results in dispersion of actin bundles (By similarity). Remodels, through its interaction with CTTN, bundled actin filaments in a GTPase-dependent manner and plays a role in orchestrating the global actomyosin cytoskeleton (PubMed:19605363). The interaction with CTTN stabilizes the interaction of DNM2 and actin filaments and stimulates the intrinsic GTPase activity that results in actin filament-barbed ends and increases the sensitivity of filaments in bundles to the actin depolymerizing factor, CFL1 (By similarity). Plays a role in the autophagy process, by participating in the formation of ATG9A vesicles destined for the autophagosomes through its interaction with SNX18 (PubMed:29437695), by mediating recycling endosome scission leading to autophagosome release through MAP1LC3B interaction (PubMed:29437695, PubMed:32315611). Also regulates maturation of apoptotic cell corpse-containing phagosomes by recruiting PIK3C3 to the phagosome membrane (By similarity). Also plays a role in cytokinesis (By similarity). May participate in centrosome cohesion through its interaction with TUBG1 (By similarity). Plays a role in the regulation of neuron morphology, axon growth and formation of neuronal growth cones (By similarity). Involved in membrane tubulation (PubMed:24135484). {ECO:0000250|UniProtKB:P39052, ECO:0000250|UniProtKB:P39054, ECO:0000269|PubMed:15731758, ECO:0000269|PubMed:17636067, ECO:0000269|PubMed:19605363, ECO:0000269|PubMed:19623537, ECO:0000269|PubMed:24135484, ECO:0000269|PubMed:29437695, ECO:0000269|PubMed:32315611, ECO:0000269|PubMed:33713620, ECO:0000269|PubMed:34744632, ECO:0000269|PubMed:36445308}. |
P51532 | SMARCA4 | S297 | ochoa | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 (SMARCA4) (EC 3.6.4.-) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (Transcription activator BRG1) | ATPase involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:15075294, PubMed:29374058, PubMed:30339381, PubMed:32459350). Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating the calcium-dependent release of a repressor complex and the recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by SMARCA4-dependent recruitment of a phospho-RB1-HDAC repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves the release of HDAC1 and recruitment of CREBBP (By similarity). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development, a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. SMARCA4/BAF190A may promote neural stem cell self-renewal/proliferation by enhancing Notch-dependent proliferative signals, while concurrently making the neural stem cell insensitive to SHH-dependent differentiating cues (By similarity). Acts as a corepressor of ZEB1 to regulate E-cadherin transcription and is required for induction of epithelial-mesenchymal transition (EMT) by ZEB1 (PubMed:20418909). Binds via DLX1 to enhancers located in the intergenic region between DLX5 and DLX6 and this binding is stabilized by the long non-coding RNA (lncRNA) Evf2 (By similarity). Binds to RNA in a promiscuous manner (By similarity). In brown adipose tissue, involved in the regulation of thermogenic genes expression (By similarity). {ECO:0000250|UniProtKB:Q3TKT4, ECO:0000250|UniProtKB:Q8K1P7, ECO:0000269|PubMed:15075294, ECO:0000269|PubMed:19571879, ECO:0000269|PubMed:20418909, ECO:0000269|PubMed:29374058, ECO:0000269|PubMed:30339381, ECO:0000269|PubMed:32459350, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
P78325 | ADAM8 | Y766 | ochoa | Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a) | Possible involvement in extravasation of leukocytes. |
P78363 | ABCA4 | S1317 | psp | Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM proteinv) (RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein) | Flippase that catalyzes in an ATP-dependent manner the transport of retinal-phosphatidylethanolamine conjugates like 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (N-Ret-PE) from the lumen to the cytoplasmic leaflet of photoreceptor outer segment disk membranes, where 11-cis-retinylidene-phosphatidylethanolamine is then isomerized to its all-trans isomer and reduced by RDH8 to produce all-trans-retinol. This transport activity ensures that all-trans-retinal generated from photoexcitation and 11-cis-retinal not needed for the regeneration of rhodopsin and cone opsins are effectively cleared from the photoreceptors, therefore preventing their accumulation and the formation of toxic bisretinoid (PubMed:10075733, PubMed:20404325, PubMed:22735453, PubMed:23144455, PubMed:24097981, PubMed:29847635, PubMed:33375396). Displays ATPase activity in vitro in absence of retinal substrate (PubMed:33605212, PubMed:39128720, PubMed:29847635, PubMed:33375396). May display GTPase activity that is strongly influenced by the lipid environment and the presence of retinoid compounds (PubMed:22735453). Binds the unprotonated form of N-retinylidene-phosphatidylethanolamine with high affinity in the absence of ATP, and ATP binding and hydrolysis induce a protein conformational change that causes N-retinylidene-phosphatidylethanolamine release (By similarity). {ECO:0000250|UniProtKB:F1MWM0, ECO:0000269|PubMed:10075733, ECO:0000269|PubMed:20404325, ECO:0000269|PubMed:22735453, ECO:0000269|PubMed:23144455, ECO:0000269|PubMed:24097981, ECO:0000269|PubMed:29847635, ECO:0000269|PubMed:33375396, ECO:0000269|PubMed:33605212, ECO:0000269|PubMed:39128720}. |
P78559 | MAP1A | S2424 | ochoa | Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2] | Structural protein involved in the filamentous cross-bridging between microtubules and other skeletal elements. |
P81408 | ENTREP3 | S464 | ochoa | Protein ENTREP3 (Endosomal transmembrane epsin interactor 3) (Protein COTE1) | None |
P81408 | ENTREP3 | S467 | ochoa | Protein ENTREP3 (Endosomal transmembrane epsin interactor 3) (Protein COTE1) | None |
Q02750 | MAP2K1 | S304 | ochoa | Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) | Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. {ECO:0000269|PubMed:14737111, ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:29433126}. |
Q05209 | PTPN12 | S372 | ochoa | Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1) | Dephosphorylates a range of proteins, and thereby regulates cellular signaling cascades (PubMed:18559503). Dephosphorylates cellular tyrosine kinases, such as ERBB2 and PTK2B/PYK2, and thereby regulates signaling via ERBB2 and PTK2B/PYK2 (PubMed:17329398, PubMed:27134172). Selectively dephosphorylates ERBB2 phosphorylated at 'Tyr-1112', 'Tyr-1196', and/or 'Tyr-1248' (PubMed:27134172). {ECO:0000269|PubMed:17329398, ECO:0000269|PubMed:18559503, ECO:0000269|PubMed:27134172}. |
Q05397 | PTK2 | S893 | ochoa | Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) | Non-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuronal cell migration, axon branching and synapse formation; required for normal development of the nervous system. Plays a role in osteogenesis and differentiation of osteoblasts. Functions in integrin signal transduction, but also in signaling downstream of numerous growth factor receptors, G-protein coupled receptors (GPCR), EPHA2, netrin receptors and LDL receptors. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade. Promotes activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling cascade. Promotes localized and transient activation of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), and thereby modulates the activity of Rho family GTPases. Signaling via CAS family members mediates activation of RAC1. Phosphorylates NEDD9 following integrin stimulation (PubMed:9360983). Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ACTN1, ARHGEF7, GRB7, RET and WASL. Promotes phosphorylation of PXN and STAT1; most likely PXN and STAT1 are phosphorylated by a SRC family kinase that is recruited to autophosphorylated PTK2/FAK1, rather than by PTK2/FAK1 itself. Promotes phosphorylation of BCAR1; GIT2 and SHC1; this requires both SRC and PTK2/FAK1. Promotes phosphorylation of BMX and PIK3R1. Isoform 6 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription. {ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:11980671, ECO:0000269|PubMed:15166238, ECO:0000269|PubMed:15561106, ECO:0000269|PubMed:15895076, ECO:0000269|PubMed:16919435, ECO:0000269|PubMed:16927379, ECO:0000269|PubMed:17395594, ECO:0000269|PubMed:17431114, ECO:0000269|PubMed:17968709, ECO:0000269|PubMed:18006843, ECO:0000269|PubMed:18206965, ECO:0000269|PubMed:18256281, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:18497331, ECO:0000269|PubMed:18677107, ECO:0000269|PubMed:19138410, ECO:0000269|PubMed:19147981, ECO:0000269|PubMed:19224453, ECO:0000269|PubMed:20332118, ECO:0000269|PubMed:20495381, ECO:0000269|PubMed:21454698, ECO:0000269|PubMed:9360983}.; FUNCTION: [Isoform 6]: Isoform 6 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription. {ECO:0000269|PubMed:20109444}. |
Q07889 | SOS1 | S1167 | ochoa|psp | Son of sevenless homolog 1 (SOS-1) | Promotes the exchange of Ras-bound GDP by GTP (PubMed:8493579). Probably by promoting Ras activation, regulates phosphorylation of MAP kinase MAPK3/ERK1 in response to EGF (PubMed:17339331). Catalytic component of a trimeric complex that participates in transduction of signals from Ras to Rac by promoting the Rac-specific guanine nucleotide exchange factor (GEF) activity (By similarity). {ECO:0000250|UniProtKB:Q62245, ECO:0000269|PubMed:17339331, ECO:0000269|PubMed:8493579}. |
Q07889 | SOS1 | S1193 | psp | Son of sevenless homolog 1 (SOS-1) | Promotes the exchange of Ras-bound GDP by GTP (PubMed:8493579). Probably by promoting Ras activation, regulates phosphorylation of MAP kinase MAPK3/ERK1 in response to EGF (PubMed:17339331). Catalytic component of a trimeric complex that participates in transduction of signals from Ras to Rac by promoting the Rac-specific guanine nucleotide exchange factor (GEF) activity (By similarity). {ECO:0000250|UniProtKB:Q62245, ECO:0000269|PubMed:17339331, ECO:0000269|PubMed:8493579}. |
Q07889 | SOS1 | S1275 | ochoa | Son of sevenless homolog 1 (SOS-1) | Promotes the exchange of Ras-bound GDP by GTP (PubMed:8493579). Probably by promoting Ras activation, regulates phosphorylation of MAP kinase MAPK3/ERK1 in response to EGF (PubMed:17339331). Catalytic component of a trimeric complex that participates in transduction of signals from Ras to Rac by promoting the Rac-specific guanine nucleotide exchange factor (GEF) activity (By similarity). {ECO:0000250|UniProtKB:Q62245, ECO:0000269|PubMed:17339331, ECO:0000269|PubMed:8493579}. |
Q08345 | DDR1 | Y513 | ochoa|psp | Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a) | Tyrosine kinase that functions as a cell surface receptor for fibrillar collagen and regulates cell attachment to the extracellular matrix, remodeling of the extracellular matrix, cell migration, differentiation, survival and cell proliferation. Collagen binding triggers a signaling pathway that involves SRC and leads to the activation of MAP kinases. Regulates remodeling of the extracellular matrix by up-regulation of the matrix metalloproteinases MMP2, MMP7 and MMP9, and thereby facilitates cell migration and wound healing. Required for normal blastocyst implantation during pregnancy, for normal mammary gland differentiation and normal lactation. Required for normal ear morphology and normal hearing (By similarity). Promotes smooth muscle cell migration, and thereby contributes to arterial wound healing. Also plays a role in tumor cell invasion. Phosphorylates PTPN11. {ECO:0000250, ECO:0000269|PubMed:12065315, ECO:0000269|PubMed:16234985, ECO:0000269|PubMed:16337946, ECO:0000269|PubMed:19401332, ECO:0000269|PubMed:20093046, ECO:0000269|PubMed:20432435, ECO:0000269|PubMed:20884741, ECO:0000269|PubMed:21044884, ECO:0000269|PubMed:9659899}. |
Q0JRZ9 | FCHO2 | S478 | ochoa | F-BAR domain only protein 2 | Functions in an early step of clathrin-mediated endocytosis. Has both a membrane binding/bending activity and the ability to recruit proteins essential to the formation of functional clathrin-coated pits. Has a lipid-binding activity with a preference for membranes enriched in phosphatidylserine and phosphoinositides (Pi(4,5) biphosphate) like the plasma membrane. Its membrane-bending activity might be important for the subsequent action of clathrin and adaptors in the formation of clathrin-coated vesicles. Involved in adaptor protein complex AP-2-dependent endocytosis of the transferrin receptor, it also functions in the AP-2-independent endocytosis of the LDL receptor. {ECO:0000269|PubMed:17540576, ECO:0000269|PubMed:20448150, ECO:0000269|PubMed:21762413, ECO:0000269|PubMed:22323290}. |
Q12774 | ARHGEF5 | Y836 | ochoa | Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM) | Guanine nucleotide exchange factor which activates Rho GTPases (PubMed:15601624). Strongly activates RHOA (PubMed:15601624). Also strongly activates RHOB, weakly activates RHOC and RHOG and shows no effect on RHOD, RHOV, RHOQ or RAC1 (By similarity). Involved in regulation of cell shape and actin cytoskeletal organization (PubMed:15601624). Plays a role in actin organization by generating a loss of actin stress fibers and the formation of membrane ruffles and filopodia (PubMed:14662653). Required for SRC-induced podosome formation (By similarity). Involved in positive regulation of immature dendritic cell migration (By similarity). {ECO:0000250|UniProtKB:E9Q7D5, ECO:0000269|PubMed:14662653, ECO:0000269|PubMed:15601624}. |
Q12888 | TP53BP1 | S1037 | ochoa | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q12929 | EPS8 | T605 | ochoa | Epidermal growth factor receptor kinase substrate 8 | Signaling adapter that controls various cellular protrusions by regulating actin cytoskeleton dynamics and architecture. Depending on its association with other signal transducers, can regulate different processes. Together with SOS1 and ABI1, forms a trimeric complex that participates in transduction of signals from Ras to Rac by activating the Rac-specific guanine nucleotide exchange factor (GEF) activity. Acts as a direct regulator of actin dynamics by binding actin filaments and has both barbed-end actin filament capping and actin bundling activities depending on the context. Displays barbed-end actin capping activity when associated with ABI1, thereby regulating actin-based motility process: capping activity is auto-inhibited and inhibition is relieved upon ABI1 interaction. Also shows actin bundling activity when associated with BAIAP2, enhancing BAIAP2-dependent membrane extensions and promoting filopodial protrusions. Involved in the regulation of processes such as axonal filopodia growth, stereocilia length, dendritic cell migration and cancer cell migration and invasion. Acts as a regulator of axonal filopodia formation in neurons: in the absence of neurotrophic factors, negatively regulates axonal filopodia formation via actin-capping activity. In contrast, it is phosphorylated in the presence of BDNF leading to inhibition of its actin-capping activity and stimulation of filopodia formation. Component of a complex with WHRN and MYO15A that localizes at stereocilia tips and is required for elongation of the stereocilia actin core. Indirectly involved in cell cycle progression; its degradation following ubiquitination being required during G2 phase to promote cell shape changes. {ECO:0000269|PubMed:15558031, ECO:0000269|PubMed:17115031}. |
Q13164 | MAPK7 | S421 | psp | Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5) | Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of STUB1-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction. {ECO:0000250|UniProtKB:P0C865, ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:11278431, ECO:0000269|PubMed:22869143, ECO:0000269|PubMed:9384584, ECO:0000269|PubMed:9790194}. |
Q13191 | CBLB | S886 | ochoa | E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B) | E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. Negatively regulates TCR (T-cell receptor), BCR (B-cell receptor) and FCER1 (high affinity immunoglobulin epsilon receptor) signal transduction pathways. In naive T-cells, inhibits VAV1 activation upon TCR engagement and imposes a requirement for CD28 costimulation for proliferation and IL-2 production. Also acts by promoting PIK3R1/p85 ubiquitination, which impairs its recruitment to the TCR and subsequent activation. In activated T-cells, inhibits PLCG1 activation and calcium mobilization upon restimulation and promotes anergy. In B-cells, acts by ubiquitinating SYK and promoting its proteasomal degradation. Slightly promotes SRC ubiquitination. May be involved in EGFR ubiquitination and internalization. May be functionally coupled with the E2 ubiquitin-protein ligase UB2D3. In association with CBL, required for proper feedback inhibition of ciliary platelet-derived growth factor receptor-alpha (PDGFRA) signaling pathway via ubiquitination and internalization of PDGFRA (By similarity). {ECO:0000250|UniProtKB:Q3TTA7, ECO:0000269|PubMed:10022120, ECO:0000269|PubMed:10086340, ECO:0000269|PubMed:11087752, ECO:0000269|PubMed:11526404, ECO:0000269|PubMed:14661060, ECO:0000269|PubMed:20525694}. |
Q13573 | SNW1 | S190 | ochoa | SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein) | Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:28076346, PubMed:28502770). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Required for the specific splicing of CDKN1A pre-mRNA; the function probably involves the recruitment of U2AF2 to the mRNA. May recruit PPIL1 to the spliceosome. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in transcriptional regulation. Modulates TGF-beta-mediated transcription via association with SMAD proteins, MYOD1-mediated transcription via association with PABPN1, RB1-mediated transcriptional repression, and retinoid-X receptor (RXR)- and vitamin D receptor (VDR)-dependent gene transcription in a cell line-specific manner probably involving coactivators NCOA1 and GRIP1. Is involved in NOTCH1-mediated transcriptional activation. Binds to multimerized forms of Notch intracellular domain (NICD) and is proposed to recruit transcriptional coactivators such as MAML1 to form an intermediate preactivation complex which associates with DNA-bound CBF-1/RBPJ to form a transcriptional activation complex by releasing SNW1 and redundant NOTCH1 NICD. {ECO:0000269|PubMed:10644367, ECO:0000269|PubMed:11278756, ECO:0000269|PubMed:11371506, ECO:0000269|PubMed:11514567, ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12840015, ECO:0000269|PubMed:14985122, ECO:0000269|PubMed:15194481, ECO:0000269|PubMed:15905409, ECO:0000269|PubMed:18794151, ECO:0000269|PubMed:19818711, ECO:0000269|PubMed:21245387, ECO:0000269|PubMed:21460037, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:9632709, ECO:0000305|PubMed:33509932}.; FUNCTION: (Microbial infection) Is recruited by HIV-1 Tat to Tat:P-TEFb:TAR RNA complexes and is involved in Tat transcription by recruitment of MYC, MEN1 and TRRAP to the HIV promoter. {ECO:0000269|PubMed:15905409, ECO:0000269|PubMed:19818711}.; FUNCTION: (Microbial infection) Proposed to be involved in transcriptional activation by EBV EBNA2 of CBF-1/RBPJ-repressed promoters. {ECO:0000269|PubMed:10644367}. |
Q14185 | DOCK1 | Y1811 | ochoa | Dedicator of cytokinesis protein 1 (180 kDa protein downstream of CRK) (DOCK180) | Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Along with DOCK1, mediates CRK/CRKL regulation of epithelial and endothelial cell spreading and migration on type IV collagen (PubMed:19004829). Functions as a guanine nucleotide exchange factor (GEF), which activates Rac Rho small GTPases by exchanging bound GDP for free GTP. Its GEF activity may be enhanced by ELMO1 (PubMed:8657152). {ECO:0000269|PubMed:19004829, ECO:0000269|PubMed:8657152}. |
Q14934 | NFATC4 | S281 | ochoa|psp | Nuclear factor of activated T-cells, cytoplasmic 4 (NF-ATc4) (NFATc4) (T-cell transcription factor NFAT3) (NF-AT3) | Ca(2+)-regulated transcription factor that is involved in several processes, including the development and function of the immune, cardiovascular, musculoskeletal, and nervous systems (PubMed:11514544, PubMed:11997522, PubMed:17213202, PubMed:17875713, PubMed:18668201, PubMed:25663301, PubMed:7749981). Involved in T-cell activation, stimulating the transcription of cytokine genes, including that of IL2 and IL4 (PubMed:18347059, PubMed:18668201, PubMed:7749981). Along with NFATC3, involved in embryonic heart development. Following JAK/STAT signaling activation and as part of a complex with NFATC3 and STAT3, binds to the alpha-beta E4 promoter region of CRYAB and activates transcription in cardiomyocytes (By similarity). Involved in mitochondrial energy metabolism required for cardiac morphogenesis and function (By similarity). Transactivates many genes involved in the cardiovascular system, including AGTR2, NPPB/BNP (in synergy with GATA4), NPPA/ANP/ANF and MYH7/beta-MHC (By similarity). Involved in the regulation of adult hippocampal neurogenesis. Involved in BDNF-driven pro-survival signaling in hippocampal adult-born neurons. Involved in the formation of long-term spatial memory and long-term potentiation (By similarity). In cochlear nucleus neurons, may play a role in deafferentation-induced apoptosis during the developmental critical period, when auditory neurons depend on afferent input for survival (By similarity). Binds to and activates the BACE1/Beta-secretase 1 promoter, hence may regulate the proteolytic processing of the amyloid precursor protein (APP) (PubMed:25663301). Plays a role in adipocyte differentiation (PubMed:11997522). May be involved in myoblast differentiation into myotubes (PubMed:17213202). Binds the consensus DNA sequence 5'-GGAAAAT-3' (Probable). In the presence of CREBBP, activates TNF transcription (PubMed:11514544). Binds to PPARG gene promoter and regulates its activity (PubMed:11997522). Binds to PPARG and REG3G gene promoters (By similarity). {ECO:0000250|UniProtKB:D3Z9H7, ECO:0000250|UniProtKB:Q8K120, ECO:0000269|PubMed:11514544, ECO:0000269|PubMed:11997522, ECO:0000269|PubMed:17213202, ECO:0000269|PubMed:17875713, ECO:0000269|PubMed:18347059, ECO:0000269|PubMed:18668201, ECO:0000269|PubMed:25663301, ECO:0000269|PubMed:7749981, ECO:0000305}. |
Q15459 | SF3A1 | S28 | ochoa | Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114) | Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:10882114, PubMed:11533230, PubMed:32494006). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:10882114, PubMed:11533230, PubMed:32494006). Within the 17S U2 SnRNP complex, SF3A1 is part of the SF3A subcomplex that contributes to the assembly of the 17S U2 snRNP, and the subsequent assembly of the pre-spliceosome 'E' complex and the pre-catalytic spliceosome 'A' complex (PubMed:10882114, PubMed:11533230). Involved in pre-mRNA splicing as a component of pre-catalytic spliceosome 'B' complexes (PubMed:29360106, PubMed:30315277). {ECO:0000269|PubMed:10882114, ECO:0000269|PubMed:11533230, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:30315277, ECO:0000269|PubMed:32494006}. |
Q15643 | TRIP11 | S1859 | ochoa | Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230) | Is a membrane tether required for vesicle tethering to Golgi. Has an essential role in the maintenance of Golgi structure and function (PubMed:25473115, PubMed:30728324). It is required for efficient anterograde and retrograde trafficking in the early secretory pathway, functioning at both the ER-to-Golgi intermediate compartment (ERGIC) and Golgi complex (PubMed:25717001). Binds the ligand binding domain of the thyroid receptor (THRB) in the presence of triiodothyronine and enhances THRB-modulated transcription. {ECO:0000269|PubMed:10189370, ECO:0000269|PubMed:25473115, ECO:0000269|PubMed:25717001, ECO:0000269|PubMed:30728324, ECO:0000269|PubMed:9256431}. |
Q15648 | MED1 | S1042 | ochoa | Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A) | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors (PubMed:10406464, PubMed:11867769, PubMed:12037571, PubMed:12218053, PubMed:12556447, PubMed:14636573, PubMed:15340084, PubMed:15471764, PubMed:15989967, PubMed:16574658, PubMed:9653119). Acts as a coactivator for GATA1-mediated transcriptional activation during erythroid differentiation of K562 erythroleukemia cells (PubMed:24245781). {ECO:0000269|PubMed:10406464, ECO:0000269|PubMed:11867769, ECO:0000269|PubMed:12037571, ECO:0000269|PubMed:12218053, ECO:0000269|PubMed:12556447, ECO:0000269|PubMed:14636573, ECO:0000269|PubMed:15340084, ECO:0000269|PubMed:15471764, ECO:0000269|PubMed:15989967, ECO:0000269|PubMed:16574658, ECO:0000269|PubMed:24245781, ECO:0000269|PubMed:9653119}. |
Q15772 | SPEG | T2826 | ochoa | Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1) | Isoform 3 may have a role in regulating the growth and differentiation of arterial smooth muscle cells. |
Q15772 | SPEG | S2933 | ochoa | Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1) | Isoform 3 may have a role in regulating the growth and differentiation of arterial smooth muscle cells. |
Q16204 | CCDC6 | S413 | ochoa|psp | Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) | None |
Q16584 | MAP3K11 | S724 | psp | Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase) | Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}. |
Q16584 | MAP3K11 | S740 | ochoa | Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase) | Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}. |
Q16799 | RTN1 | S560 | ochoa | Reticulon-1 (Neuroendocrine-specific protein) | Inhibits amyloid precursor protein processing, probably by blocking BACE1 activity. {ECO:0000269|PubMed:15286784}. |
Q2M2I3 | FAM83E | S351 | ochoa | Protein FAM83E | May play a role in MAPK signaling. {ECO:0000303|PubMed:24736947}. |
Q2TAZ0 | ATG2A | S1309 | ochoa | Autophagy-related protein 2 homolog A | Lipid transfer protein involved in autophagosome assembly (PubMed:28561066, PubMed:30952800, PubMed:31271352). Tethers the edge of the isolation membrane (IM) to the endoplasmic reticulum (ER) and mediates direct lipid transfer from ER to IM for IM expansion (PubMed:30952800, PubMed:31271352). Binds to the ER exit site (ERES), which is the membrane source for autophagosome formation, and extracts phospholipids from the membrane source and transfers them to ATG9 (ATG9A or ATG9B) to the IM for membrane expansion (PubMed:30952800, PubMed:31271352). Lipid transfer activity is enhanced by WIPI1 and WDR45/WIPI4, which promote ATG2A-association with phosphatidylinositol 3-monophosphate (PI3P)-containing membranes (PubMed:31271352). Also regulates lipid droplets morphology and distribution within the cell (PubMed:22219374, PubMed:28561066). {ECO:0000269|PubMed:22219374, ECO:0000269|PubMed:28561066, ECO:0000269|PubMed:30952800, ECO:0000269|PubMed:31271352}. |
Q4KMP7 | TBC1D10B | S22 | ochoa | TBC1 domain family member 10B (Rab27A-GAP-beta) | Acts as a GTPase-activating protein for RAB3A, RAB22A, RAB27A, and RAB35. Does not act on RAB2A and RAB6A. {ECO:0000269|PubMed:16923811, ECO:0000269|PubMed:19077034}. |
Q4KMP7 | TBC1D10B | S661 | ochoa | TBC1 domain family member 10B (Rab27A-GAP-beta) | Acts as a GTPase-activating protein for RAB3A, RAB22A, RAB27A, and RAB35. Does not act on RAB2A and RAB6A. {ECO:0000269|PubMed:16923811, ECO:0000269|PubMed:19077034}. |
Q53ET0 | CRTC2 | S519 | ochoa | CREB-regulated transcription coactivator 2 (Transducer of regulated cAMP response element-binding protein 2) (TORC-2) (Transducer of CREB protein 2) | Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates gluconeogenesis as a component of the LKB1/AMPK/TORC2 signaling pathway. Regulates the expression of specific genes such as the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial biogenesis in muscle cells. Also coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR). {ECO:0000269|PubMed:14506290, ECO:0000269|PubMed:14536081, ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:16809310, ECO:0000269|PubMed:16817901, ECO:0000269|PubMed:16980408, ECO:0000269|PubMed:17210223}. |
Q53ET0 | CRTC2 | S520 | ochoa | CREB-regulated transcription coactivator 2 (Transducer of regulated cAMP response element-binding protein 2) (TORC-2) (Transducer of CREB protein 2) | Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates gluconeogenesis as a component of the LKB1/AMPK/TORC2 signaling pathway. Regulates the expression of specific genes such as the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial biogenesis in muscle cells. Also coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR). {ECO:0000269|PubMed:14506290, ECO:0000269|PubMed:14536081, ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:16809310, ECO:0000269|PubMed:16817901, ECO:0000269|PubMed:16980408, ECO:0000269|PubMed:17210223}. |
Q5JRA6 | MIA3 | S1670 | ochoa | Transport and Golgi organization protein 1 homolog (TANGO1) (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3) | Plays a role in the transport of cargos that are too large to fit into COPII-coated vesicles and require specific mechanisms to be incorporated into membrane-bound carriers and exported from the endoplasmic reticulum. This protein is required for collagen VII (COL7A1) secretion by loading COL7A1 into transport carriers. It may participate in cargo loading of COL7A1 at endoplasmic reticulum exit sites by binding to COPII coat subunits Sec23/24 and guiding SH3-bound COL7A1 into a growing carrier. Does not play a role in global protein secretion and is apparently specific to COL7A1 cargo loading. However, it may participate in secretion of other proteins in cells that do not secrete COL7A1. It is also specifically required for the secretion of lipoproteins by participating in their export from the endoplasmic reticulum (PubMed:19269366, PubMed:27138255). Required for correct assembly of COPII coat components at endoplasmic reticulum exit sites (ERES) and for the localization of SEC16A and membrane-bound ER-resident complexes consisting of MIA2 and PREB/SEC12 to ERES (PubMed:28442536). {ECO:0000269|PubMed:19269366, ECO:0000269|PubMed:27138255, ECO:0000269|PubMed:28442536}. |
Q5JSH3 | WDR44 | T228 | ochoa | WD repeat-containing protein 44 (Rab11-binding protein) (Rab11BP) (Rabphilin-11) | Downstream effector for Rab11 which regulates Rab11 intracellular membrane trafficking functions such as endocytic recycling, intracellular ciliogenesis and protein export (PubMed:31204173, PubMed:32344433). ATK1-mediated phosphorylation of WDR44 induces binding to Rab11 which activates endocytic recycling of transferrin receptor back to the plasma membrane (PubMed:31204173). When bound to Rab11, prevents the formation of the ciliogenic Rab11-Rabin8/RAB3IP-RAB11FIP3 complex, therefore inhibiting preciliary trafficking and ciliogenesis (PubMed:31204173). Participates in neo-synthesized protein export by connecting the endoplasmic reticulum (ER) with the endosomal tubule via direct interactions with the integral ER proteins VAPA or VAPB and the endosomal protein GRAFs (GRAF1/ARHGAP26 or GRAF2/ARHGAP10), which facilitates the transfer of proteins such as E-cadherin, MPP14 and CFTR into a Rab8-Rab10-Rab11-dependent export route (PubMed:32344433). {ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:32344433}. |
Q5SNT2 | TMEM201 | S561 | ochoa | Transmembrane protein 201 (Spindle-associated membrane protein 1) | Critical regulator of angiogenesis and endothelial cell (EC) migration (PubMed:35311970). Promotes the migration of endothelial cells, which is essential for angiogenesis (PubMed:35311970). Interacts with the linker of nucleoskeleton and cytoskeleton (LINC) complex, which plays a vital role in connecting the cell's cytoskeleton to the nuclear envelope (PubMed:35311970). This interaction is essential for maintaining cellular structure and facilitating the movement of endothelial cells, which is critical for proper vascular development (PubMed:35311970). Involved in nuclear movement during fibroblast polarization and migration (By similarity). Overexpression can recruit Ran GTPase to the nuclear periphery (PubMed:27541860). {ECO:0000250|UniProtKB:A2A8U2, ECO:0000269|PubMed:35311970, ECO:0000305|PubMed:27541860}.; FUNCTION: [Isoform 2]: May define a distinct membrane domain in the vicinity of the mitotic spindle (PubMed:19494128). Involved in the organization of the nuclear envelope implicating EMD, SUN1 and A-type lamina (PubMed:21610090). {ECO:0000269|PubMed:19494128, ECO:0000269|PubMed:21610090}. |
Q5T0Z8 | C6orf132 | S260 | ochoa | Uncharacterized protein C6orf132 | None |
Q5T5P2 | KIAA1217 | S1030 | ochoa | Sickle tail protein homolog | Required for normal development of intervertebral disks. {ECO:0000250|UniProtKB:A2AQ25}. |
Q5VV67 | PPRC1 | S841 | ochoa | Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC) | Acts as a coactivator during transcriptional activation of nuclear genes related to mitochondrial biogenesis and cell growth. Involved in the transcription coactivation of CREB and NRF1 target genes. {ECO:0000269|PubMed:11340167, ECO:0000269|PubMed:16908542}. |
Q5VWG9 | TAF3 | S667 | ochoa | Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit) (TAF(II)140) (TAF140) (TAFII-140) (TAFII140) | The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription (PubMed:33795473). TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) (PubMed:33795473). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (PubMed:33795473). The TFIID complex structure can be divided into 3 modules TFIID-A, TFIID-B, and TFIID-C (PubMed:33795473). TAF3 forms the TFIID-A module together with TAF5 and TBP (PubMed:33795473). Required in complex with TBPL2 for the differentiation of myoblasts into myocytes (PubMed:11438666). The TAF3-TBPL2 complex replaces TFIID at specific promoters at an early stage in the differentiation process (PubMed:11438666). {ECO:0000269|PubMed:11438666, ECO:0000269|PubMed:33795473}. |
Q5VZ89 | DENND4C | S1662 | ochoa | DENN domain-containing protein 4C | Guanine nucleotide exchange factor (GEF) activating RAB10. Promotes the exchange of GDP to GTP, converting inactive GDP-bound RAB10 into its active GTP-bound form. Thereby, stimulates SLC2A4/GLUT4 glucose transporter-enriched vesicles delivery to the plasma membrane in response to insulin. {ECO:0000269|PubMed:20937701}. |
Q63HR2 | TNS2 | S820 | ochoa | Tensin-2 (EC 3.1.3.48) (C1 domain-containing phosphatase and tensin homolog) (C1-TEN) (Tensin-like C1 domain-containing phosphatase) | Tyrosine-protein phosphatase which regulates cell motility, proliferation and muscle-response to insulin (PubMed:15817639, PubMed:23401856). Phosphatase activity is mediated by binding to phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3) via the SH2 domain (PubMed:30092354). In muscles and under catabolic conditions, dephosphorylates IRS1 leading to its degradation and muscle atrophy (PubMed:23401856, PubMed:30092354). Negatively regulates PI3K-AKT pathway activation (PubMed:15817639, PubMed:23401856, PubMed:30092354). Dephosphorylates nephrin NPHS1 in podocytes which regulates activity of the mTORC1 complex (PubMed:28955049). Under normal glucose conditions, NPHS1 outcompetes IRS1 for binding to phosphatidylinositol 3-kinase (PI3K) which balances mTORC1 activity but high glucose conditions lead to up-regulation of TNS2, increased NPHS1 dephosphorylation and activation of mTORC1, contributing to podocyte hypertrophy and proteinuria (PubMed:28955049). Required for correct podocyte morphology, podocyte-glomerular basement membrane interaction and integrity of the glomerular filtration barrier (By similarity). Enhances RHOA activation in the presence of DLC1 (PubMed:26427649). Plays a role in promoting DLC1-dependent remodeling of the extracellular matrix (PubMed:20069572). {ECO:0000250|UniProtKB:Q8CGB6, ECO:0000269|PubMed:15817639, ECO:0000269|PubMed:20069572, ECO:0000269|PubMed:23401856, ECO:0000269|PubMed:26427649, ECO:0000269|PubMed:28955049, ECO:0000269|PubMed:30092354}. |
Q68EM7 | ARHGAP17 | S560 | ochoa | Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) | Rho GTPase-activating protein involved in the maintenance of tight junction by regulating the activity of CDC42, thereby playing a central role in apical polarity of epithelial cells. Specifically acts as a GTPase activator for the CDC42 GTPase by converting it to an inactive GDP-bound state. The complex formed with AMOT acts by regulating the uptake of polarity proteins at tight junctions, possibly by deciding whether tight junction transmembrane proteins are recycled back to the plasma membrane or sent elsewhere. Participates in the Ca(2+)-dependent regulation of exocytosis, possibly by catalyzing GTPase activity of Rho family proteins and by inducing the reorganization of the cortical actin filaments. Acts as a GTPase activator in vitro for RAC1. {ECO:0000269|PubMed:11431473, ECO:0000269|PubMed:16678097}. |
Q6DN14 | MCTP1 | S198 | ochoa | Multiple C2 and transmembrane domain-containing protein 1 | Calcium sensor which is essential for the stabilization of normal baseline neurotransmitter release and for the induction and long-term maintenance of presynaptic homeostatic plasticity. {ECO:0000250|UniProtKB:A1ZBD6}. |
Q6IQ23 | PLEKHA7 | S907 | ochoa | Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7) | Required for zonula adherens biogenesis and maintenance (PubMed:19041755). Acts via its interaction with CAMSAP3, which anchors microtubules at their minus-ends to zonula adherens, leading to the recruitment of KIFC3 kinesin to the junctional site (PubMed:19041755). Mediates docking of ADAM10 to zonula adherens through a PDZD11-dependent interaction with the ADAM10-binding protein TSPAN33 (PubMed:30463011). {ECO:0000269|PubMed:19041755, ECO:0000269|PubMed:30463011}. |
Q6N022 | TENM4 | S196 | ochoa | Teneurin-4 (Ten-4) (Protein Odd Oz/ten-m homolog 4) (Tenascin-M4) (Ten-m4) (Teneurin transmembrane protein 4) | Involved in neural development, regulating the establishment of proper connectivity within the nervous system. Plays a role in the establishment of the anterior-posterior axis during gastrulation. Regulates the differentiation and cellular process formation of oligodendrocytes and myelination of small-diameter axons in the central nervous system (CNS) (PubMed:26188006). Promotes activation of focal adhesion kinase. May function as a cellular signal transducer (By similarity). {ECO:0000250|UniProtKB:Q3UHK6, ECO:0000269|PubMed:26188006}. |
Q6NTF9 | RHBDD2 | S276 | ochoa | Rhomboid domain-containing protein 2 | None |
Q6NUJ5 | PWWP2B | S84 | ochoa | PWWP domain-containing protein 2B | Chromatin-binding protein that acts as an adapter between distinct nucleosome components (H3K36me3 or H2A.Z) and chromatin-modifying complexes, contributing to the regulation of the levels of histone acetylation at actively transcribed genes (PubMed:30228260). Competes with CHD4 and MBD3 for interaction with MTA1 to form a NuRD subcomplex, preventing the formation of full NuRD complex (containing CHD4 and MBD3), leading to recruitment of HDACs to gene promoters resulting in turn in the deacetylation of nearby H3K27 and H2A.Z (PubMed:30228260). Plays a role in facilitating transcriptional elongation through regulation of histone acetylation (By similarity). Negatively regulates brown adipocyte thermogenesis by interacting with and stabilizing HDAC1 at the UCP1 gene promoter, thereby promoting histone deacetylation at the promoter leading to the repression of UCP1 expression (By similarity). {ECO:0000250|UniProtKB:Q69Z61, ECO:0000269|PubMed:30228260}. |
Q6P1L5 | FAM117B | S124 | ochoa | Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein) | None |
Q6P1L5 | FAM117B | S151 | ochoa | Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein) | None |
Q6P1L5 | FAM117B | S152 | ochoa | Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein) | None |
Q6PJG2 | MIDEAS | S636 | ochoa | Mitotic deacetylase-associated SANT domain protein (ELM2 and SANT domain-containing protein 1) | None |
Q6UUV7 | CRTC3 | S429 | ochoa | CREB-regulated transcription coactivator 3 (Transducer of regulated cAMP response element-binding protein 3) (TORC-3) (Transducer of CREB protein 3) | Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates the expression of specific CREB-activated genes such as the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial biogenesis in muscle cells. Also coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR). {ECO:0000269|PubMed:14506290, ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:15466468, ECO:0000269|PubMed:16817901, ECO:0000269|PubMed:16980408, ECO:0000269|PubMed:17210223, ECO:0000269|PubMed:17644518}. |
Q6ZRI6 | C15orf39 | S458 | ochoa | Uncharacterized protein C15orf39 | None |
Q6ZRS2 | SRCAP | S1859 | ochoa | Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator) | Catalytic component of the SRCAP complex which mediates the ATP-dependent exchange of histone H2AZ/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling. Acts as a coactivator for CREB-mediated transcription, steroid receptor-mediated transcription, and Notch-mediated transcription. {ECO:0000269|PubMed:10347196, ECO:0000269|PubMed:11522779, ECO:0000269|PubMed:14500758, ECO:0000269|PubMed:16024792, ECO:0000269|PubMed:16634648, ECO:0000269|PubMed:17617668}. |
Q6ZU65 | UBN2 | S78 | ochoa | Ubinuclein-2 | None |
Q70E73 | RAPH1 | S610 | ochoa | Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1) | Mediator of localized membrane signals. Implicated in the regulation of lamellipodial dynamics. Negatively regulates cell adhesion. |
Q70E73 | RAPH1 | S853 | ochoa | Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1) | Mediator of localized membrane signals. Implicated in the regulation of lamellipodial dynamics. Negatively regulates cell adhesion. |
Q70E73 | RAPH1 | S856 | ochoa | Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1) | Mediator of localized membrane signals. Implicated in the regulation of lamellipodial dynamics. Negatively regulates cell adhesion. |
Q765P7 | MTSS2 | S569 | ochoa | Protein MTSS 2 (Actin-bundling with BAIAP2 homology protein 1) (ABBA-1) (MTSS1-like protein) | Involved in plasma membrane dynamics. Potentiated PDGF-mediated formation of membrane ruffles and lamellipodia in fibroblasts, acting via RAC1 activation (PubMed:14752106). May function in actin bundling (PubMed:14752106). {ECO:0000269|PubMed:14752106}. |
Q7L591 | DOK3 | S330 | ochoa | Docking protein 3 (Downstream of tyrosine kinase 3) | DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK3 is a negative regulator of JNK signaling in B-cells through interaction with INPP5D/SHIP1. May modulate ABL1 function (By similarity). {ECO:0000250}. |
Q7Z2Z1 | TICRR | S1359 | ochoa | Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein) | Regulator of DNA replication and S/M and G2/M checkpoints. Regulates the triggering of DNA replication initiation via its interaction with TOPBP1 by participating in CDK2-mediated loading of CDC45L onto replication origins. Required for the transition from pre-replication complex (pre-RC) to pre-initiation complex (pre-IC). Required to prevent mitotic entry after treatment with ionizing radiation. {ECO:0000269|PubMed:20116089}. |
Q7Z3K3 | POGZ | S274 | ochoa | Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635) | Plays a role in mitotic cell cycle progression and is involved in kinetochore assembly and mitotic sister chromatid cohesion. Probably through its association with CBX5 plays a role in mitotic chromosome segregation by regulating aurora kinase B/AURKB activation and AURKB and CBX5 dissociation from chromosome arms (PubMed:20562864). Promotes the repair of DNA double-strand breaks through the homologous recombination pathway (PubMed:26721387). {ECO:0000269|PubMed:20562864, ECO:0000269|PubMed:26721387}. |
Q7Z5L9 | IRF2BP2 | S383 | ochoa | Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2) | Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities (PubMed:12799427). Represses the NFAT1-dependent transactivation of NFAT-responsive promoters (PubMed:21576369). Acts as a coactivator of VEGFA expression in cardiac and skeletal muscles (PubMed:20702774). Plays a role in immature B-cell differentiation (PubMed:27016798). {ECO:0000269|PubMed:12799427, ECO:0000269|PubMed:20702774, ECO:0000269|PubMed:21576369, ECO:0000269|PubMed:27016798}. |
Q7Z5L9 | IRF2BP2 | T384 | ochoa | Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2) | Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities (PubMed:12799427). Represses the NFAT1-dependent transactivation of NFAT-responsive promoters (PubMed:21576369). Acts as a coactivator of VEGFA expression in cardiac and skeletal muscles (PubMed:20702774). Plays a role in immature B-cell differentiation (PubMed:27016798). {ECO:0000269|PubMed:12799427, ECO:0000269|PubMed:20702774, ECO:0000269|PubMed:21576369, ECO:0000269|PubMed:27016798}. |
Q86U86 | PBRM1 | S1453 | ochoa | Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation. {ECO:0000269|PubMed:21248752, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
Q86UY5 | FAM83A | S348 | ochoa | Protein FAM83A (Tumor antigen BJ-TSA-9) (Tumor-specific gene expressed in prostate protein) | Involved in mitochondrial maintenance during adipogenesis. May be acting by playing a role in the maintenance of normal mitochondrial function. {ECO:0000250|UniProtKB:Q8K2P2}. |
Q86VE0 | MYPOP | S206 | ochoa | Myb-related transcription factor, partner of profilin (Myb-related protein p42POP) (Partner of profilin) | Transcriptional repressor; DNA-binding protein that specifically recognizes the core sequence 5'-YAAC[GT]G-3'. Dimerization with PFN1 reduces its DNA-binding capacity (By similarity). {ECO:0000250}. |
Q86VP3 | PACS2 | S331 | ochoa | Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein) | Multifunctional sorting protein that controls the endoplasmic reticulum (ER)-mitochondria communication, including the apposition of mitochondria with the ER and ER homeostasis. In addition, in response to apoptotic inducer, translocates BIB to mitochondria, which initiates a sequence of events including the formation of mitochondrial truncated BID, the release of cytochrome c, the activation of caspase-3 thereby causing cell death. May also be involved in ion channel trafficking, directing acidic cluster-containing ion channels to distinct subcellular compartments. {ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:15692567}. |
Q86X29 | LSR | S321 | ochoa | Lipolysis-stimulated lipoprotein receptor (Angulin-1) | Probable role in the clearance of triglyceride-rich lipoprotein from blood. Binds chylomicrons, LDL and VLDL in presence of free fatty acids and allows their subsequent uptake in the cells (By similarity). Maintains epithelial barrier function by recruiting MARVELD2/tricellulin to tricellular tight junctions (By similarity). {ECO:0000250|UniProtKB:Q99KG5, ECO:0000250|UniProtKB:Q9WU74}. |
Q86X51 | EZHIP | S465 | ochoa | EZH inhibitory protein | Inhibits PRC2/EED-EZH1 and PRC2/EED-EZH2 complex function by inhibiting EZH1/EZH2 methyltransferase activity, thereby causing down-regulation of histone H3 trimethylation on 'Lys-27' (H3K27me3) (PubMed:29909548, PubMed:30923826, PubMed:31086175, PubMed:31451685). Probably inhibits methyltransferase activity by limiting the stimulatory effect of cofactors such as AEBP2 and JARID2 (PubMed:30923826). Inhibits H3K27me3 deposition during spermatogenesis and oogenesis (By similarity). {ECO:0000250|UniProtKB:B1B0V2, ECO:0000269|PubMed:29909548, ECO:0000269|PubMed:30923826, ECO:0000269|PubMed:31086175, ECO:0000269|PubMed:31451685}. |
Q8IUC6 | TICAM1 | S343 | ochoa | TIR domain-containing adapter molecule 1 (TICAM-1) (Proline-rich, vinculin and TIR domain-containing protein B) (Putative NF-kappa-B-activating protein 502H) (Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta) (MyD88-3) (TIR domain-containing adapter protein inducing IFN-beta) | Involved in innate immunity against invading pathogens. Adapter used by TLR3, TLR4 (through TICAM2) and TLR5 to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis (PubMed:12471095, PubMed:12539043, PubMed:14739303, PubMed:28747347, PubMed:35215908). Ligand binding to these receptors results in TRIF recruitment through its TIR domain (PubMed:12471095, PubMed:12539043, PubMed:14739303). Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively (PubMed:12471095, PubMed:12539043, PubMed:14739303). Phosphorylation by TBK1 on the pLxIS motif leads to recruitment and subsequent activation of the transcription factor IRF3 to induce expression of type I interferon and exert a potent immunity against invading pathogens (PubMed:25636800). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of pro-inflammatory cytokines (By similarity). {ECO:0000250|UniProtKB:Q80UF7, ECO:0000269|PubMed:12471095, ECO:0000269|PubMed:12539043, ECO:0000269|PubMed:14739303, ECO:0000269|PubMed:25636800, ECO:0000269|PubMed:35215908}. |
Q8IV04 | TBC1D10C | T415 | psp | Carabin (TBC1 domain family member 10C) | Inhibits the Ras signaling pathway through its intrinsic Ras GTPase-activating protein (GAP) activity. Acts as a negative feedback inhibitor of the calcineurin signaling pathway that also mediates crosstalk between calcineurin and Ras. {ECO:0000269|PubMed:17230191}. |
Q8IV56 | PRR15 | S55 | ochoa | Proline-rich protein 15 | May have a role in proliferation and/or differentiation. {ECO:0000250}. |
Q8IVT5 | KSR1 | T273 | ochoa | Kinase suppressor of Ras 1 (EC 2.7.11.1) | Part of a multiprotein signaling complex which promotes phosphorylation of Raf family members and activation of downstream MAP kinases (By similarity). Independently of its kinase activity, acts as MAP2K1/MEK1 and MAP2K2/MEK2-dependent allosteric activator of BRAF; upon binding to MAP2K1/MEK1 or MAP2K2/MEK2, dimerizes with BRAF and promotes BRAF-mediated phosphorylation of MAP2K1/MEK1 and/or MAP2K2/MEK2 (PubMed:29433126). Promotes activation of MAPK1 and/or MAPK3, both in response to EGF and to cAMP (By similarity). Its kinase activity is unsure (By similarity). Some protein kinase activity has been detected in vitro, however the physiological relevance of this activity is unknown (By similarity). {ECO:0000250|UniProtKB:Q61097, ECO:0000269|PubMed:29433126}. |
Q8IX07 | ZFPM1 | S914 | ochoa | Zinc finger protein ZFPM1 (Friend of GATA protein 1) (FOG-1) (Friend of GATA 1) (Zinc finger protein 89A) (Zinc finger protein multitype 1) | Transcription regulator that plays an essential role in erythroid and megakaryocytic cell differentiation. Essential cofactor that acts via the formation of a heterodimer with transcription factors of the GATA family GATA1, GATA2 and GATA3. Such heterodimer can both activate or repress transcriptional activity, depending on the cell and promoter context. The heterodimer formed with GATA proteins is essential to activate expression of genes such as NFE2, ITGA2B, alpha- and beta-globin, while it represses expression of KLF1. May be involved in regulation of some genes in gonads. May also be involved in cardiac development, in a non-redundant way with ZFPM2/FOG2 (By similarity). {ECO:0000250}. |
Q8IXQ3 | C9orf40 | S83 | ochoa | Uncharacterized protein C9orf40 | None |
Q8IYB3 | SRRM1 | S391 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IZ21 | PHACTR4 | T246 | ochoa | Phosphatase and actin regulator 4 | Regulator of protein phosphatase 1 (PP1) required for neural tube and optic fissure closure, and enteric neural crest cell (ENCCs) migration during development. Acts as an activator of PP1 by interacting with PPP1CA and preventing phosphorylation of PPP1CA at 'Thr-320'. During neural tube closure, localizes to the ventral neural tube and activates PP1, leading to down-regulate cell proliferation within cranial neural tissue and the neural retina. Also acts as a regulator of migration of enteric neural crest cells (ENCCs) by activating PP1, leading to dephosphorylation and subsequent activation of cofilin (COF1 or COF2) and repression of the integrin signaling through the RHO/ROCK pathway (By similarity). {ECO:0000250}. |
Q8IZP0 | ABI1 | S187 | ochoa | Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1) | May act in negative regulation of cell growth and transformation by interacting with nonreceptor tyrosine kinases ABL1 and/or ABL2. May play a role in regulation of EGF-induced Erk pathway activation. Involved in cytoskeletal reorganization and EGFR signaling. Together with EPS8 participates in transduction of signals from Ras to Rac. In vitro, a trimeric complex of ABI1, EPS8 and SOS1 exhibits Rac specific guanine nucleotide exchange factor (GEF) activity and ABI1 seems to act as an adapter in the complex. Regulates ABL1/c-Abl-mediated phosphorylation of ENAH. Recruits WASF1 to lamellipodia and there seems to regulate WASF1 protein level. In brain, seems to regulate the dendritic outgrowth and branching as well as to determine the shape and number of synaptic contacts of developing neurons. {ECO:0000269|PubMed:11003655, ECO:0000269|PubMed:18328268}. |
Q8N3F8 | MICALL1 | S515 | ochoa | MICAL-like protein 1 (Molecule interacting with Rab13) (MIRab13) | Lipid-binding protein with higher affinity for phosphatidic acid, a lipid enriched in recycling endosome membranes. On endosome membranes, acts as a downstream effector of Rab proteins recruiting cytosolic proteins to regulate membrane tubulation (PubMed:19864458, PubMed:20801876, PubMed:23596323, PubMed:34100897). Involved in a late step of receptor-mediated endocytosis regulating for instance endocytosed-EGF receptor trafficking (PubMed:21795389). Alternatively, regulates slow endocytic recycling of endocytosed proteins back to the plasma membrane (PubMed:19864458). Also involved in cargo protein delivery to the plasma membrane (PubMed:34100897). Plays a role in ciliogenesis coordination, recruits EHD1 to primary cilium where it is anchored to the centriole through interaction with tubulins (PubMed:31615969). May indirectly play a role in neurite outgrowth (By similarity). {ECO:0000250|UniProtKB:Q8BGT6, ECO:0000269|PubMed:19864458, ECO:0000269|PubMed:20801876, ECO:0000269|PubMed:21795389, ECO:0000269|PubMed:23596323, ECO:0000269|PubMed:31615969, ECO:0000269|PubMed:34100897}. |
Q8N4C8 | MINK1 | S631 | ochoa | Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) | Serine/threonine kinase which acts as a negative regulator of Ras-related Rap2-mediated signal transduction to control neuronal structure and AMPA receptor trafficking (PubMed:10708748, PubMed:16337592). Required for normal synaptic density, dendrite complexity, as well as surface AMPA receptor expression in hippocampal neurons (By similarity). Can activate the JNK and MAPK14/p38 pathways and mediates stimulation of the stress-activated protein kinase MAPK14/p38 MAPK downstream of the Raf/ERK pathway. Phosphorylates TANC1 upon stimulation by RAP2A, MBP and SMAD1 (PubMed:18930710, PubMed:21690388). Has an essential function in negative selection of thymocytes, perhaps by coupling NCK1 to activation of JNK1 (By similarity). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000250|UniProtKB:F1LP90, ECO:0000250|UniProtKB:Q9JM52, ECO:0000269|PubMed:10708748, ECO:0000269|PubMed:16337592, ECO:0000269|PubMed:18930710, ECO:0000269|PubMed:21690388, ECO:0000269|PubMed:26437443}.; FUNCTION: Isoform 4 can activate the JNK pathway. Involved in the regulation of actin cytoskeleton reorganization, cell-matrix adhesion, cell-cell adhesion and cell migration. |
Q8N4C8 | MINK1 | Y706 | ochoa | Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) | Serine/threonine kinase which acts as a negative regulator of Ras-related Rap2-mediated signal transduction to control neuronal structure and AMPA receptor trafficking (PubMed:10708748, PubMed:16337592). Required for normal synaptic density, dendrite complexity, as well as surface AMPA receptor expression in hippocampal neurons (By similarity). Can activate the JNK and MAPK14/p38 pathways and mediates stimulation of the stress-activated protein kinase MAPK14/p38 MAPK downstream of the Raf/ERK pathway. Phosphorylates TANC1 upon stimulation by RAP2A, MBP and SMAD1 (PubMed:18930710, PubMed:21690388). Has an essential function in negative selection of thymocytes, perhaps by coupling NCK1 to activation of JNK1 (By similarity). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000250|UniProtKB:F1LP90, ECO:0000250|UniProtKB:Q9JM52, ECO:0000269|PubMed:10708748, ECO:0000269|PubMed:16337592, ECO:0000269|PubMed:18930710, ECO:0000269|PubMed:21690388, ECO:0000269|PubMed:26437443}.; FUNCTION: Isoform 4 can activate the JNK pathway. Involved in the regulation of actin cytoskeleton reorganization, cell-matrix adhesion, cell-cell adhesion and cell migration. |
Q8N884 | CGAS | S116 | ochoa|psp | Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (h-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1) | Nucleotidyltransferase that catalyzes the formation of cyclic GMP-AMP (2',3'-cGAMP) from ATP and GTP and plays a key role in innate immunity (PubMed:21478870, PubMed:23258413, PubMed:23707061, PubMed:23707065, PubMed:23722159, PubMed:24077100, PubMed:24116191, PubMed:24462292, PubMed:25131990, PubMed:26300263, PubMed:29976794, PubMed:30799039, PubMed:31142647, PubMed:32814054, PubMed:33273464, PubMed:33542149, PubMed:37217469, PubMed:37802025). Catalysis involves both the formation of a 2',5' phosphodiester linkage at the GpA step and the formation of a 3',5' phosphodiester linkage at the ApG step, producing c[G(2',5')pA(3',5')p] (PubMed:28214358, PubMed:28363908). Acts as a key DNA sensor: directly binds double-stranded DNA (dsDNA), inducing the formation of liquid-like droplets in which CGAS is activated, leading to synthesis of 2',3'-cGAMP, a second messenger that binds to and activates STING1, thereby triggering type-I interferon production (PubMed:28314590, PubMed:28363908, PubMed:29976794, PubMed:32817552, PubMed:33230297, PubMed:33606975, PubMed:35322803, PubMed:35438208, PubMed:35460603, PubMed:35503863). Preferentially recognizes and binds curved long dsDNAs of a minimal length of 40 bp (PubMed:30007416). Acts as a key foreign DNA sensor, the presence of double-stranded DNA (dsDNA) in the cytoplasm being a danger signal that triggers the immune responses (PubMed:28363908). Has antiviral activity by sensing the presence of dsDNA from DNA viruses in the cytoplasm (PubMed:28363908, PubMed:35613581). Also acts as an innate immune sensor of infection by retroviruses, such as HIV-2, by detecting the presence of reverse-transcribed DNA in the cytosol (PubMed:23929945, PubMed:24269171, PubMed:30270045, PubMed:32852081). In contrast, HIV-1 is poorly sensed by CGAS, due to its capsid that cloaks viral DNA from CGAS detection (PubMed:24269171, PubMed:30270045, PubMed:32852081). Detection of retroviral reverse-transcribed DNA in the cytosol may be indirect and be mediated via interaction with PQBP1, which directly binds reverse-transcribed retroviral DNA (PubMed:26046437). Also detects the presence of DNA from bacteria, such as M.tuberculosis (PubMed:26048138). 2',3'-cGAMP can be transferred from producing cells to neighboring cells through gap junctions, leading to promote STING1 activation and convey immune response to connecting cells (PubMed:24077100). 2',3'-cGAMP can also be transferred between cells by virtue of packaging within viral particles contributing to IFN-induction in newly infected cells in a cGAS-independent but STING1-dependent manner (PubMed:26229115). Also senses the presence of neutrophil extracellular traps (NETs) that are translocated to the cytosol following phagocytosis, leading to synthesis of 2',3'-cGAMP (PubMed:33688080). In addition to foreign DNA, can also be activated by endogenous nuclear or mitochondrial DNA (PubMed:28738408, PubMed:28759889, PubMed:31299200, PubMed:33031745, PubMed:33230297). When self-DNA leaks into the cytosol during cellular stress (such as mitochondrial stress, SARS-CoV-2 infection causing severe COVID-19 disease, DNA damage, mitotic arrest or senescence), or is present in form of cytosolic micronuclei, CGAS is activated leading to a state of sterile inflammation (PubMed:28738408, PubMed:28759889, PubMed:31299200, PubMed:33031745, PubMed:33230297, PubMed:35045565). Acts as a regulator of cellular senescence by binding to cytosolic chromatin fragments that are present in senescent cells, leading to trigger type-I interferon production via STING1 and promote cellular senescence (By similarity). Also involved in the inflammatory response to genome instability and double-stranded DNA breaks: acts by localizing to micronuclei arising from genome instability (PubMed:28738408, PubMed:28759889). Micronuclei, which are frequently found in cancer cells, consist of chromatin surrounded by their own nuclear membrane: following breakdown of the micronuclear envelope, a process associated with chromothripsis, CGAS binds self-DNA exposed to the cytosol, leading to 2',3'-cGAMP synthesis and subsequent activation of STING1 and type-I interferon production (PubMed:28738408, PubMed:28759889). Activated in response to prolonged mitotic arrest, promoting mitotic cell death (PubMed:31299200). In a healthy cell, CGAS is however kept inactive even in cellular events that directly expose it to self-DNA, such as mitosis, when cGAS associates with chromatin directly after nuclear envelope breakdown or remains in the form of postmitotic persistent nuclear cGAS pools bound to chromatin (PubMed:31299200, PubMed:33542149). Nuclear CGAS is inactivated by chromatin via direct interaction with nucleosomes, which block CGAS from DNA binding and thus prevent CGAS-induced autoimmunity (PubMed:31299200, PubMed:32911482, PubMed:32912999, PubMed:33051594, PubMed:33542149). Also acts as a suppressor of DNA repair in response to DNA damage: inhibits homologous recombination repair by interacting with PARP1, the CGAS-PARP1 interaction leading to impede the formation of the PARP1-TIMELESS complex (PubMed:30356214, PubMed:31544964). In addition to DNA, also sense translation stress: in response to translation stress, translocates to the cytosol and associates with collided ribosomes, promoting its activation and triggering type-I interferon production (PubMed:34111399). In contrast to other mammals, human CGAS displays species-specific mechanisms of DNA recognition and produces less 2',3'-cGAMP, allowing a more fine-tuned response to pathogens (PubMed:30007416). {ECO:0000250|UniProtKB:Q8C6L5, ECO:0000269|PubMed:21478870, ECO:0000269|PubMed:23258413, ECO:0000269|PubMed:23707061, ECO:0000269|PubMed:23707065, ECO:0000269|PubMed:23722159, ECO:0000269|PubMed:23929945, ECO:0000269|PubMed:24077100, ECO:0000269|PubMed:24116191, ECO:0000269|PubMed:24269171, ECO:0000269|PubMed:24462292, ECO:0000269|PubMed:25131990, ECO:0000269|PubMed:26046437, ECO:0000269|PubMed:26048138, ECO:0000269|PubMed:26229115, ECO:0000269|PubMed:26300263, ECO:0000269|PubMed:28214358, ECO:0000269|PubMed:28314590, ECO:0000269|PubMed:28363908, ECO:0000269|PubMed:28738408, ECO:0000269|PubMed:28759889, ECO:0000269|PubMed:29976794, ECO:0000269|PubMed:30007416, ECO:0000269|PubMed:30270045, ECO:0000269|PubMed:30356214, ECO:0000269|PubMed:30799039, ECO:0000269|PubMed:31142647, ECO:0000269|PubMed:31299200, ECO:0000269|PubMed:31544964, ECO:0000269|PubMed:32814054, ECO:0000269|PubMed:32817552, ECO:0000269|PubMed:32852081, ECO:0000269|PubMed:32911482, ECO:0000269|PubMed:32912999, ECO:0000269|PubMed:33031745, ECO:0000269|PubMed:33051594, ECO:0000269|PubMed:33230297, ECO:0000269|PubMed:33273464, ECO:0000269|PubMed:33542149, ECO:0000269|PubMed:33606975, ECO:0000269|PubMed:33688080, ECO:0000269|PubMed:34111399, ECO:0000269|PubMed:35045565, ECO:0000269|PubMed:35322803, ECO:0000269|PubMed:35438208, ECO:0000269|PubMed:35460603, ECO:0000269|PubMed:35503863, ECO:0000269|PubMed:35613581, ECO:0000269|PubMed:37217469, ECO:0000269|PubMed:37802025}. |
Q8NAX2 | KDF1 | S153 | ochoa | Keratinocyte differentiation factor 1 | Plays a role in the regulation of the epidermis formation during early development. Required both as an inhibitor of basal cell proliferation and a promoter of differentiation of basal progenitor cell progeny (By similarity). {ECO:0000250|UniProtKB:A2A9F4}. |
Q8ND24 | RNF214 | S516 | ochoa | RING finger protein 214 | None |
Q8NEZ4 | KMT2C | S1889 | ochoa | Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:22266653, PubMed:24081332, PubMed:25561738). Likely plays a redundant role with KMT2D in enriching H3K4me1 mark on primed and active enhancer elements (PubMed:24081332). {ECO:0000269|PubMed:22266653, ECO:0000269|PubMed:24081332, ECO:0000269|PubMed:25561738}. |
Q8NFH5 | NUP35 | S58 | ochoa | Nucleoporin NUP35 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53) | Functions as a component of the nuclear pore complex (NPC). NPC components, collectively referred to as nucleoporins (NUPs), can play the role of both NPC structural components and of docking or interaction partners for transiently associated nuclear transport factors. May play a role in the association of MAD1 with the NPC. {ECO:0000269|PubMed:15703211}. |
Q8NFH8 | REPS2 | S461 | ochoa | RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2) | Involved in ligand-dependent receptor mediated endocytosis of the EGF and insulin receptors as part of the Ral signaling pathway (PubMed:10393179, PubMed:12771942, PubMed:9422736). By controlling growth factor receptors endocytosis may regulate cell survival (PubMed:12771942). Through ASAP1 may regulate cell adhesion and migration (PubMed:12149250). {ECO:0000269|PubMed:10393179, ECO:0000269|PubMed:12149250, ECO:0000269|PubMed:12771942, ECO:0000269|PubMed:9422736}. |
Q8NHM5 | KDM2B | S1029 | ochoa | Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B) | Histone demethylase that demethylates 'Lys-4' and 'Lys-36' of histone H3, thereby playing a central role in histone code (PubMed:16362057, PubMed:17994099, PubMed:26237645). Preferentially demethylates trimethylated H3 'Lys-4' and dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36' (PubMed:16362057, PubMed:17994099, PubMed:26237645). Preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation (PubMed:16362057, PubMed:17994099). May also serve as a substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex (Probable). {ECO:0000269|PubMed:16362057, ECO:0000269|PubMed:17994099, ECO:0000269|PubMed:26237645, ECO:0000305}. |
Q8NHM5 | KDM2B | S1031 | ochoa | Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B) | Histone demethylase that demethylates 'Lys-4' and 'Lys-36' of histone H3, thereby playing a central role in histone code (PubMed:16362057, PubMed:17994099, PubMed:26237645). Preferentially demethylates trimethylated H3 'Lys-4' and dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36' (PubMed:16362057, PubMed:17994099, PubMed:26237645). Preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation (PubMed:16362057, PubMed:17994099). May also serve as a substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex (Probable). {ECO:0000269|PubMed:16362057, ECO:0000269|PubMed:17994099, ECO:0000269|PubMed:26237645, ECO:0000305}. |
Q8TBC3 | SHKBP1 | S631 | ochoa | SH3KBP1-binding protein 1 (SETA-binding protein 1) | Inhibits CBL-SH3KBP1 complex mediated down-regulation of EGFR signaling by sequestration of SH3KBP1. Binds to SH3KBP1 and prevents its interaction with CBL and inhibits translocation of SH3KBP1 to EGFR containing vesicles upon EGF stimulation. {ECO:0000250|UniProtKB:Q6P7W2}. |
Q8TDZ2 | MICAL1 | S810 | ochoa | [F-actin]-monooxygenase MICAL1 (EC 1.14.13.225) (EC 1.6.3.1) (Molecule interacting with CasL protein 1) (MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains) | Monooxygenase that promotes depolymerization of F-actin by mediating oxidation of specific methionine residues on actin to form methionine-sulfoxide, resulting in actin filament disassembly and preventing repolymerization (PubMed:29343822). In the absence of actin, it also functions as a NADPH oxidase producing H(2)O(2) (PubMed:21864500, PubMed:26845023, PubMed:29343822). Acts as a cytoskeletal regulator that connects NEDD9 to intermediate filaments. Also acts as a negative regulator of apoptosis via its interaction with STK38 and STK38L; acts by antagonizing STK38 and STK38L activation by MST1/STK4. Involved in regulation of lamina-specific connectivity in the nervous system such as the development of lamina-restricted hippocampal connections. Through redox regulation of the actin cytoskeleton controls the intracellular distribution of secretory vesicles containing L1/neurofascin/NgCAM family proteins in neurons, thereby regulating their cell surface levels (By similarity). May act as Rab effector protein and play a role in vesicle trafficking. Promotes endosomal tubule extension by associating with RAB8 (RAB8A or RAB8B), RAB10 and GRAF (GRAF1/ARHGAP26 or GRAF2/ARHGAP10) on the endosomal membrane which may connect GRAFs to Rabs, thereby participating in neosynthesized Rab8-Rab10-Rab11-dependent protein export (PubMed:32344433). {ECO:0000250|UniProtKB:Q8VDP3, ECO:0000269|PubMed:18305261, ECO:0000269|PubMed:21864500, ECO:0000269|PubMed:26845023, ECO:0000269|PubMed:28230050, ECO:0000269|PubMed:29343822, ECO:0000269|PubMed:32344433, ECO:0000305|PubMed:27552051}. |
Q8TF74 | WIPF2 | S235 | ochoa | WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein) | Plays an active role in the formation of cell surface protrusions downstream of activated PDGFB receptors. Plays an important role in actin-microspike formation through cooperation with WASL. May cooperate with WASP and WASL to induce mobilization and reorganization of the actin filament system. {ECO:0000269|PubMed:11829459, ECO:0000269|PubMed:12213210}. |
Q8WWM7 | ATXN2L | S32 | ochoa | Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein) | Involved in the regulation of stress granule and P-body formation. {ECO:0000269|PubMed:23209657}. |
Q8WX93 | PALLD | S808 | psp | Palladin (SIH002) (Sarcoma antigen NY-SAR-77) | Cytoskeletal protein required for organization of normal actin cytoskeleton. Roles in establishing cell morphology, motility, cell adhesion and cell-extracellular matrix interactions in a variety of cell types. May function as a scaffolding molecule with the potential to influence both actin polymerization and the assembly of existing actin filaments into higher-order arrays. Binds to proteins that bind to either monomeric or filamentous actin. Localizes at sites where active actin remodeling takes place, such as lamellipodia and membrane ruffles. Different isoforms may have functional differences. Involved in the control of morphological and cytoskeletal changes associated with dendritic cell maturation. Involved in targeting ACTN to specific subcellular foci. {ECO:0000269|PubMed:11598191, ECO:0000269|PubMed:15147863, ECO:0000269|PubMed:17537434}. |
Q8WXD9 | CASKIN1 | S1257 | ochoa | Caskin-1 (CASK-interacting protein 1) | May link the scaffolding protein CASK to downstream intracellular effectors. {ECO:0000250}. |
Q8WXE0 | CASKIN2 | S700 | ochoa | Caskin-2 (CASK-interacting protein 2) | None |
Q8WXE0 | CASKIN2 | T853 | ochoa | Caskin-2 (CASK-interacting protein 2) | None |
Q8WXX7 | AUTS2 | S319 | ochoa | Autism susceptibility gene 2 protein | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:25519132). The PRC1-like complex that contains PCGF5, RNF2, CSNK2B, RYBP and AUTS2 has decreased histone H2A ubiquitination activity, due to the phosphorylation of RNF2 by CSNK2B (PubMed:25519132). As a consequence, the complex mediates transcriptional activation (PubMed:25519132). In the cytoplasm, plays a role in axon and dendrite elongation and in neuronal migration during embryonic brain development. Promotes reorganization of the actin cytoskeleton, lamellipodia formation and neurite elongation via its interaction with RAC guanine nucleotide exchange factors, which then leads to the activation of RAC1 (By similarity). {ECO:0000250|UniProtKB:A0A087WPF7, ECO:0000269|PubMed:25519132}. |
Q92558 | WASF1 | S333 | ochoa | Actin-binding protein WASF1 (Protein WAVE-1) (Verprolin homology domain-containing protein 1) (Wiskott-Aldrich syndrome protein family member 1) (WASP family protein member 1) | Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation (PubMed:29961568). The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex (By similarity). As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity). Also involved in the regulation of mitochondrial dynamics (PubMed:29961568). {ECO:0000250|UniProtKB:Q8R5H6, ECO:0000269|PubMed:29961568, ECO:0000269|PubMed:9889097}. |
Q92558 | WASF1 | S336 | ochoa | Actin-binding protein WASF1 (Protein WAVE-1) (Verprolin homology domain-containing protein 1) (Wiskott-Aldrich syndrome protein family member 1) (WASP family protein member 1) | Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation (PubMed:29961568). The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex (By similarity). As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity). Also involved in the regulation of mitochondrial dynamics (PubMed:29961568). {ECO:0000250|UniProtKB:Q8R5H6, ECO:0000269|PubMed:29961568, ECO:0000269|PubMed:9889097}. |
Q92558 | WASF1 | T337 | ochoa | Actin-binding protein WASF1 (Protein WAVE-1) (Verprolin homology domain-containing protein 1) (Wiskott-Aldrich syndrome protein family member 1) (WASP family protein member 1) | Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation (PubMed:29961568). The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex (By similarity). As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity). Also involved in the regulation of mitochondrial dynamics (PubMed:29961568). {ECO:0000250|UniProtKB:Q8R5H6, ECO:0000269|PubMed:29961568, ECO:0000269|PubMed:9889097}. |
Q92558 | WASF1 | S338 | ochoa | Actin-binding protein WASF1 (Protein WAVE-1) (Verprolin homology domain-containing protein 1) (Wiskott-Aldrich syndrome protein family member 1) (WASP family protein member 1) | Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation (PubMed:29961568). The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex (By similarity). As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity). Also involved in the regulation of mitochondrial dynamics (PubMed:29961568). {ECO:0000250|UniProtKB:Q8R5H6, ECO:0000269|PubMed:29961568, ECO:0000269|PubMed:9889097}. |
Q92558 | WASF1 | S339 | ochoa | Actin-binding protein WASF1 (Protein WAVE-1) (Verprolin homology domain-containing protein 1) (Wiskott-Aldrich syndrome protein family member 1) (WASP family protein member 1) | Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation (PubMed:29961568). The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex (By similarity). As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity). Also involved in the regulation of mitochondrial dynamics (PubMed:29961568). {ECO:0000250|UniProtKB:Q8R5H6, ECO:0000269|PubMed:29961568, ECO:0000269|PubMed:9889097}. |
Q92667 | AKAP1 | S73 | ochoa | A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84) | Binds to type I and II regulatory subunits of protein kinase A and anchors them to the cytoplasmic face of the mitochondrial outer membrane (By similarity). Involved in mitochondrial-mediated antiviral innate immunity (PubMed:31522117). Promotes translocation of NDUFS1 into mitochondria to regulate mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) activity (By similarity). {ECO:0000250|UniProtKB:O08715, ECO:0000269|PubMed:31522117}. |
Q92918 | MAP4K1 | S454 | ochoa | Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1) | Serine/threonine-protein kinase, which plays a role in the response to environmental stress (PubMed:24362026). Appears to act upstream of the JUN N-terminal pathway (PubMed:8824585). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). May play a role in hematopoietic lineage decisions and growth regulation (PubMed:24362026, PubMed:8824585). Together with CLNK, it enhances CD3-triggered activation of T-cells and subsequent IL2 production (By similarity). {ECO:0000250|UniProtKB:P70218, ECO:0000269|PubMed:24362026, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:8824585}. |
Q93052 | LPP | S151 | ochoa | Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma) | May play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. May be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. Also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus. {ECO:0000269|PubMed:10637295}. |
Q969T9 | WBP2 | Y231 | psp | WW domain-binding protein 2 (WBP-2) | Acts as a transcriptional coactivator of estrogen and progesterone receptors (ESR1 and PGR) upon hormone activation (PubMed:16772533). In presence of estrogen, binds to ESR1-responsive promoters (PubMed:16772533). Synergizes with YAP1 to enhance PGR activity (PubMed:16772533). Modulates expression of post-synaptic scaffolding proteins via regulation of ESR1, ESR2 and PGR (By similarity). {ECO:0000250|UniProtKB:P97765, ECO:0000269|PubMed:16772533}. |
Q96BH1 | RNF25 | S288 | ochoa | E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING finger protein AO7) | E3 ubiquitin-protein ligase that plays a key role in the RNF14-RNF25 translation quality control pathway, a pathway that takes place when a ribosome has stalled during translation, and which promotes ubiquitination and degradation of translation factors on stalled ribosomes (PubMed:36638793, PubMed:37651229, PubMed:37951216). Catalyzes ubiquitination of RPS27A in response to ribosome collisions, promoting activation of RNF14 (PubMed:36638793). RNF25 catalyzes ubiquitination of other ribosomal proteins on stalled ribosomes, such as RPL0, RPL1, RPL12, RPS13 and RPS17 (PubMed:36638793). Also involved in ubiquitination and degradation of stalled ETF1/eRF1 (PubMed:36638793, PubMed:37651229). Independently of its function in the response to stalled ribosomes, mediates ubiquitination and subsequent proteasomal degradation of NKD2 (By similarity). May also stimulate transcription mediated by NF-kappa-B via its interaction with RELA/p65 (PubMed:12748188). {ECO:0000250|UniProtKB:Q9QZR0, ECO:0000269|PubMed:12748188, ECO:0000269|PubMed:36638793, ECO:0000269|PubMed:37651229, ECO:0000269|PubMed:37951216}. |
Q96D31 | ORAI1 | S27 | psp | Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A) | Pore-forming subunit of two major inward rectifying Ca(2+) channels at the plasma membrane: Ca(2+) release-activated Ca(2+) (CRAC) channels and arachidonate-regulated Ca(2+)-selective (ARC) channels (Probable) (PubMed:16645049, PubMed:16733527, PubMed:16807233, PubMed:16921383, PubMed:19249086, PubMed:19706554, PubMed:23307288, PubMed:26956484, PubMed:28219928). Assembles with ORAI2 and ORAI3 to form hexameric CRAC channels that mediate Ca(2+) influx upon depletion of endoplasmic reticulum Ca(2+) store and channel activation by Ca(2+) sensor STIM1, a process known as store-operated Ca(2+) entry (SOCE). Various pore subunit combinations may account for distinct CRAC channel spatiotemporal and cell-type specific dynamics. ORAI1 mainly contributes to the generation of Ca(2+) plateaus involved in sustained Ca(2+) entry and is dispensable for cytosolic Ca(2+) oscillations, whereas ORAI2 and ORAI3 generate oscillatory patterns. CRAC channels assemble in Ca(2+) signaling microdomains where Ca(2+) influx is coupled to calmodulin and calcineurin signaling and activation of NFAT transcription factors recruited to ORAI1 via AKAP5. Activates NFATC2/NFAT1 and NFATC3/NFAT4-mediated transcriptional responses. CRAC channels are the main pathway for Ca(2+) influx in T cells and promote the immune response to pathogens by activating NFAT-dependent cytokine and chemokine transcription (PubMed:16582901, PubMed:17442569, PubMed:19182790, PubMed:20354224, PubMed:22641696, PubMed:26221052, PubMed:32415068, PubMed:33941685). Assembles with ORAI3 to form channels that mediate store-independent Ca(2+) influx in response to inflammatory metabolites arachidonate or its derivative leukotriene C4, termed ARC and LRC channels respectively (PubMed:19622606, PubMed:32415068). Plays a prominent role in Ca(2+) influx at the basolateral membrane of mammary epithelial cells independently of the Ca(2+) content of endoplasmic reticulum or Golgi stores. May mediate transepithelial transport of large quantities of Ca(2+) for milk secretion (By similarity) (PubMed:20887894). {ECO:0000250|UniProtKB:Q8BWG9, ECO:0000269|PubMed:16582901, ECO:0000269|PubMed:16645049, ECO:0000269|PubMed:16733527, ECO:0000269|PubMed:16807233, ECO:0000269|PubMed:16921383, ECO:0000269|PubMed:17442569, ECO:0000269|PubMed:19182790, ECO:0000269|PubMed:19249086, ECO:0000269|PubMed:19622606, ECO:0000269|PubMed:19706554, ECO:0000269|PubMed:20354224, ECO:0000269|PubMed:20887894, ECO:0000269|PubMed:22641696, ECO:0000269|PubMed:23307288, ECO:0000269|PubMed:26221052, ECO:0000269|PubMed:26956484, ECO:0000269|PubMed:28219928, ECO:0000269|PubMed:32415068, ECO:0000269|PubMed:33941685, ECO:0000305|PubMed:16766533}.; FUNCTION: [Isoform alpha]: Pore-forming subunit of both CRAC and ARC channels. Couples Ca(2+) influx to NFAT-mediated transcriptional responses. {ECO:0000269|PubMed:16921383, ECO:0000269|PubMed:17442569, ECO:0000269|PubMed:19182790, ECO:0000269|PubMed:19249086, ECO:0000269|PubMed:19622606, ECO:0000269|PubMed:19706554, ECO:0000269|PubMed:22641696, ECO:0000269|PubMed:26221052, ECO:0000269|PubMed:33941685}.; FUNCTION: [Isoform beta]: Pore-forming subunit of CRAC channels exclusively. {ECO:0000269|PubMed:22641696, ECO:0000269|PubMed:26221052, ECO:0000269|PubMed:33941685}. |
Q96HB5 | CCDC120 | Y398 | ochoa | Coiled-coil domain-containing protein 120 | Centriolar protein required for centriole subdistal appendage assembly and microtubule anchoring in interphase cells (PubMed:28422092). Together with CCDC68, cooperate with subdistal appendage components ODF2, NIN and CEP170 for hierarchical subdistal appendage assembly (PubMed:28422092). Recruits NIN and CEP170 to centrosomes (PubMed:28422092). Also required for neurite growth. Localizes CYTH2 to vesicles to allow its transport along neurites, and subsequent ARF6 activation and neurite growth. {ECO:0000269|PubMed:25326380}. |
Q96JM3 | CHAMP1 | S331 | ochoa | Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828) | Required for proper alignment of chromosomes at metaphase and their accurate segregation during mitosis. Involved in the maintenance of spindle microtubules attachment to the kinetochore during sister chromatid biorientation. May recruit CENPE and CENPF to the kinetochore. {ECO:0000269|PubMed:21063390}. |
Q96JM3 | CHAMP1 | S367 | ochoa | Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828) | Required for proper alignment of chromosomes at metaphase and their accurate segregation during mitosis. Involved in the maintenance of spindle microtubules attachment to the kinetochore during sister chromatid biorientation. May recruit CENPE and CENPF to the kinetochore. {ECO:0000269|PubMed:21063390}. |
Q96JZ2 | HSH2D | S175 | ochoa | Hematopoietic SH2 domain-containing protein (Hematopoietic SH2 protein) (Adaptor in lymphocytes of unknown function X) | May be a modulator of the apoptotic response through its ability to affect mitochondrial stability (By similarity). Adapter protein involved in tyrosine kinase and CD28 signaling. Seems to affect CD28-mediated activation of the RE/AP element of the interleukin-2 promoter. {ECO:0000250, ECO:0000269|PubMed:11700021, ECO:0000269|PubMed:12960172, ECO:0000269|PubMed:15284240}. |
Q96PN7 | TRERF1 | S725 | ochoa | Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132) | Binds DNA and activates transcription of CYP11A1. Interaction with CREBBP and EP300 results in a synergistic transcriptional activation of CYP11A1. {ECO:0000269|PubMed:11349124, ECO:0000269|PubMed:16371131}. |
Q96ST3 | SIN3A | S251 | ochoa | Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) | Acts as a transcriptional repressor. Corepressor for REST. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Also interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. Acts cooperatively with OGT to repress transcription in parallel with histone deacetylation. Involved in the control of the circadian rhythms. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression (By similarity). Required for cortical neuron differentiation and callosal axon elongation (By similarity). {ECO:0000250|UniProtKB:Q60520, ECO:0000269|PubMed:12150998}. |
Q99700 | ATXN2 | S565 | ochoa | Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) | Involved in EGFR trafficking, acting as negative regulator of endocytic EGFR internalization at the plasma membrane. {ECO:0000269|PubMed:18602463}. |
Q9BQI5 | SGIP1 | S335 | ochoa | SH3-containing GRB2-like protein 3-interacting protein 1 (Endophilin-3-interacting protein) | May function in clathrin-mediated endocytosis. Has both a membrane binding/tubulating activity and the ability to recruit proteins essential to the formation of functional clathrin-coated pits. Has a preference for membranes enriched in phosphatidylserine and phosphoinositides and is required for the endocytosis of the transferrin receptor. May also bind tubulin. May play a role in the regulation of energy homeostasis. {ECO:0000250|UniProtKB:Q8VD37}. |
Q9BRK4 | LZTS2 | S296 | ochoa | Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1) | Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin. {ECO:0000255|HAMAP-Rule:MF_03026, ECO:0000269|PubMed:17000760, ECO:0000269|PubMed:17351128, ECO:0000269|PubMed:17950943, ECO:0000269|PubMed:18490357}. |
Q9BRK4 | LZTS2 | T298 | ochoa | Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1) | Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin. {ECO:0000255|HAMAP-Rule:MF_03026, ECO:0000269|PubMed:17000760, ECO:0000269|PubMed:17351128, ECO:0000269|PubMed:17950943, ECO:0000269|PubMed:18490357}. |
Q9BST9 | RTKN | S520 | ochoa | Rhotekin | Mediates Rho signaling to activate NF-kappa-B and may confer increased resistance to apoptosis to cells in gastric tumorigenesis. May play a novel role in the organization of septin structures. {ECO:0000269|PubMed:10940294, ECO:0000269|PubMed:15480428, ECO:0000269|PubMed:16007136}. |
Q9BTC0 | DIDO1 | S1242 | ochoa | Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1) | Putative transcription factor, weakly pro-apoptotic when overexpressed (By similarity). Tumor suppressor. Required for early embryonic stem cell development. {ECO:0000250, ECO:0000269|PubMed:16127461}.; FUNCTION: [Isoform 2]: Displaces isoform 4 at the onset of differentiation, required for repression of stemness genes. {ECO:0000269|PubMed:16127461}. |
Q9BTC0 | DIDO1 | Y1244 | ochoa | Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1) | Putative transcription factor, weakly pro-apoptotic when overexpressed (By similarity). Tumor suppressor. Required for early embryonic stem cell development. {ECO:0000250, ECO:0000269|PubMed:16127461}.; FUNCTION: [Isoform 2]: Displaces isoform 4 at the onset of differentiation, required for repression of stemness genes. {ECO:0000269|PubMed:16127461}. |
Q9BVA0 | KATNB1 | S421 | ochoa | Katanin p80 WD40 repeat-containing subunit B1 (Katanin p80 subunit B1) (p80 katanin) | Participates in a complex which severs microtubules in an ATP-dependent manner. May act to target the enzymatic subunit of this complex to sites of action such as the centrosome. Microtubule severing may promote rapid reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. Microtubule release from the mitotic spindle poles may allow depolymerization of the microtubule end proximal to the spindle pole, leading to poleward microtubule flux and poleward motion of chromosome. Microtubule release within the cell body of neurons may be required for their transport into neuronal processes by microtubule-dependent motor proteins. This transport is required for axonal growth. {ECO:0000255|HAMAP-Rule:MF_03022, ECO:0000269|PubMed:10751153}. |
Q9BX66 | SORBS1 | S228 | ochoa | Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP) | Plays a role in tyrosine phosphorylation of CBL by linking CBL to the insulin receptor. Required for insulin-stimulated glucose transport. Involved in formation of actin stress fibers and focal adhesions (By similarity). {ECO:0000250|UniProtKB:Q62417}. |
Q9BY89 | KIAA1671 | S1598 | ochoa | Uncharacterized protein KIAA1671 | None |
Q9BYB0 | SHANK3 | S891 | ochoa | SH3 and multiple ankyrin repeat domains protein 3 (Shank3) (Proline-rich synapse-associated protein 2) (ProSAP2) | Major scaffold postsynaptic density protein which interacts with multiple proteins and complexes to orchestrate the dendritic spine and synapse formation, maturation and maintenance. Interconnects receptors of the postsynaptic membrane including NMDA-type and metabotropic glutamate receptors via complexes with GKAP/PSD-95 and HOMER, respectively, and the actin-based cytoskeleton. Plays a role in the structural and functional organization of the dendritic spine and synaptic junction through the interaction with Arp2/3 and WAVE1 complex as well as the promotion of the F-actin clusters. By way of this control of actin dynamics, participates in the regulation of developing neurons growth cone motility and the NMDA receptor-signaling. Also modulates GRIA1 exocytosis and GRM5/MGLUR5 expression and signaling to control the AMPA and metabotropic glutamate receptor-mediated synaptic transmission and plasticity. May be required at an early stage of synapse formation and be inhibited by IGF1 to promote synapse maturation. {ECO:0000269|PubMed:24132240}. |
Q9C0B5 | ZDHHC5 | S296 | ochoa | Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375) | Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates such as CTNND2, CD36, GSDMD, NLRP3, NOD1, NOD2, STAT3 and S1PR1 thus plays a role in various biological processes including cell adhesion, inflammation, fatty acid uptake, bacterial sensing or cardiac functions (PubMed:21820437, PubMed:29185452, PubMed:31402609, PubMed:31649195, PubMed:34293401, PubMed:38092000, PubMed:38530158, PubMed:38599239). Plays an important role in the regulation of synapse efficacy by mediating palmitoylation of delta-catenin/CTNND2, thereby increasing synaptic delivery and surface stabilization of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) (PubMed:26334723). Under basal conditions, remains at the synaptic membrane through FYN-mediated phosphorylation that prevents association with endocytic proteins (PubMed:26334723). Neuronal activity enhances the internalization and trafficking of DHHC5 from spines to dendritic shafts where it palmitoylates delta-catenin/CTNND2 (PubMed:26334723). Regulates cell adhesion at the plasma membrane by palmitoylating GOLGA7B and DSG2 (PubMed:31402609). Plays a role in innate immune response by mediating the palmitoylation of NOD1 and NOD2 and their proper recruitment to the bacterial entry site and phagosomes (PubMed:31649195, PubMed:34293401). Also participates in fatty acid uptake by palmitoylating CD36 and thereby targeting it to the plasma membrane (PubMed:32958780). Upon binding of fatty acids to CD36, gets phosphorylated by LYN leading to inactivation and subsequent CD36 caveolar endocytosis (PubMed:32958780). Controls oligodendrocyte development by catalyzing STAT3 palmitoylation (By similarity). Acts as a regulator of inflammatory response by mediating palmitoylation of NLRP3 and GSDMD (PubMed:38092000, PubMed:38530158, PubMed:38599239). Palmitoylates NLRP3 to promote inflammasome assembly and activation (PubMed:38092000). Activates pyroptosis by catalyzing palmitoylation of gasdermin-D (GSDMD), thereby promoting membrane translocation and pore formation of GSDMD (PubMed:38530158, PubMed:38599239). {ECO:0000250|UniProtKB:Q8VDZ4, ECO:0000269|PubMed:21820437, ECO:0000269|PubMed:26334723, ECO:0000269|PubMed:29185452, ECO:0000269|PubMed:31402609, ECO:0000269|PubMed:31649195, ECO:0000269|PubMed:32958780, ECO:0000269|PubMed:34293401, ECO:0000269|PubMed:38092000, ECO:0000269|PubMed:38530158, ECO:0000269|PubMed:38599239}. |
Q9C0C4 | SEMA4C | S742 | ochoa | Semaphorin-4C | Cell surface receptor for PLXNB2 that plays an important role in cell-cell signaling. PLXNB2 binding promotes downstream activation of RHOA and phosphorylation of ERBB2 at 'Tyr-1248'. Required for normal brain development, axon guidance and cell migration (By similarity). Probable signaling receptor which may play a role in myogenic differentiation through activation of the stress-activated MAPK cascade. {ECO:0000250, ECO:0000269|PubMed:17498836}. |
Q9C0H5 | ARHGAP39 | S445 | ochoa | Rho GTPase-activating protein 39 | None |
Q9GZM8 | NDEL1 | S306 | ochoa | Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1) | Required for organization of the cellular microtubule array and microtubule anchoring at the centrosome. May regulate microtubule organization at least in part by targeting the microtubule severing protein KATNA1 to the centrosome. Also positively regulates the activity of the minus-end directed microtubule motor protein dynein. May enhance dynein-mediated microtubule sliding by targeting dynein to the microtubule plus ends. Required for several dynein- and microtubule-dependent processes such as the maintenance of Golgi integrity, the centripetal motion of secretory vesicles and the coupling of the nucleus and centrosome. Also required during brain development for the migration of newly formed neurons from the ventricular/subventricular zone toward the cortical plate. Plays a role, together with DISC1, in the regulation of neurite outgrowth. Required for mitosis in some cell types but appears to be dispensible for mitosis in cortical neuronal progenitors, which instead requires NDE1. Facilitates the polymerization of neurofilaments from the individual subunits NEFH and NEFL. Positively regulates lysosome peripheral distribution and ruffled border formation in osteoclasts (By similarity). Plays a role, together with DISC1, in the regulation of neurite outgrowth (By similarity). May act as a RAB9A/B effector that tethers RAB9-associated late endosomes to the dynein motor for their retrograde transport to the trans-Golgi network (PubMed:34793709). {ECO:0000250|UniProtKB:Q78PB6, ECO:0000250|UniProtKB:Q9ERR1, ECO:0000269|PubMed:12556484, ECO:0000269|PubMed:14970193, ECO:0000269|PubMed:16291865, ECO:0000269|PubMed:17600710, ECO:0000269|PubMed:34793709}. |
Q9H4Z2 | ZNF335 | S989 | ochoa | Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1) | Component or associated component of some histone methyltransferase complexes may regulate transcription through recruitment of those complexes on gene promoters (PubMed:19131338, PubMed:23178126). Enhances ligand-dependent transcriptional activation by nuclear hormone receptors (PubMed:12215545, PubMed:18180299, PubMed:19131338). Plays an important role in neural progenitor cell proliferation and self-renewal through the regulation of specific genes involved brain development, including REST (PubMed:23178126). Also controls the expression of genes involved in somatic development and regulates, for instance, lymphoblast proliferation (PubMed:23178126). {ECO:0000269|PubMed:12215545, ECO:0000269|PubMed:18180299, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:23178126}. |
Q9H792 | PEAK1 | Y880 | ochoa | Inactive tyrosine-protein kinase PEAK1 (Pseudopodium-enriched atypical kinase 1) (Sugen kinase 269) (Tyrosine-protein kinase SgK269) | Probable catalytically inactive kinase. Scaffolding protein that regulates the cytoskeleton to control cell spreading and migration by modulating focal adhesion dynamics (PubMed:20534451, PubMed:23105102, PubMed:35687021). Acts as a scaffold for mediating EGFR signaling (PubMed:23846654). {ECO:0000269|PubMed:20534451, ECO:0000269|PubMed:23105102, ECO:0000269|PubMed:23846654, ECO:0000269|PubMed:35687021}. |
Q9H7D0 | DOCK5 | T1800 | ochoa | Dedicator of cytokinesis protein 5 | Guanine nucleotide exchange factor (GEF) for Rho and Rac. GEF proteins activate small GTPases by exchanging bound GDP for free GTP (By similarity). Along with DOCK1, mediates CRK/CRKL regulation of epithelial and endothelial cell spreading and migration on type IV collagen (PubMed:19004829). {ECO:0000250|UniProtKB:B2RY04, ECO:0000269|PubMed:19004829}. |
Q9H7D0 | DOCK5 | S1802 | ochoa | Dedicator of cytokinesis protein 5 | Guanine nucleotide exchange factor (GEF) for Rho and Rac. GEF proteins activate small GTPases by exchanging bound GDP for free GTP (By similarity). Along with DOCK1, mediates CRK/CRKL regulation of epithelial and endothelial cell spreading and migration on type IV collagen (PubMed:19004829). {ECO:0000250|UniProtKB:B2RY04, ECO:0000269|PubMed:19004829}. |
Q9H7D0 | DOCK5 | S1803 | ochoa | Dedicator of cytokinesis protein 5 | Guanine nucleotide exchange factor (GEF) for Rho and Rac. GEF proteins activate small GTPases by exchanging bound GDP for free GTP (By similarity). Along with DOCK1, mediates CRK/CRKL regulation of epithelial and endothelial cell spreading and migration on type IV collagen (PubMed:19004829). {ECO:0000250|UniProtKB:B2RY04, ECO:0000269|PubMed:19004829}. |
Q9H7D0 | DOCK5 | S1834 | ochoa | Dedicator of cytokinesis protein 5 | Guanine nucleotide exchange factor (GEF) for Rho and Rac. GEF proteins activate small GTPases by exchanging bound GDP for free GTP (By similarity). Along with DOCK1, mediates CRK/CRKL regulation of epithelial and endothelial cell spreading and migration on type IV collagen (PubMed:19004829). {ECO:0000250|UniProtKB:B2RY04, ECO:0000269|PubMed:19004829}. |
Q9H7D0 | DOCK5 | T1835 | ochoa | Dedicator of cytokinesis protein 5 | Guanine nucleotide exchange factor (GEF) for Rho and Rac. GEF proteins activate small GTPases by exchanging bound GDP for free GTP (By similarity). Along with DOCK1, mediates CRK/CRKL regulation of epithelial and endothelial cell spreading and migration on type IV collagen (PubMed:19004829). {ECO:0000250|UniProtKB:B2RY04, ECO:0000269|PubMed:19004829}. |
Q9H7M9 | VSIR | S272 | ochoa | V-type immunoglobulin domain-containing suppressor of T-cell activation (Platelet receptor Gi24) (Stress-induced secreted protein-1) (Sisp-1) (V-set domain-containing immunoregulatory receptor) (V-set immunoregulatory receptor) | Immunoregulatory receptor which inhibits the T-cell response (PubMed:24691993). May promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling (By similarity). May stimulate MMP14-mediated MMP2 activation (PubMed:20666777). {ECO:0000250|UniProtKB:Q9D659, ECO:0000269|PubMed:20666777, ECO:0000269|PubMed:24691993}. |
Q9H7P9 | PLEKHG2 | S1310 | ochoa | Pleckstrin homology domain-containing family G member 2 (PH domain-containing family G member 2) | May be a transforming oncogene with exchange activity for CDC42 (By similarity). May be a guanine-nucleotide exchange factor (GEF) for RAC1 and CDC42. Activated by the binding to subunits beta and gamma of the heterotrimeric guanine nucleotide-binding protein (G protein) (PubMed:18045877). Involved in the regulation of actin polymerization (PubMed:26573021). {ECO:0000250|UniProtKB:Q6KAU7, ECO:0000269|PubMed:18045877, ECO:0000269|PubMed:26573021}. |
Q9HA65 | TBC1D17 | S602 | ochoa | TBC1 domain family member 17 | Probable RAB GTPase-activating protein that inhibits RAB8A/B function. Reduces Rab8 recruitment to tubules emanating from the endocytic recycling compartment (ERC) and inhibits Rab8-mediated endocytic trafficking, such as that of transferrin receptor (TfR) (PubMed:22854040). Involved in regulation of autophagy. {ECO:0000269|PubMed:22854040, ECO:0000269|PubMed:24752605}. |
Q9NP62 | GCM1 | S326 | psp | Chorion-specific transcription factor GCMa (hGCMa) (GCM motif protein 1) (Glial cells missing homolog 1) | Transcription factor involved in the control of expression of placental growth factor (PGF) and other placenta-specific genes (PubMed:10542267, PubMed:18160678). Binds to the trophoblast-specific element 2 (TSE2) of the aromatase gene enhancer (PubMed:10542267). Binds to the SYDE1 promoter (PubMed:27917469). Has a central role in mediating the differentiation of trophoblast cells along both the villous and extravillous pathways in placental development (PubMed:19219068). {ECO:0000269|PubMed:10542267, ECO:0000269|PubMed:18160678, ECO:0000269|PubMed:19219068, ECO:0000269|PubMed:27917469}. |
Q9NPG3 | UBN1 | S953 | ochoa | Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein) | Acts as a novel regulator of senescence. Involved in the formation of senescence-associated heterochromatin foci (SAHF), which represses expression of proliferation-promoting genes. Binds to proliferation-promoting genes. May be required for replication-independent chromatin assembly. {ECO:0000269|PubMed:14718166, ECO:0000269|PubMed:19029251}. |
Q9NQC3 | RTN4 | S124 | ochoa | Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5) | Required to induce the formation and stabilization of endoplasmic reticulum (ER) tubules (PubMed:24262037, PubMed:25612671, PubMed:27619977). They regulate membrane morphogenesis in the ER by promoting tubular ER production (PubMed:24262037, PubMed:25612671, PubMed:27619977, PubMed:27786289). They influence nuclear envelope expansion, nuclear pore complex formation and proper localization of inner nuclear membrane proteins (PubMed:26906412). However each isoform have specific functions mainly depending on their tissue expression specificities (Probable). {ECO:0000269|PubMed:24262037, ECO:0000269|PubMed:25612671, ECO:0000269|PubMed:26906412, ECO:0000269|PubMed:27619977, ECO:0000269|PubMed:27786289, ECO:0000305}.; FUNCTION: [Isoform A]: Developmental neurite growth regulatory factor with a role as a negative regulator of axon-axon adhesion and growth, and as a facilitator of neurite branching. Regulates neurite fasciculation, branching and extension in the developing nervous system. Involved in down-regulation of growth, stabilization of wiring and restriction of plasticity in the adult CNS (PubMed:10667797, PubMed:11201742). Regulates the radial migration of cortical neurons via an RTN4R-LINGO1 containing receptor complex (By similarity). Acts as a negative regulator of central nervous system angiogenesis. Inhibits spreading, migration and sprouting of primary brain microvascular endothelial cells (MVECs). Also induces the retraction of MVECs lamellipodia and filopodia in a ROCK pathway-dependent manner (By similarity). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:10667797, ECO:0000269|PubMed:11201742, ECO:0000269|PubMed:19699797}.; FUNCTION: [Isoform B]: Mainly function in endothelial cells and vascular smooth muscle cells, is also involved in immune system regulation (Probable). Modulator of vascular remodeling, promotes the migration of endothelial cells but inhibits the migration of vascular smooth muscle cells. Regulates endothelial sphingolipid biosynthesis with direct effects on vascular function and blood pressure. Inhibits serine palmitoyltransferase, SPTLC1, the rate-limiting enzyme of the novo sphingolipid biosynthetic pathway, thereby controlling production of endothelial sphingosine-1-phosphate (S1P). Required to promote macrophage homing and functions such as cytokine/chemokine gene expression involved in angiogenesis, arteriogenesis and tissue repair. Mediates ICAM1 induced transendothelial migration of leukocytes such as monocytes and neutrophils and acute inflammation. Necessary for immune responses triggered by nucleic acid sensing TLRs, such as TLR9, is required for proper TLR9 location to endolysosomes. Also involved in immune response to LPS. Plays a role in liver regeneration through the modulation of hepatocytes proliferation (By similarity). Reduces the anti-apoptotic activity of Bcl-xl and Bcl-2. This is likely consecutive to their change in subcellular location, from the mitochondria to the endoplasmic reticulum, after binding and sequestration (PubMed:11126360). With isoform C, inhibits BACE1 activity and amyloid precursor protein processing (PubMed:16965550). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:11126360, ECO:0000269|PubMed:16965550, ECO:0000305}.; FUNCTION: [Isoform C]: Regulates cardiomyocyte apoptosis upon hypoxic conditions (By similarity). With isoform B, inhibits BACE1 activity and amyloid precursor protein processing (PubMed:16965550). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:16965550}. |
Q9NQC3 | RTN4 | S129 | ochoa | Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5) | Required to induce the formation and stabilization of endoplasmic reticulum (ER) tubules (PubMed:24262037, PubMed:25612671, PubMed:27619977). They regulate membrane morphogenesis in the ER by promoting tubular ER production (PubMed:24262037, PubMed:25612671, PubMed:27619977, PubMed:27786289). They influence nuclear envelope expansion, nuclear pore complex formation and proper localization of inner nuclear membrane proteins (PubMed:26906412). However each isoform have specific functions mainly depending on their tissue expression specificities (Probable). {ECO:0000269|PubMed:24262037, ECO:0000269|PubMed:25612671, ECO:0000269|PubMed:26906412, ECO:0000269|PubMed:27619977, ECO:0000269|PubMed:27786289, ECO:0000305}.; FUNCTION: [Isoform A]: Developmental neurite growth regulatory factor with a role as a negative regulator of axon-axon adhesion and growth, and as a facilitator of neurite branching. Regulates neurite fasciculation, branching and extension in the developing nervous system. Involved in down-regulation of growth, stabilization of wiring and restriction of plasticity in the adult CNS (PubMed:10667797, PubMed:11201742). Regulates the radial migration of cortical neurons via an RTN4R-LINGO1 containing receptor complex (By similarity). Acts as a negative regulator of central nervous system angiogenesis. Inhibits spreading, migration and sprouting of primary brain microvascular endothelial cells (MVECs). Also induces the retraction of MVECs lamellipodia and filopodia in a ROCK pathway-dependent manner (By similarity). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:10667797, ECO:0000269|PubMed:11201742, ECO:0000269|PubMed:19699797}.; FUNCTION: [Isoform B]: Mainly function in endothelial cells and vascular smooth muscle cells, is also involved in immune system regulation (Probable). Modulator of vascular remodeling, promotes the migration of endothelial cells but inhibits the migration of vascular smooth muscle cells. Regulates endothelial sphingolipid biosynthesis with direct effects on vascular function and blood pressure. Inhibits serine palmitoyltransferase, SPTLC1, the rate-limiting enzyme of the novo sphingolipid biosynthetic pathway, thereby controlling production of endothelial sphingosine-1-phosphate (S1P). Required to promote macrophage homing and functions such as cytokine/chemokine gene expression involved in angiogenesis, arteriogenesis and tissue repair. Mediates ICAM1 induced transendothelial migration of leukocytes such as monocytes and neutrophils and acute inflammation. Necessary for immune responses triggered by nucleic acid sensing TLRs, such as TLR9, is required for proper TLR9 location to endolysosomes. Also involved in immune response to LPS. Plays a role in liver regeneration through the modulation of hepatocytes proliferation (By similarity). Reduces the anti-apoptotic activity of Bcl-xl and Bcl-2. This is likely consecutive to their change in subcellular location, from the mitochondria to the endoplasmic reticulum, after binding and sequestration (PubMed:11126360). With isoform C, inhibits BACE1 activity and amyloid precursor protein processing (PubMed:16965550). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:11126360, ECO:0000269|PubMed:16965550, ECO:0000305}.; FUNCTION: [Isoform C]: Regulates cardiomyocyte apoptosis upon hypoxic conditions (By similarity). With isoform B, inhibits BACE1 activity and amyloid precursor protein processing (PubMed:16965550). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:16965550}. |
Q9NRA0 | SPHK2 | S484 | ochoa | Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91) | Catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro-dihydrosphingosine, D-erythro-sphingosine and L-threo-dihydrosphingosine. Binds phosphoinositides (PubMed:12954646, PubMed:19168031). In contrast to prosurvival SPHK1, has a positive effect on intracellular ceramide levels, inhibits cells growth and enhances apoptosis (PubMed:16118219). In mitochondria, is important for cytochrome-c oxidase assembly and mitochondrial respiration. The SPP produced in mitochondria binds PHB2 and modulates the regulation via PHB2 of complex IV assembly and respiration (PubMed:20959514). In nucleus, plays a role in epigenetic regulation of gene expression. Interacts with HDAC1 and HDAC2 and, through SPP production, inhibits their enzymatic activity, preventing the removal of acetyl groups from lysine residues with histones. Up-regulates acetylation of histone H3-K9, histone H4-K5 and histone H2B-K12 (PubMed:19729656). In nucleus, may have an inhibitory effect on DNA synthesis and cell cycle (PubMed:12954646, PubMed:16103110). In mast cells, is the main regulator of SPP production which mediates calcium influx, NF-kappa-B activation, cytokine production, such as TNF and IL6, and degranulation of mast cells (By similarity). In dopaminergic neurons, is involved in promoting mitochondrial functions regulating ATP and ROS levels (By similarity). Also involved in the regulation of glucose and lipid metabolism (By similarity). {ECO:0000250|UniProtKB:Q9JIA7, ECO:0000269|PubMed:12954646, ECO:0000269|PubMed:16103110, ECO:0000269|PubMed:16118219, ECO:0000269|PubMed:19168031, ECO:0000269|PubMed:19729656, ECO:0000269|PubMed:20959514}. |
Q9NTJ3 | SMC4 | S50 | ochoa | Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog) | Central component of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. {ECO:0000269|PubMed:11136719}. |
Q9NYB9 | ABI2 | S187 | psp | Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1) | Regulator of actin cytoskeleton dynamics underlying cell motility and adhesion. Functions as a component of the WAVE complex, which activates actin nucleating machinery Arp2/3 to drive lamellipodia formation (PubMed:21107423). Acts as a regulator and substrate of nonreceptor tyrosine kinases ABL1 and ABL2 involved in processes linked to cell growth and differentiation. Positively regulates ABL1-mediated phosphorylation of ENAH, which is required for proper polymerization of nucleated actin filaments at the leading edge (PubMed:10498863, PubMed:7590236, PubMed:8649853). Contributes to the regulation of actin assembly at the tips of neuron projections. In particular, controls dendritic spine morphogenesis and may promote dendritic spine specification toward large mushroom-type spines known as repositories of memory in the brain (By similarity). In hippocampal neurons, may mediate actin-dependent BDNF-NTRK2 early endocytic trafficking that triggers dendrite outgrowth (By similarity). Participates in ocular lens morphogenesis, likely by regulating lamellipodia-driven adherens junction formation at the epithelial cell-secondary lens fiber interface (By similarity). Also required for nascent adherens junction assembly in epithelial cells (PubMed:15572692). {ECO:0000250|UniProtKB:P62484, ECO:0000269|PubMed:10498863, ECO:0000269|PubMed:15572692, ECO:0000269|PubMed:21107423, ECO:0000269|PubMed:7590236, ECO:0000269|PubMed:8649853}. |
Q9NZN8 | CNOT2 | S108 | ochoa | CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2) | Component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Required for the CCR4-NOT complex structural integrity. Can repress transcription and may link the CCR4-NOT complex to transcriptional regulation; the repressive function may specifically involve the N-Cor repressor complex containing HDAC3, NCOR1 and NCOR2. Involved in the maintenance of embryonic stem (ES) cell identity. {ECO:0000269|PubMed:14707134, ECO:0000269|PubMed:16712523, ECO:0000269|PubMed:21299754, ECO:0000269|PubMed:22367759}. |
Q9P0K7 | RAI14 | S260 | ochoa | Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14) | Plays a role in actin regulation at the ectoplasmic specialization, a type of cell junction specific to testis. Important for establishment of sperm polarity and normal spermatid adhesion. May also promote integrity of Sertoli cell tight junctions at the blood-testis barrier. {ECO:0000250|UniProtKB:Q5U312}. |
Q9P1Y6 | PHRF1 | S955 | ochoa | PHD and RING finger domain-containing protein 1 | None |
Q9P206 | NHSL3 | S526 | ochoa | NHS-like protein 3 | Able to directly activate the TNF-NFkappaB signaling pathway. {ECO:0000269|PubMed:32854746}. |
Q9P266 | JCAD | S371 | ochoa | Junctional cadherin 5-associated protein (Junctional protein associated with coronary artery disease) (JCAD) | None |
Q9P266 | JCAD | S913 | ochoa | Junctional cadherin 5-associated protein (Junctional protein associated with coronary artery disease) (JCAD) | None |
Q9P273 | TENM3 | S199 | ochoa | Teneurin-3 (Ten-3) (Protein Odd Oz/ten-m homolog 3) (Tenascin-M3) (Ten-m3) (Teneurin transmembrane protein 3) | Involved in neural development by regulating the establishment of proper connectivity within the nervous system. Acts in both pre- and postsynaptic neurons in the hippocampus to control the assembly of a precise topographic projection: required in both CA1 and subicular neurons for the precise targeting of proximal CA1 axons to distal subiculum, probably by promoting homophilic cell adhesion. Required for proper dendrite morphogenesis and axon targeting in the vertebrate visual system, thereby playing a key role in the development of the visual pathway. Regulates the formation in ipsilateral retinal mapping to both the dorsal lateral geniculate nucleus (dLGN) and the superior colliculus (SC). May also be involved in the differentiation of the fibroblast-like cells in the superficial layer of mandibular condylar cartilage into chondrocytes. {ECO:0000250|UniProtKB:Q9WTS6}. |
Q9P2A4 | ABI3 | S216 | psp | ABI gene family member 3 (New molecule including SH3) (Nesh) | May inhibit tumor metastasis (By similarity). In vitro, reduces cell motility. {ECO:0000250, ECO:0000269|PubMed:11956071}. |
Q9UBW5 | BIN2 | S429 | ochoa | Bridging integrator 2 (Breast cancer-associated protein 1) | Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis. {ECO:0000269|PubMed:23285027}. |
Q9ULH1 | ASAP1 | S812 | ochoa | Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) | Possesses phosphatidylinositol 4,5-bisphosphate-dependent GTPase-activating protein activity for ARF1 (ADP ribosylation factor 1) and ARF5 and a lesser activity towards ARF6. May coordinate membrane trafficking with cell growth or actin cytoskeleton remodeling by binding to both SRC and PIP2. May function as a signal transduction protein involved in the differentiation of fibroblasts into adipocytes and possibly other cell types. Part of the ciliary targeting complex containing Rab11, ASAP1, Rabin8/RAB3IP, RAB11FIP3 and ARF4, which direct preciliary vesicle trafficking to mother centriole and ciliogenesis initiation (PubMed:25673879). {ECO:0000250, ECO:0000269|PubMed:20393563, ECO:0000269|PubMed:25673879}. |
Q9ULH1 | ASAP1 | T813 | ochoa | Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) | Possesses phosphatidylinositol 4,5-bisphosphate-dependent GTPase-activating protein activity for ARF1 (ADP ribosylation factor 1) and ARF5 and a lesser activity towards ARF6. May coordinate membrane trafficking with cell growth or actin cytoskeleton remodeling by binding to both SRC and PIP2. May function as a signal transduction protein involved in the differentiation of fibroblasts into adipocytes and possibly other cell types. Part of the ciliary targeting complex containing Rab11, ASAP1, Rabin8/RAB3IP, RAB11FIP3 and ARF4, which direct preciliary vesicle trafficking to mother centriole and ciliogenesis initiation (PubMed:25673879). {ECO:0000250, ECO:0000269|PubMed:20393563, ECO:0000269|PubMed:25673879}. |
Q9ULH7 | MRTFB | S225 | ochoa | Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2) | Acts as a transcriptional coactivator of serum response factor (SRF). Required for skeletal myogenic differentiation. {ECO:0000269|PubMed:14565952}. |
Q9UMN6 | KMT2B | S602 | ochoa | Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.364) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism. Part of chromatin remodeling machinery predominantly forms H3K4me1 and H3K4me2 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17707229, PubMed:25561738). Likely plays a redundant role with KMT2C in enriching H3K4me1 marks on primed and active enhancer elements (PubMed:24081332). Plays a central role in beta-globin locus transcription regulation by being recruited by NFE2 (PubMed:17707229). Plays an important role in controlling bulk H3K4me during oocyte growth and preimplantation development (By similarity). Required during the transcriptionally active period of oocyte growth for the establishment and/or maintenance of bulk H3K4 trimethylation (H3K4me3), global transcriptional silencing that preceeds resumption of meiosis, oocyte survival and normal zygotic genome activation (By similarity). {ECO:0000250|UniProtKB:O08550, ECO:0000269|PubMed:17707229, ECO:0000269|PubMed:24081332, ECO:0000269|PubMed:25561738}. |
Q9UPN7 | PPP6R1 | S756 | ochoa | Serine/threonine-protein phosphatase 6 regulatory subunit 1 (SAPS domain family member 1) | Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. Involved in the PP6-mediated dephosphorylation of NFKBIE opposing its degradation in response to TNF-alpha. {ECO:0000269|PubMed:16769727}. |
Q9UPT8 | ZC3H4 | T530 | ochoa | Zinc finger CCCH domain-containing protein 4 | RNA-binding protein that suppresses transcription of long non-coding RNAs (lncRNAs) (PubMed:33767452, PubMed:33913806). LncRNAs are defined as transcripts more than 200 nucleotides that are not translated into protein (PubMed:33767452, PubMed:33913806). Together with WDR82, part of a transcription termination checkpoint that promotes transcription termination of lncRNAs and their subsequent degradation by the exosome (PubMed:33767452, PubMed:33913806). The transcription termination checkpoint is activated by the inefficiently spliced first exon of lncRNAs (PubMed:33767452). {ECO:0000269|PubMed:33767452, ECO:0000269|PubMed:33913806}. |
Q9UPT8 | ZC3H4 | S531 | ochoa | Zinc finger CCCH domain-containing protein 4 | RNA-binding protein that suppresses transcription of long non-coding RNAs (lncRNAs) (PubMed:33767452, PubMed:33913806). LncRNAs are defined as transcripts more than 200 nucleotides that are not translated into protein (PubMed:33767452, PubMed:33913806). Together with WDR82, part of a transcription termination checkpoint that promotes transcription termination of lncRNAs and their subsequent degradation by the exosome (PubMed:33767452, PubMed:33913806). The transcription termination checkpoint is activated by the inefficiently spliced first exon of lncRNAs (PubMed:33767452). {ECO:0000269|PubMed:33767452, ECO:0000269|PubMed:33913806}. |
Q9UQB3 | CTNND2 | S201 | ochoa | Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) | Has a critical role in neuronal development, particularly in the formation and/or maintenance of dendritic spines and synapses (PubMed:25807484). Involved in the regulation of Wnt signaling (PubMed:25807484). It probably acts on beta-catenin turnover, facilitating beta-catenin interaction with GSK3B, phosphorylation, ubiquitination and degradation (By similarity). Functions as a transcriptional activator when bound to ZBTB33 (By similarity). May be involved in neuronal cell adhesion and tissue morphogenesis and integrity by regulating adhesion molecules. {ECO:0000250|UniProtKB:O35927, ECO:0000269|PubMed:25807484, ECO:0000269|PubMed:9971746}. |
Q9Y2H0 | DLGAP4 | S763 | ochoa | Disks large-associated protein 4 (DAP-4) (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4) (SAPAP-4) | May play a role in the molecular organization of synapses and neuronal cell signaling. Could be an adapter protein linking ion channel to the subsynaptic cytoskeleton. May induce enrichment of PSD-95/SAP90 at the plasma membrane. |
Q9Y2H6 | FNDC3A | S114 | ochoa | Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts) | Mediates spermatid-Sertoli adhesion during spermatogenesis. {ECO:0000250}. |
Q9Y2J4 | AMOTL2 | S723 | ochoa | Angiomotin-like protein 2 (Leman coiled-coil protein) (LCCP) | Regulates the translocation of phosphorylated SRC to peripheral cell-matrix adhesion sites. Required for proper architecture of actin filaments. Plays a role in coupling actin fibers to cell junctions in endothelial cells and is therefore required for correct endothelial cell morphology via facilitating transcellular transmission of mechanical force resulting in endothelial cell elongation (By similarity). Required for the anchoring of radial actin fibers to CDH1 junction complexes at the cell membrane which facilitates organization of radial actin fiber structure and cellular response to contractile forces (PubMed:28842668). This contributes to maintenance of cell area, size, shape, epithelial sheet organization and trophectoderm cell properties that facilitate blastocyst zona hatching (PubMed:28842668). Inhibits the Wnt/beta-catenin signaling pathway, probably by recruiting CTNNB1 to recycling endosomes and hence preventing its translocation to the nucleus. Participates in angiogenesis. Activates the Hippo signaling pathway in response to cell contact inhibition via interaction with and ubiquitination by Crumbs complex-bound WWP1 (PubMed:34404733). Ubiquitinated AMOTL2 then interacts with LATS2 which in turn phosphorylates YAP1, excluding it from the nucleus and localizing it to the cytoplasm and tight junctions, therefore ultimately repressing YAP1-driven transcription of target genes (PubMed:17293535, PubMed:21205866, PubMed:26598551). Acts to inhibit WWTR1/TAZ transcriptional coactivator activity via sequestering WWTR1/TAZ in the cytoplasm and at tight junctions (PubMed:23911299). Regulates the size and protein composition of the podosome cortex and core at myofibril neuromuscular junctions (PubMed:23525008). Selectively promotes FGF-induced MAPK activation through SRC (PubMed:17293535). May play a role in the polarity, proliferation and migration of endothelial cells. {ECO:0000250|UniProtKB:Q8K371, ECO:0000269|PubMed:17293535, ECO:0000269|PubMed:21205866, ECO:0000269|PubMed:21937427, ECO:0000269|PubMed:22362771, ECO:0000269|PubMed:23525008, ECO:0000269|PubMed:23911299, ECO:0000269|PubMed:26598551, ECO:0000269|PubMed:28842668, ECO:0000269|PubMed:34404733}. |
Q9Y4H2 | IRS2 | Y1253 | ochoa | Insulin receptor substrate 2 (IRS-2) | Signaling adapter protein that participates in the signal transduction from two prominent receptor tyrosine kinases, insulin receptor/INSR and insulin-like growth factor I receptor/IGF1R (PubMed:25879670). Plays therefore an important role in development, growth, glucose homeostasis as well as lipid metabolism (PubMed:24616100). Upon phosphorylation by the insulin receptor, functions as a signaling scaffold that propagates insulin action through binding to SH2 domain-containing proteins including the p85 regulatory subunit of PI3K, NCK1, NCK2, GRB2 or SHP2 (PubMed:15316008, PubMed:19109239). Recruitment of GRB2 leads to the activation of the guanine nucleotide exchange factor SOS1 which in turn triggers the Ras/Raf/MEK/MAPK signaling cascade (By similarity). Activation of the PI3K/AKT pathway is responsible for most of insulin metabolic effects in the cell, and the Ras/Raf/MEK/MAPK is involved in the regulation of gene expression and in cooperation with the PI3K pathway regulates cell growth and differentiation. Acts a positive regulator of the Wnt/beta-catenin signaling pathway through suppression of DVL2 autophagy-mediated degradation leading to cell proliferation (PubMed:24616100). Plays a role in cell cycle progression by promoting a robust spindle assembly checkpoint (SAC) during M-phase (PubMed:32554797). In macrophages, IL4-induced tyrosine phosphorylation of IRS2 leads to the recruitment and activation of phosphoinositide 3-kinase (PI3K) (PubMed:19109239). {ECO:0000250|UniProtKB:P35570, ECO:0000269|PubMed:15316008, ECO:0000269|PubMed:19109239, ECO:0000269|PubMed:24616100, ECO:0000269|PubMed:25879670, ECO:0000269|PubMed:32554797}. |
Q9Y5K6 | CD2AP | S404 | ochoa | CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains) | Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton (PubMed:10339567). In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity). May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By similarity). May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis (PubMed:15800069). Plays a role in epithelial cell junctions formation (PubMed:22891260). {ECO:0000250|UniProtKB:F1LRS8, ECO:0000250|UniProtKB:Q9JLQ0, ECO:0000269|PubMed:10339567, ECO:0000269|PubMed:15800069, ECO:0000269|PubMed:22891260}. |
Q9Y6W5 | WASF2 | S308 | ochoa|psp | Actin-binding protein WASF2 (Protein WAVE-2) (Verprolin homology domain-containing protein 2) (Wiskott-Aldrich syndrome protein family member 2) (WASP family protein member 2) | Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex. {ECO:0000269|PubMed:10381382, ECO:0000269|PubMed:16275905}. |
Q9Y6W5 | WASF2 | S351 | psp | Actin-binding protein WASF2 (Protein WAVE-2) (Verprolin homology domain-containing protein 2) (Wiskott-Aldrich syndrome protein family member 2) (WASP family protein member 2) | Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex. {ECO:0000269|PubMed:10381382, ECO:0000269|PubMed:16275905}. |
Q12965 | MYO1E | T939 | Sugiyama | Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E) | Actin-based motor molecule with ATPase activity (PubMed:11940582, PubMed:36316095). Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. Binds to membranes containing anionic phospholipids via its tail domain. Involved in clathrin-mediated endocytosis and intracellular movement of clathrin-coated vesicles (PubMed:36316095). Required for normal morphology of the glomerular basement membrane, normal development of foot processes by kidney podocytes and normal kidney function. In dendritic cells, may control the movement of class II-containing cytoplasmic vesicles along the actin cytoskeleton by connecting them with the actin network via ARL14EP and ARL14. {ECO:0000269|PubMed:11940582, ECO:0000269|PubMed:17257598, ECO:0000269|PubMed:20860408, ECO:0000269|PubMed:36316095}. |
O15027 | SEC16A | Y1161 | Sugiyama | Protein transport protein Sec16A (SEC16 homolog A) (p250) | Acts as a molecular scaffold that plays a key role in the organization of the endoplasmic reticulum exit sites (ERES), also known as transitional endoplasmic reticulum (tER). SAR1A-GTP-dependent assembly of SEC16A on the ER membrane forms an organized scaffold defining an ERES. Required for secretory cargo traffic from the endoplasmic reticulum to the Golgi apparatus (PubMed:17005010, PubMed:17192411, PubMed:17428803, PubMed:21768384, PubMed:22355596). Mediates the recruitment of MIA3/TANGO to ERES (PubMed:28442536). Regulates both conventional (ER/Golgi-dependent) and GORASP2-mediated unconventional (ER/Golgi-independent) trafficking of CFTR to cell membrane (PubMed:28067262). Positively regulates the protein stability of E3 ubiquitin-protein ligases RNF152 and RNF183 and the ER localization of RNF183 (PubMed:29300766). Acts as a RAB10 effector in the regulation of insulin-induced SLC2A4/GLUT4 glucose transporter-enriched vesicles delivery to the cell membrane in adipocytes (By similarity). {ECO:0000250|UniProtKB:E9QAT4, ECO:0000269|PubMed:17005010, ECO:0000269|PubMed:17192411, ECO:0000269|PubMed:17428803, ECO:0000269|PubMed:21768384, ECO:0000269|PubMed:22355596, ECO:0000269|PubMed:28067262, ECO:0000269|PubMed:28442536, ECO:0000269|PubMed:29300766}. |
P08151 | GLI1 | S550 | GPS6 | Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI) | Acts as a transcriptional activator (PubMed:10806483, PubMed:19706761, PubMed:19878745, PubMed:24076122, PubMed:24217340, PubMed:24311597). Binds to the DNA consensus sequence 5'-GACCACCCA-3' (PubMed:2105456, PubMed:24217340, PubMed:8378770). Regulates the transcription of specific genes during normal development (PubMed:19706761). Plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Mediates SHH signaling (PubMed:19706761, PubMed:28973407). Plays a role in cell proliferation and differentiation via its role in SHH signaling (PubMed:11238441, PubMed:28973407). {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441, ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:2105456, ECO:0000269|PubMed:24076122, ECO:0000269|PubMed:24217340, ECO:0000269|PubMed:24311597, ECO:0000269|PubMed:28973407, ECO:0000269|PubMed:8378770}.; FUNCTION: [Isoform 2]: Acts as a transcriptional activator, but activates a different set of genes than isoform 1. Activates expression of CD24, unlike isoform 1. Mediates SHH signaling. Promotes cancer cell migration. {ECO:0000269|PubMed:19706761}. |
Q96PV0 | SYNGAP1 | S779 | SIGNOR | Ras/Rap GTPase-activating protein SynGAP (Neuronal RasGAP) (Synaptic Ras GTPase-activating protein 1) (Synaptic Ras-GAP 1) | Major constituent of the PSD essential for postsynaptic signaling. Inhibitory regulator of the Ras-cAMP pathway. Member of the NMDAR signaling complex in excitatory synapses, it may play a role in NMDAR-dependent control of AMPAR potentiation, AMPAR membrane trafficking and synaptic plasticity. Regulates AMPAR-mediated miniature excitatory postsynaptic currents. Exhibits dual GTPase-activating specificity for Ras and Rap. May be involved in certain forms of brain injury, leading to long-term learning and memory deficits (By similarity). {ECO:0000250}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 0.000452 | 3.345 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.000855 | 3.068 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 0.000988 | 3.005 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 0.000949 | 3.023 |
R-HSA-9664407 | Parasite infection | 0.000949 | 3.023 |
R-HSA-9664417 | Leishmania phagocytosis | 0.000949 | 3.023 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.001112 | 2.954 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.001261 | 2.899 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 0.001612 | 2.793 |
R-HSA-8853659 | RET signaling | 0.002291 | 2.640 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 0.003383 | 2.471 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.003629 | 2.440 |
R-HSA-5635851 | GLI proteins bind promoters of Hh responsive genes to promote transcription | 0.004736 | 2.325 |
R-HSA-199991 | Membrane Trafficking | 0.005116 | 2.291 |
R-HSA-112412 | SOS-mediated signalling | 0.007279 | 2.138 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 0.007362 | 2.133 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 0.007362 | 2.133 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.006265 | 2.203 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.006960 | 2.157 |
R-HSA-177929 | Signaling by EGFR | 0.009173 | 2.037 |
R-HSA-194138 | Signaling by VEGF | 0.009150 | 2.039 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 0.010177 | 1.992 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 0.010079 | 1.997 |
R-HSA-74749 | Signal attenuation | 0.012001 | 1.921 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 0.012181 | 1.914 |
R-HSA-428540 | Activation of RAC1 | 0.015718 | 1.804 |
R-HSA-5673000 | RAF activation | 0.015548 | 1.808 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.016562 | 1.781 |
R-HSA-5602566 | TICAM1 deficiency - HSE | 0.024899 | 1.604 |
R-HSA-177504 | Retrograde neurotrophin signalling | 0.022084 | 1.656 |
R-HSA-9027284 | Erythropoietin activates RAS | 0.024406 | 1.612 |
R-HSA-354194 | GRB2:SOS provides linkage to MAPK signaling for Integrins | 0.026823 | 1.571 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 0.031581 | 1.501 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 0.031581 | 1.501 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 0.031581 | 1.501 |
R-HSA-418885 | DCC mediated attractive signaling | 0.024406 | 1.612 |
R-HSA-6802949 | Signaling by RAS mutants | 0.031581 | 1.501 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 0.022084 | 1.656 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 0.024406 | 1.612 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.023414 | 1.631 |
R-HSA-9634285 | Constitutive Signaling by Overexpressed ERBB2 | 0.017737 | 1.751 |
R-HSA-9706369 | Negative regulation of FLT3 | 0.026823 | 1.571 |
R-HSA-9675151 | Disorders of Developmental Biology | 0.029333 | 1.533 |
R-HSA-9682385 | FLT3 signaling in disease | 0.017613 | 1.754 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 0.026996 | 1.569 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 0.020984 | 1.678 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 0.022084 | 1.656 |
R-HSA-166520 | Signaling by NTRKs | 0.019526 | 1.709 |
R-HSA-9675108 | Nervous system development | 0.021505 | 1.667 |
R-HSA-422475 | Axon guidance | 0.028259 | 1.549 |
R-HSA-8854214 | TBC/RABGAPs | 0.027334 | 1.563 |
R-HSA-9607240 | FLT3 Signaling | 0.023414 | 1.631 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.023414 | 1.631 |
R-HSA-3214858 | RMTs methylate histone arginines | 0.028713 | 1.542 |
R-HSA-1433559 | Regulation of KIT signaling | 0.022084 | 1.656 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.018700 | 1.728 |
R-HSA-2028269 | Signaling by Hippo | 0.031932 | 1.496 |
R-HSA-5637810 | Constitutive Signaling by EGFRvIII | 0.031932 | 1.496 |
R-HSA-5637812 | Signaling by EGFRvIII in Cancer | 0.031932 | 1.496 |
R-HSA-9827857 | Specification of primordial germ cells | 0.031932 | 1.496 |
R-HSA-5602571 | TRAF3 deficiency - HSE | 0.037116 | 1.430 |
R-HSA-198765 | Signalling to ERK5 | 0.049181 | 1.308 |
R-HSA-9918454 | Defective visual phototransduction due to ABCA4 loss of function | 0.049181 | 1.308 |
R-HSA-9944997 | Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | 0.061096 | 1.214 |
R-HSA-9944971 | Loss of Function of KMT2D in Kabuki Syndrome | 0.061096 | 1.214 |
R-HSA-9013957 | TLR3-mediated TICAM1-dependent programmed cell death | 0.072861 | 1.138 |
R-HSA-9652169 | Signaling by MAP2K mutants | 0.072861 | 1.138 |
R-HSA-74713 | IRS activation | 0.084480 | 1.073 |
R-HSA-9673768 | Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | 0.084480 | 1.073 |
R-HSA-9706377 | FLT3 signaling by CBL mutants | 0.084480 | 1.073 |
R-HSA-182218 | Nef Mediated CD8 Down-regulation | 0.095955 | 1.018 |
R-HSA-9027283 | Erythropoietin activates STAT5 | 0.107286 | 0.969 |
R-HSA-428890 | Role of ABL in ROBO-SLIT signaling | 0.118476 | 0.926 |
R-HSA-2562578 | TRIF-mediated programmed cell death | 0.118476 | 0.926 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 0.118476 | 0.926 |
R-HSA-9828211 | Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | 0.129526 | 0.888 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 0.040242 | 1.395 |
R-HSA-9014325 | TICAM1,TRAF6-dependent induction of TAK1 complex | 0.151214 | 0.820 |
R-HSA-2468052 | Establishment of Sister Chromatid Cohesion | 0.151214 | 0.820 |
R-HSA-110056 | MAPK3 (ERK1) activation | 0.151214 | 0.820 |
R-HSA-9027277 | Erythropoietin activates Phospholipase C gamma (PLCG) | 0.151214 | 0.820 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 0.172365 | 0.764 |
R-HSA-9824878 | Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | 0.172365 | 0.764 |
R-HSA-202670 | ERKs are inactivated | 0.172365 | 0.764 |
R-HSA-9027276 | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 0.182743 | 0.738 |
R-HSA-179812 | GRB2 events in EGFR signaling | 0.182743 | 0.738 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 0.192992 | 0.714 |
R-HSA-9006335 | Signaling by Erythropoietin | 0.072761 | 1.138 |
R-HSA-182971 | EGFR downregulation | 0.080022 | 1.097 |
R-HSA-937072 | TRAF6-mediated induction of TAK1 complex within TLR4 complex | 0.213106 | 0.671 |
R-HSA-168927 | TICAM1, RIP1-mediated IKK complex recruitment | 0.213106 | 0.671 |
R-HSA-1963640 | GRB2 events in ERBB2 signaling | 0.232722 | 0.633 |
R-HSA-372708 | p130Cas linkage to MAPK signaling for integrins | 0.242347 | 0.616 |
R-HSA-73779 | RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 0.119242 | 0.924 |
R-HSA-912631 | Regulation of signaling by CBL | 0.261237 | 0.583 |
R-HSA-937041 | IKK complex recruitment mediated by RIP1 | 0.261237 | 0.583 |
R-HSA-5674135 | MAP2K and MAPK activation | 0.127573 | 0.894 |
R-HSA-167161 | HIV Transcription Initiation | 0.127573 | 0.894 |
R-HSA-75953 | RNA Polymerase II Transcription Initiation | 0.127573 | 0.894 |
R-HSA-350054 | Notch-HLH transcription pathway | 0.297623 | 0.526 |
R-HSA-1221632 | Meiotic synapsis | 0.179949 | 0.745 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 0.211801 | 0.674 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 0.234873 | 0.629 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.272027 | 0.565 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.313744 | 0.503 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.282170 | 0.549 |
R-HSA-9013973 | TICAM1-dependent activation of IRF3/IRF7 | 0.172365 | 0.764 |
R-HSA-936964 | Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | 0.232722 | 0.633 |
R-HSA-9656223 | Signaling by RAF1 mutants | 0.127573 | 0.894 |
R-HSA-76042 | RNA Polymerase II Transcription Initiation And Promoter Clearance | 0.144620 | 0.840 |
R-HSA-198203 | PI3K/AKT activation | 0.151214 | 0.820 |
R-HSA-5620916 | VxPx cargo-targeting to cilium | 0.270506 | 0.568 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.259720 | 0.585 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.259720 | 0.585 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.259720 | 0.585 |
R-HSA-203641 | NOSTRIN mediated eNOS trafficking | 0.118476 | 0.926 |
R-HSA-190873 | Gap junction degradation | 0.140438 | 0.853 |
R-HSA-6802957 | Oncogenic MAPK signaling | 0.114070 | 0.943 |
R-HSA-8941856 | RUNX3 regulates NOTCH signaling | 0.182743 | 0.738 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 0.095169 | 1.022 |
R-HSA-73776 | RNA Polymerase II Promoter Escape | 0.136036 | 0.866 |
R-HSA-72172 | mRNA Splicing | 0.313087 | 0.504 |
R-HSA-1250196 | SHC1 events in ERBB2 signaling | 0.076364 | 1.117 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 0.107021 | 0.971 |
R-HSA-416993 | Trafficking of GluR2-containing AMPA receptors | 0.251851 | 0.599 |
R-HSA-167162 | RNA Polymerase II HIV Promoter Escape | 0.127573 | 0.894 |
R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell | 0.213106 | 0.671 |
R-HSA-9703465 | Signaling by FLT3 fusion proteins | 0.062307 | 1.205 |
R-HSA-167590 | Nef Mediated CD4 Down-regulation | 0.118476 | 0.926 |
R-HSA-8851805 | MET activates RAS signaling | 0.182743 | 0.738 |
R-HSA-74751 | Insulin receptor signalling cascade | 0.230244 | 0.638 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.060333 | 1.219 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.060333 | 1.219 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.173577 | 0.761 |
R-HSA-198753 | ERK/MAPK targets | 0.279659 | 0.553 |
R-HSA-437239 | Recycling pathway of L1 | 0.153314 | 0.814 |
R-HSA-9022538 | Loss of MECP2 binding ability to 5mC-DNA | 0.061096 | 1.214 |
R-HSA-193634 | Axonal growth inhibition (RHOA activation) | 0.129526 | 0.888 |
R-HSA-196025 | Formation of annular gap junctions | 0.129526 | 0.888 |
R-HSA-428543 | Inactivation of CDC42 and RAC1 | 0.140438 | 0.853 |
R-HSA-5140745 | WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 0.151214 | 0.820 |
R-HSA-9034864 | Activated NTRK3 signals through RAS | 0.161856 | 0.791 |
R-HSA-9026519 | Activated NTRK2 signals through RAS | 0.172365 | 0.764 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 0.172365 | 0.764 |
R-HSA-8866427 | VLDLR internalisation and degradation | 0.182743 | 0.738 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 0.192992 | 0.714 |
R-HSA-180336 | SHC1 events in EGFR signaling | 0.213106 | 0.671 |
R-HSA-1250347 | SHC1 events in ERBB4 signaling | 0.232722 | 0.633 |
R-HSA-5654704 | SHC-mediated cascade:FGFR3 | 0.279659 | 0.553 |
R-HSA-5654719 | SHC-mediated cascade:FGFR4 | 0.288697 | 0.540 |
R-HSA-5654688 | SHC-mediated cascade:FGFR1 | 0.315142 | 0.501 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 0.216399 | 0.665 |
R-HSA-2428924 | IGF1R signaling cascade | 0.230244 | 0.638 |
R-HSA-112399 | IRS-mediated signalling | 0.198070 | 0.703 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 0.262729 | 0.580 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 0.234873 | 0.629 |
R-HSA-6807004 | Negative regulation of MET activity | 0.270506 | 0.568 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 0.200295 | 0.698 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 0.184411 | 0.734 |
R-HSA-2428933 | SHC-related events triggered by IGF1R | 0.182743 | 0.738 |
R-HSA-5099900 | WNT5A-dependent internalization of FZD4 | 0.222976 | 0.652 |
R-HSA-164938 | Nef-mediates down modulation of cell surface receptors by recruiting them to cla... | 0.242347 | 0.616 |
R-HSA-139853 | Elevation of cytosolic Ca2+ levels | 0.242347 | 0.616 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 0.200295 | 0.698 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.106901 | 0.971 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 0.288697 | 0.540 |
R-HSA-5632684 | Hedgehog 'on' state | 0.262729 | 0.580 |
R-HSA-193697 | p75NTR regulates axonogenesis | 0.140438 | 0.853 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.098042 | 1.009 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.070660 | 1.151 |
R-HSA-9701898 | STAT3 nuclear events downstream of ALK signaling | 0.213106 | 0.671 |
R-HSA-5674499 | Negative feedback regulation of MAPK pathway | 0.095955 | 1.018 |
R-HSA-8964046 | VLDL clearance | 0.118476 | 0.926 |
R-HSA-881907 | Gastrin-CREB signalling pathway via PKC and MAPK | 0.037389 | 1.427 |
R-HSA-2179392 | EGFR Transactivation by Gastrin | 0.151214 | 0.820 |
R-HSA-354192 | Integrin signaling | 0.087496 | 1.058 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 0.297623 | 0.526 |
R-HSA-6806834 | Signaling by MET | 0.100979 | 0.996 |
R-HSA-170968 | Frs2-mediated activation | 0.192992 | 0.714 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 0.315142 | 0.501 |
R-HSA-5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | 0.043174 | 1.365 |
R-HSA-1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 0.043174 | 1.365 |
R-HSA-164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 0.306437 | 0.514 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 0.144620 | 0.840 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 0.127573 | 0.894 |
R-HSA-373752 | Netrin-1 signaling | 0.140314 | 0.853 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.159081 | 0.798 |
R-HSA-1643713 | Signaling by EGFR in Cancer | 0.062307 | 1.205 |
R-HSA-9028731 | Activated NTRK2 signals through FRS2 and FRS3 | 0.182743 | 0.738 |
R-HSA-9673770 | Signaling by PDGFRA extracellular domain mutants | 0.213106 | 0.671 |
R-HSA-9673767 | Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 0.213106 | 0.671 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.273820 | 0.563 |
R-HSA-1295596 | Spry regulation of FGF signaling | 0.213106 | 0.671 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 0.251851 | 0.599 |
R-HSA-6794361 | Neurexins and neuroligins | 0.175459 | 0.756 |
R-HSA-5683057 | MAPK family signaling cascades | 0.183367 | 0.737 |
R-HSA-167172 | Transcription of the HIV genome | 0.248788 | 0.604 |
R-HSA-8849469 | PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | 0.129526 | 0.888 |
R-HSA-9022702 | MECP2 regulates transcription of neuronal ligands | 0.151214 | 0.820 |
R-HSA-9671555 | Signaling by PDGFR in disease | 0.046183 | 1.336 |
R-HSA-429947 | Deadenylation of mRNA | 0.055651 | 1.255 |
R-HSA-1810476 | RIP-mediated NFkB activation via ZBP1 | 0.213106 | 0.671 |
R-HSA-210744 | Regulation of gene expression in late stage (branching morphogenesis) pancreatic... | 0.222976 | 0.652 |
R-HSA-445355 | Smooth Muscle Contraction | 0.179949 | 0.745 |
R-HSA-204005 | COPII-mediated vesicle transport | 0.258080 | 0.588 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 0.304505 | 0.516 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 0.076364 | 1.117 |
R-HSA-5654706 | FRS-mediated FGFR3 signaling | 0.288697 | 0.540 |
R-HSA-5654712 | FRS-mediated FGFR4 signaling | 0.297623 | 0.526 |
R-HSA-5654693 | FRS-mediated FGFR1 signaling | 0.323737 | 0.490 |
R-HSA-1592230 | Mitochondrial biogenesis | 0.085266 | 1.069 |
R-HSA-5654743 | Signaling by FGFR4 | 0.136036 | 0.866 |
R-HSA-375165 | NCAM signaling for neurite out-growth | 0.221006 | 0.656 |
R-HSA-169893 | Prolonged ERK activation events | 0.222976 | 0.652 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 0.131788 | 0.880 |
R-HSA-5654741 | Signaling by FGFR3 | 0.144620 | 0.840 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.142147 | 0.847 |
R-HSA-8964038 | LDL clearance | 0.049268 | 1.307 |
R-HSA-9005895 | Pervasive developmental disorders | 0.182743 | 0.738 |
R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome | 0.182743 | 0.738 |
R-HSA-9697154 | Disorders of Nervous System Development | 0.182743 | 0.738 |
R-HSA-975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 0.203112 | 0.692 |
R-HSA-167044 | Signalling to RAS | 0.279659 | 0.553 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.259762 | 0.585 |
R-HSA-1227986 | Signaling by ERBB2 | 0.211801 | 0.674 |
R-HSA-5654738 | Signaling by FGFR2 | 0.304505 | 0.516 |
R-HSA-8964043 | Plasma lipoprotein clearance | 0.115130 | 0.939 |
R-HSA-187687 | Signalling to ERKs | 0.099076 | 1.004 |
R-HSA-5654736 | Signaling by FGFR1 | 0.193517 | 0.713 |
R-HSA-376176 | Signaling by ROBO receptors | 0.150803 | 0.822 |
R-HSA-9670439 | Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT m... | 0.297623 | 0.526 |
R-HSA-1474165 | Reproduction | 0.114433 | 0.941 |
R-HSA-4839726 | Chromatin organization | 0.055658 | 1.254 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 0.276675 | 0.558 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 0.144620 | 0.840 |
R-HSA-5653656 | Vesicle-mediated transport | 0.034191 | 1.466 |
R-HSA-912526 | Interleukin receptor SHC signaling | 0.306437 | 0.514 |
R-HSA-373760 | L1CAM interactions | 0.226338 | 0.645 |
R-HSA-450294 | MAP kinase activation | 0.216399 | 0.665 |
R-HSA-373753 | Nephrin family interactions | 0.270506 | 0.568 |
R-HSA-9764790 | Positive Regulation of CDH1 Gene Transcription | 0.151214 | 0.820 |
R-HSA-193648 | NRAGE signals death through JNK | 0.048061 | 1.318 |
R-HSA-210993 | Tie2 Signaling | 0.251851 | 0.599 |
R-HSA-448424 | Interleukin-17 signaling | 0.258080 | 0.588 |
R-HSA-162582 | Signal Transduction | 0.104611 | 0.980 |
R-HSA-5655291 | Signaling by FGFR4 in disease | 0.203112 | 0.692 |
R-HSA-9824594 | Regulation of MITF-M-dependent genes involved in apoptosis | 0.279659 | 0.553 |
R-HSA-110357 | Displacement of DNA glycosylase by APEX1 | 0.118476 | 0.926 |
R-HSA-5684264 | MAP3K8 (TPL2)-dependent MAPK1/3 activation | 0.203112 | 0.692 |
R-HSA-3214842 | HDMs demethylate histones | 0.323737 | 0.490 |
R-HSA-140534 | Caspase activation via Death Receptors in the presence of ligand | 0.222976 | 0.652 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 0.279659 | 0.553 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.043391 | 1.363 |
R-HSA-2586552 | Signaling by Leptin | 0.151214 | 0.820 |
R-HSA-1834941 | STING mediated induction of host immune responses | 0.261237 | 0.583 |
R-HSA-9034015 | Signaling by NTRK3 (TRKC) | 0.288697 | 0.540 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.038308 | 1.417 |
R-HSA-9658195 | Leishmania infection | 0.038308 | 1.417 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 0.267378 | 0.573 |
R-HSA-9842663 | Signaling by LTK | 0.182743 | 0.738 |
R-HSA-391160 | Signal regulatory protein family interactions | 0.203112 | 0.692 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 0.288697 | 0.540 |
R-HSA-8949215 | Mitochondrial calcium ion transport | 0.288697 | 0.540 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.207212 | 0.684 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.193902 | 0.712 |
R-HSA-186797 | Signaling by PDGF | 0.221006 | 0.656 |
R-HSA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 0.251851 | 0.599 |
R-HSA-445144 | Signal transduction by L1 | 0.270506 | 0.568 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.249627 | 0.603 |
R-HSA-9007101 | Rab regulation of trafficking | 0.085266 | 1.069 |
R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 0.306437 | 0.514 |
R-HSA-9703648 | Signaling by FLT3 ITD and TKD mutants | 0.315142 | 0.501 |
R-HSA-9707616 | Heme signaling | 0.059605 | 1.225 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.051622 | 1.287 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.197092 | 0.705 |
R-HSA-1266695 | Interleukin-7 signaling | 0.058946 | 1.230 |
R-HSA-1433557 | Signaling by SCF-KIT | 0.136036 | 0.866 |
R-HSA-9669938 | Signaling by KIT in disease | 0.297623 | 0.526 |
R-HSA-2453864 | Retinoid cycle disease events | 0.323737 | 0.490 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 0.225622 | 0.647 |
R-HSA-8848021 | Signaling by PTK6 | 0.225622 | 0.647 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 0.049268 | 1.307 |
R-HSA-9008059 | Interleukin-37 signaling | 0.076364 | 1.117 |
R-HSA-9675143 | Diseases of the neuronal system | 0.323737 | 0.490 |
R-HSA-2474795 | Diseases associated with visual transduction | 0.323737 | 0.490 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 0.258080 | 0.588 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.209978 | 0.678 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.251782 | 0.599 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.219763 | 0.658 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.095923 | 1.018 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 0.258080 | 0.588 |
R-HSA-8983432 | Interleukin-15 signaling | 0.182743 | 0.738 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.083761 | 1.077 |
R-HSA-2559583 | Cellular Senescence | 0.243618 | 0.613 |
R-HSA-9909396 | Circadian clock | 0.286870 | 0.542 |
R-HSA-1059683 | Interleukin-6 signaling | 0.192992 | 0.714 |
R-HSA-5210891 | Uptake and function of anthrax toxins | 0.242347 | 0.616 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.318354 | 0.497 |
R-HSA-982772 | Growth hormone receptor signaling | 0.306437 | 0.514 |
R-HSA-73887 | Death Receptor Signaling | 0.173577 | 0.761 |
R-HSA-6783589 | Interleukin-6 family signaling | 0.315142 | 0.501 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 0.198070 | 0.703 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.325767 | 0.487 |
R-HSA-1500620 | Meiosis | 0.327552 | 0.485 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.327552 | 0.485 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.327950 | 0.484 |
R-HSA-8874081 | MET activates PTK2 signaling | 0.332225 | 0.479 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 0.332225 | 0.479 |
R-HSA-9022699 | MECP2 regulates neuronal receptors and channels | 0.332225 | 0.479 |
R-HSA-5357769 | Caspase activation via extrinsic apoptotic signalling pathway | 0.332225 | 0.479 |
R-HSA-397014 | Muscle contraction | 0.335770 | 0.474 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.336717 | 0.473 |
R-HSA-5654699 | SHC-mediated cascade:FGFR2 | 0.340607 | 0.468 |
R-HSA-9006115 | Signaling by NTRK2 (TRKB) | 0.340607 | 0.468 |
R-HSA-5655332 | Signaling by FGFR3 in disease | 0.340607 | 0.468 |
R-HSA-168249 | Innate Immune System | 0.342675 | 0.465 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.345088 | 0.462 |
R-HSA-5654732 | Negative regulation of FGFR3 signaling | 0.348885 | 0.457 |
R-HSA-5654700 | FRS-mediated FGFR2 signaling | 0.348885 | 0.457 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.355355 | 0.449 |
R-HSA-5654733 | Negative regulation of FGFR4 signaling | 0.357059 | 0.447 |
R-HSA-450282 | MAPK targets/ Nuclear events mediated by MAP kinases | 0.357059 | 0.447 |
R-HSA-418360 | Platelet calcium homeostasis | 0.357059 | 0.447 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 0.357059 | 0.447 |
R-HSA-5654708 | Downstream signaling of activated FGFR3 | 0.357059 | 0.447 |
R-HSA-446652 | Interleukin-1 family signaling | 0.362190 | 0.441 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 0.365131 | 0.438 |
R-HSA-2424491 | DAP12 signaling | 0.365131 | 0.438 |
R-HSA-5654716 | Downstream signaling of activated FGFR4 | 0.365131 | 0.438 |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | 0.365131 | 0.438 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 0.365131 | 0.438 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 0.365131 | 0.438 |
R-HSA-74752 | Signaling by Insulin receptor | 0.368477 | 0.434 |
R-HSA-2682334 | EPH-Ephrin signaling | 0.368477 | 0.434 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 0.368477 | 0.434 |
R-HSA-195721 | Signaling by WNT | 0.372897 | 0.428 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 0.372968 | 0.428 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 0.373102 | 0.428 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 0.373102 | 0.428 |
R-HSA-399719 | Trafficking of AMPA receptors | 0.373102 | 0.428 |
R-HSA-5694530 | Cargo concentration in the ER | 0.373102 | 0.428 |
R-HSA-186763 | Downstream signal transduction | 0.373102 | 0.428 |
R-HSA-162906 | HIV Infection | 0.378432 | 0.422 |
R-HSA-162587 | HIV Life Cycle | 0.379224 | 0.421 |
R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | 0.380974 | 0.419 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.380974 | 0.419 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 0.388747 | 0.410 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 0.388747 | 0.410 |
R-HSA-5654726 | Negative regulation of FGFR1 signaling | 0.388747 | 0.410 |
R-HSA-399721 | Glutamate binding, activation of AMPA receptors and synaptic plasticity | 0.388747 | 0.410 |
R-HSA-9930044 | Nuclear RNA decay | 0.388747 | 0.410 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 0.388747 | 0.410 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.388747 | 0.410 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.395223 | 0.403 |
R-HSA-390522 | Striated Muscle Contraction | 0.396423 | 0.402 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 0.396423 | 0.402 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 0.396423 | 0.402 |
R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination | 0.396423 | 0.402 |
R-HSA-190236 | Signaling by FGFR | 0.399632 | 0.398 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.399632 | 0.398 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.399632 | 0.398 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.399632 | 0.398 |
R-HSA-5654727 | Negative regulation of FGFR2 signaling | 0.404003 | 0.394 |
R-HSA-180746 | Nuclear import of Rev protein | 0.404003 | 0.394 |
R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected ... | 0.404003 | 0.394 |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian expression | 0.404003 | 0.394 |
R-HSA-5610787 | Hedgehog 'off' state | 0.408404 | 0.389 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.411488 | 0.386 |
R-HSA-5654696 | Downstream signaling of activated FGFR2 | 0.411488 | 0.386 |
R-HSA-5654687 | Downstream signaling of activated FGFR1 | 0.411488 | 0.386 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 0.411488 | 0.386 |
R-HSA-9842860 | Regulation of endogenous retroelements | 0.417114 | 0.380 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 0.417114 | 0.380 |
R-HSA-1500931 | Cell-Cell communication | 0.417592 | 0.379 |
R-HSA-432720 | Lysosome Vesicle Biogenesis | 0.418880 | 0.378 |
R-HSA-212436 | Generic Transcription Pathway | 0.424914 | 0.372 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.426179 | 0.370 |
R-HSA-8875878 | MET promotes cell motility | 0.433388 | 0.363 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 0.433388 | 0.363 |
R-HSA-202131 | Metabolism of nitric oxide: NOS3 activation and regulation | 0.433388 | 0.363 |
R-HSA-109582 | Hemostasis | 0.435937 | 0.361 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.436272 | 0.360 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.436272 | 0.360 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.440506 | 0.356 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 0.440506 | 0.356 |
R-HSA-201556 | Signaling by ALK | 0.440506 | 0.356 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.447535 | 0.349 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 0.447535 | 0.349 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.447535 | 0.349 |
R-HSA-5260271 | Diseases of Immune System | 0.447535 | 0.349 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 0.447535 | 0.349 |
R-HSA-451927 | Interleukin-2 family signaling | 0.447535 | 0.349 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 0.454476 | 0.342 |
R-HSA-9694548 | Maturation of spike protein | 0.454476 | 0.342 |
R-HSA-73933 | Resolution of Abasic Sites (AP sites) | 0.454476 | 0.342 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 0.461330 | 0.336 |
R-HSA-6811438 | Intra-Golgi traffic | 0.461330 | 0.336 |
R-HSA-9615017 | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 0.461330 | 0.336 |
R-HSA-5655302 | Signaling by FGFR1 in disease | 0.461330 | 0.336 |
R-HSA-110329 | Cleavage of the damaged pyrimidine | 0.468099 | 0.330 |
R-HSA-73928 | Depyrimidination | 0.468099 | 0.330 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 0.474783 | 0.324 |
R-HSA-2172127 | DAP12 interactions | 0.481384 | 0.318 |
R-HSA-3928662 | EPHB-mediated forward signaling | 0.481384 | 0.318 |
R-HSA-190828 | Gap junction trafficking | 0.481384 | 0.318 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 0.487902 | 0.312 |
R-HSA-2453902 | The canonical retinoid cycle in rods (twilight vision) | 0.487902 | 0.312 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 0.494338 | 0.306 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 0.494338 | 0.306 |
R-HSA-75153 | Apoptotic execution phase | 0.494338 | 0.306 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.498899 | 0.302 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.500346 | 0.301 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.500346 | 0.301 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 0.500694 | 0.300 |
R-HSA-68877 | Mitotic Prometaphase | 0.500726 | 0.300 |
R-HSA-68875 | Mitotic Prophase | 0.504307 | 0.297 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.506970 | 0.295 |
R-HSA-5620924 | Intraflagellar transport | 0.506970 | 0.295 |
R-HSA-9031628 | NGF-stimulated transcription | 0.506970 | 0.295 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.508248 | 0.294 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.510078 | 0.292 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.512168 | 0.291 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.512168 | 0.291 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 0.513168 | 0.290 |
R-HSA-157858 | Gap junction trafficking and regulation | 0.513168 | 0.290 |
R-HSA-9766229 | Degradation of CDH1 | 0.513168 | 0.290 |
R-HSA-1266738 | Developmental Biology | 0.515631 | 0.288 |
R-HSA-2132295 | MHC class II antigen presentation | 0.516068 | 0.287 |
R-HSA-5658442 | Regulation of RAS by GAPs | 0.519289 | 0.285 |
R-HSA-109704 | PI3K Cascade | 0.519289 | 0.285 |
R-HSA-5655253 | Signaling by FGFR2 in disease | 0.519289 | 0.285 |
R-HSA-162909 | Host Interactions of HIV factors | 0.519947 | 0.284 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.528503 | 0.277 |
R-HSA-72187 | mRNA 3'-end processing | 0.531301 | 0.275 |
R-HSA-5339562 | Uptake and actions of bacterial toxins | 0.531301 | 0.275 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 0.537194 | 0.270 |
R-HSA-73929 | Base-Excision Repair, AP Site Formation | 0.543014 | 0.265 |
R-HSA-9012852 | Signaling by NOTCH3 | 0.548761 | 0.261 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 0.554436 | 0.256 |
R-HSA-5578775 | Ion homeostasis | 0.554436 | 0.256 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.554436 | 0.256 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.560040 | 0.252 |
R-HSA-9764561 | Regulation of CDH1 Function | 0.560040 | 0.252 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.564174 | 0.249 |
R-HSA-449147 | Signaling by Interleukins | 0.570127 | 0.244 |
R-HSA-191859 | snRNP Assembly | 0.571038 | 0.243 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.571038 | 0.243 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.571038 | 0.243 |
R-HSA-186712 | Regulation of beta-cell development | 0.571038 | 0.243 |
R-HSA-68882 | Mitotic Anaphase | 0.572834 | 0.242 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.575614 | 0.240 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.575697 | 0.240 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.576434 | 0.239 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.576434 | 0.239 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.576434 | 0.239 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.576434 | 0.239 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.576434 | 0.239 |
R-HSA-5362517 | Signaling by Retinoic Acid | 0.576434 | 0.239 |
R-HSA-983189 | Kinesins | 0.576434 | 0.239 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 0.576434 | 0.239 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 0.576434 | 0.239 |
R-HSA-418990 | Adherens junctions interactions | 0.578549 | 0.238 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.581763 | 0.235 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.581763 | 0.235 |
R-HSA-9793380 | Formation of paraxial mesoderm | 0.581763 | 0.235 |
R-HSA-5358351 | Signaling by Hedgehog | 0.582673 | 0.235 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.587025 | 0.231 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.587025 | 0.231 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 0.592221 | 0.228 |
R-HSA-936837 | Ion transport by P-type ATPases | 0.597352 | 0.224 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 0.607422 | 0.217 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.612362 | 0.213 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 0.617241 | 0.210 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.617241 | 0.210 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.626451 | 0.203 |
R-HSA-8939211 | ESR-mediated signaling | 0.630398 | 0.200 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 0.631514 | 0.200 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 0.636153 | 0.196 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.636153 | 0.196 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.642320 | 0.192 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.645257 | 0.190 |
R-HSA-1226099 | Signaling by FGFR in disease | 0.645257 | 0.190 |
R-HSA-9013694 | Signaling by NOTCH4 | 0.645257 | 0.190 |
R-HSA-1236394 | Signaling by ERBB4 | 0.645257 | 0.190 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.648518 | 0.188 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.649724 | 0.187 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 0.649724 | 0.187 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.651585 | 0.186 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.654134 | 0.184 |
R-HSA-9006936 | Signaling by TGFB family members | 0.657655 | 0.182 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.657655 | 0.182 |
R-HSA-9694635 | Translation of Structural Proteins | 0.658490 | 0.181 |
R-HSA-4086400 | PCP/CE pathway | 0.662791 | 0.179 |
R-HSA-109581 | Apoptosis | 0.663641 | 0.178 |
R-HSA-421270 | Cell-cell junction organization | 0.665700 | 0.177 |
R-HSA-9659379 | Sensory processing of sound | 0.667038 | 0.176 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 0.667038 | 0.176 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.669543 | 0.174 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.671231 | 0.173 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.675372 | 0.170 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 0.679462 | 0.168 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.695313 | 0.158 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.695313 | 0.158 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 0.695313 | 0.158 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.699152 | 0.155 |
R-HSA-74160 | Gene expression (Transcription) | 0.702847 | 0.153 |
R-HSA-156902 | Peptide chain elongation | 0.706687 | 0.151 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.713331 | 0.147 |
R-HSA-168255 | Influenza Infection | 0.713794 | 0.146 |
R-HSA-73884 | Base Excision Repair | 0.714033 | 0.146 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 0.717638 | 0.144 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.717638 | 0.144 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 0.717638 | 0.144 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.718277 | 0.144 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 0.721197 | 0.142 |
R-HSA-6798695 | Neutrophil degranulation | 0.722436 | 0.141 |
R-HSA-156842 | Eukaryotic Translation Elongation | 0.724712 | 0.140 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 0.724712 | 0.140 |
R-HSA-446728 | Cell junction organization | 0.726739 | 0.139 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 0.731609 | 0.136 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 0.734993 | 0.134 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.735002 | 0.134 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 0.738335 | 0.132 |
R-HSA-72764 | Eukaryotic Translation Termination | 0.738335 | 0.132 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 0.738335 | 0.132 |
R-HSA-5617833 | Cilium Assembly | 0.741266 | 0.130 |
R-HSA-2730905 | Role of LAT2/NTAL/LAB on calcium mobilization | 0.741635 | 0.130 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.741635 | 0.130 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 0.741635 | 0.130 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 0.744893 | 0.128 |
R-HSA-8957275 | Post-translational protein phosphorylation | 0.748110 | 0.126 |
R-HSA-68886 | M Phase | 0.749652 | 0.125 |
R-HSA-9614085 | FOXO-mediated transcription | 0.751287 | 0.124 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.754424 | 0.122 |
R-HSA-70171 | Glycolysis | 0.754424 | 0.122 |
R-HSA-382556 | ABC-family proteins mediated transport | 0.754424 | 0.122 |
R-HSA-8953854 | Metabolism of RNA | 0.756086 | 0.121 |
R-HSA-2408557 | Selenocysteine synthesis | 0.757522 | 0.121 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 0.757522 | 0.121 |
R-HSA-9020702 | Interleukin-1 signaling | 0.757522 | 0.121 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 0.760581 | 0.119 |
R-HSA-192823 | Viral mRNA Translation | 0.763601 | 0.117 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.764262 | 0.117 |
R-HSA-2262752 | Cellular responses to stress | 0.765310 | 0.116 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 0.766584 | 0.115 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 0.766584 | 0.115 |
R-HSA-9833110 | RSV-host interactions | 0.769529 | 0.114 |
R-HSA-418346 | Platelet homeostasis | 0.775308 | 0.111 |
R-HSA-5357801 | Programmed Cell Death | 0.777197 | 0.109 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 0.778144 | 0.109 |
R-HSA-211000 | Gene Silencing by RNA | 0.778144 | 0.109 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 0.780944 | 0.107 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 0.780944 | 0.107 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.783708 | 0.106 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.791796 | 0.101 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.791796 | 0.101 |
R-HSA-2871796 | FCERI mediated MAPK activation | 0.791796 | 0.101 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.791796 | 0.101 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 0.794424 | 0.100 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.797020 | 0.099 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.797020 | 0.099 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 0.799583 | 0.097 |
R-HSA-8953897 | Cellular responses to stimuli | 0.804420 | 0.095 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 0.804612 | 0.094 |
R-HSA-72613 | Eukaryotic Translation Initiation | 0.807079 | 0.093 |
R-HSA-72737 | Cap-dependent Translation Initiation | 0.807079 | 0.093 |
R-HSA-168256 | Immune System | 0.807404 | 0.093 |
R-HSA-70326 | Glucose metabolism | 0.809516 | 0.092 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 0.811921 | 0.090 |
R-HSA-5693538 | Homology Directed Repair | 0.811921 | 0.090 |
R-HSA-1640170 | Cell Cycle | 0.816267 | 0.088 |
R-HSA-3371556 | Cellular response to heat stress | 0.818959 | 0.087 |
R-HSA-5663205 | Infectious disease | 0.822839 | 0.085 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.823504 | 0.084 |
R-HSA-114608 | Platelet degranulation | 0.834377 | 0.079 |
R-HSA-69481 | G2/M Checkpoints | 0.834377 | 0.079 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.840578 | 0.075 |
R-HSA-9843745 | Adipogenesis | 0.844583 | 0.073 |
R-HSA-5576891 | Cardiac conduction | 0.844583 | 0.073 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.846548 | 0.072 |
R-HSA-1474228 | Degradation of the extracellular matrix | 0.846548 | 0.072 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.848488 | 0.071 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.856007 | 0.068 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.857828 | 0.067 |
R-HSA-9948299 | Ribosome-associated quality control | 0.859627 | 0.066 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.863731 | 0.064 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.865253 | 0.063 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.866880 | 0.062 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.868283 | 0.061 |
R-HSA-416476 | G alpha (q) signalling events | 0.874628 | 0.058 |
R-HSA-2187338 | Visual phototransduction | 0.876409 | 0.057 |
R-HSA-69242 | S Phase | 0.877973 | 0.057 |
R-HSA-9758941 | Gastrulation | 0.879518 | 0.056 |
R-HSA-9711123 | Cellular response to chemical stress | 0.879562 | 0.056 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 0.884036 | 0.054 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.885504 | 0.053 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.886068 | 0.053 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.886953 | 0.052 |
R-HSA-1989781 | PPARA activates gene expression | 0.888385 | 0.051 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.889435 | 0.051 |
R-HSA-9610379 | HCMV Late Events | 0.891194 | 0.050 |
R-HSA-9711097 | Cellular response to starvation | 0.892572 | 0.049 |
R-HSA-2408522 | Selenoamino acid metabolism | 0.900482 | 0.046 |
R-HSA-5619102 | SLC transporter disorders | 0.904217 | 0.044 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.908981 | 0.041 |
R-HSA-72306 | tRNA processing | 0.908981 | 0.041 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.911274 | 0.040 |
R-HSA-1643685 | Disease | 0.918476 | 0.037 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.919610 | 0.036 |
R-HSA-69275 | G2/M Transition | 0.925793 | 0.033 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.927664 | 0.033 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.927664 | 0.033 |
R-HSA-983712 | Ion channel transport | 0.928582 | 0.032 |
R-HSA-9679506 | SARS-CoV Infections | 0.934299 | 0.030 |
R-HSA-9609690 | HCMV Early Events | 0.934691 | 0.029 |
R-HSA-1474244 | Extracellular matrix organization | 0.937009 | 0.028 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.937945 | 0.028 |
R-HSA-428157 | Sphingolipid metabolism | 0.938733 | 0.027 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.940279 | 0.027 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.947448 | 0.023 |
R-HSA-112316 | Neuronal System | 0.947505 | 0.023 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.947910 | 0.023 |
R-HSA-73894 | DNA Repair | 0.953664 | 0.021 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.957178 | 0.019 |
R-HSA-72312 | rRNA processing | 0.959316 | 0.018 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.961840 | 0.017 |
R-HSA-1280218 | Adaptive Immune System | 0.962249 | 0.017 |
R-HSA-157118 | Signaling by NOTCH | 0.963279 | 0.016 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.966430 | 0.015 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.966801 | 0.015 |
R-HSA-9609646 | HCMV Infection | 0.967696 | 0.014 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.970089 | 0.013 |
R-HSA-9824446 | Viral Infection Pathways | 0.979254 | 0.009 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.981873 | 0.008 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.987358 | 0.006 |
R-HSA-8957322 | Metabolism of steroids | 0.987519 | 0.005 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.990103 | 0.004 |
R-HSA-388396 | GPCR downstream signalling | 0.991086 | 0.004 |
R-HSA-913531 | Interferon Signaling | 0.994246 | 0.003 |
R-HSA-382551 | Transport of small molecules | 0.996016 | 0.002 |
R-HSA-372790 | Signaling by GPCR | 0.996073 | 0.002 |
R-HSA-72766 | Translation | 0.996829 | 0.001 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.997737 | 0.001 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.999731 | 0.000 |
R-HSA-597592 | Post-translational protein modification | 0.999799 | 0.000 |
R-HSA-9709957 | Sensory Perception | 0.999999 | 0.000 |
R-HSA-556833 | Metabolism of lipids | 0.999999 | 0.000 |
R-HSA-392499 | Metabolism of proteins | 1.000000 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000 | -0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CLK3 |
0.872 | 0.456 | 1 | 0.872 |
HIPK4 |
0.872 | 0.507 | 1 | 0.871 |
HIPK2 |
0.870 | 0.543 | 1 | 0.848 |
KIS |
0.864 | 0.493 | 1 | 0.881 |
DYRK2 |
0.864 | 0.502 | 1 | 0.885 |
CDK18 |
0.862 | 0.510 | 1 | 0.839 |
HIPK1 |
0.860 | 0.496 | 1 | 0.893 |
NLK |
0.860 | 0.438 | 1 | 0.893 |
SRPK1 |
0.858 | 0.311 | -3 | 0.758 |
COT |
0.856 | 0.116 | 2 | 0.859 |
CDK7 |
0.856 | 0.459 | 1 | 0.873 |
JNK2 |
0.856 | 0.497 | 1 | 0.845 |
CDK19 |
0.855 | 0.473 | 1 | 0.841 |
CDK1 |
0.855 | 0.468 | 1 | 0.855 |
P38B |
0.854 | 0.513 | 1 | 0.856 |
ERK5 |
0.854 | 0.330 | 1 | 0.863 |
PIM3 |
0.854 | 0.193 | -3 | 0.841 |
CDKL5 |
0.853 | 0.272 | -3 | 0.781 |
ICK |
0.853 | 0.367 | -3 | 0.819 |
CDK8 |
0.853 | 0.449 | 1 | 0.857 |
ERK1 |
0.852 | 0.482 | 1 | 0.853 |
P38A |
0.850 | 0.488 | 1 | 0.889 |
CDK17 |
0.850 | 0.472 | 1 | 0.804 |
CDKL1 |
0.850 | 0.229 | -3 | 0.783 |
P38G |
0.850 | 0.476 | 1 | 0.803 |
DYRK4 |
0.850 | 0.476 | 1 | 0.855 |
JNK3 |
0.850 | 0.470 | 1 | 0.859 |
MAK |
0.849 | 0.485 | -2 | 0.816 |
CDK5 |
0.849 | 0.440 | 1 | 0.879 |
MOS |
0.849 | 0.178 | 1 | 0.773 |
CDK14 |
0.848 | 0.469 | 1 | 0.862 |
CDK3 |
0.847 | 0.429 | 1 | 0.819 |
CLK2 |
0.847 | 0.356 | -3 | 0.761 |
DYRK1A |
0.846 | 0.426 | 1 | 0.882 |
NDR2 |
0.846 | 0.175 | -3 | 0.845 |
P38D |
0.846 | 0.502 | 1 | 0.813 |
SKMLCK |
0.846 | 0.172 | -2 | 0.831 |
MTOR |
0.845 | 0.141 | 1 | 0.766 |
CDC7 |
0.845 | 0.087 | 1 | 0.735 |
CDK10 |
0.845 | 0.445 | 1 | 0.859 |
HIPK3 |
0.845 | 0.443 | 1 | 0.873 |
PRKD1 |
0.844 | 0.210 | -3 | 0.823 |
CDK16 |
0.844 | 0.462 | 1 | 0.812 |
CDK13 |
0.843 | 0.406 | 1 | 0.859 |
PIM1 |
0.843 | 0.174 | -3 | 0.796 |
RSK2 |
0.843 | 0.164 | -3 | 0.767 |
DYRK1B |
0.842 | 0.437 | 1 | 0.861 |
CLK4 |
0.842 | 0.284 | -3 | 0.759 |
GRK1 |
0.841 | 0.184 | -2 | 0.781 |
PRKD2 |
0.840 | 0.167 | -3 | 0.776 |
SRPK2 |
0.840 | 0.237 | -3 | 0.688 |
CLK1 |
0.839 | 0.295 | -3 | 0.729 |
CDK12 |
0.839 | 0.410 | 1 | 0.843 |
PRPK |
0.839 | -0.049 | -1 | 0.808 |
CHAK2 |
0.839 | 0.096 | -1 | 0.811 |
P90RSK |
0.839 | 0.151 | -3 | 0.770 |
CAMK1B |
0.838 | 0.058 | -3 | 0.812 |
DYRK3 |
0.838 | 0.369 | 1 | 0.883 |
AURC |
0.837 | 0.133 | -2 | 0.632 |
ERK2 |
0.837 | 0.413 | 1 | 0.865 |
CDK9 |
0.837 | 0.387 | 1 | 0.863 |
ATR |
0.837 | 0.039 | 1 | 0.736 |
NDR1 |
0.836 | 0.070 | -3 | 0.822 |
SRPK3 |
0.835 | 0.199 | -3 | 0.723 |
CAMLCK |
0.834 | 0.071 | -2 | 0.803 |
NIK |
0.833 | 0.028 | -3 | 0.826 |
IKKB |
0.833 | -0.055 | -2 | 0.692 |
MAPKAPK3 |
0.833 | 0.083 | -3 | 0.780 |
NUAK2 |
0.832 | 0.068 | -3 | 0.820 |
RIPK3 |
0.832 | -0.017 | 3 | 0.711 |
WNK1 |
0.832 | -0.001 | -2 | 0.852 |
RAF1 |
0.832 | -0.111 | 1 | 0.728 |
DAPK2 |
0.832 | 0.078 | -3 | 0.821 |
MOK |
0.832 | 0.408 | 1 | 0.881 |
MAPKAPK2 |
0.832 | 0.115 | -3 | 0.756 |
PKN2 |
0.831 | 0.033 | -3 | 0.809 |
PKN3 |
0.831 | 0.034 | -3 | 0.800 |
PKCD |
0.831 | 0.069 | 2 | 0.788 |
PKACG |
0.831 | 0.070 | -2 | 0.705 |
TBK1 |
0.830 | -0.065 | 1 | 0.630 |
RSK4 |
0.830 | 0.165 | -3 | 0.759 |
RSK3 |
0.830 | 0.099 | -3 | 0.755 |
AMPKA1 |
0.830 | 0.056 | -3 | 0.833 |
PRP4 |
0.830 | 0.303 | -3 | 0.754 |
LATS2 |
0.830 | 0.073 | -5 | 0.746 |
MPSK1 |
0.829 | 0.282 | 1 | 0.751 |
MST4 |
0.829 | 0.003 | 2 | 0.855 |
JNK1 |
0.829 | 0.413 | 1 | 0.831 |
BMPR2 |
0.829 | -0.202 | -2 | 0.802 |
LATS1 |
0.829 | 0.165 | -3 | 0.846 |
GRK5 |
0.828 | -0.050 | -3 | 0.806 |
PKACB |
0.828 | 0.129 | -2 | 0.637 |
MLK2 |
0.828 | 0.027 | 2 | 0.820 |
P70S6KB |
0.827 | 0.063 | -3 | 0.775 |
CDK2 |
0.827 | 0.280 | 1 | 0.873 |
PDHK4 |
0.827 | -0.244 | 1 | 0.757 |
MARK4 |
0.827 | 0.015 | 4 | 0.828 |
CAMK2D |
0.826 | 0.019 | -3 | 0.806 |
AMPKA2 |
0.826 | 0.071 | -3 | 0.811 |
IKKE |
0.825 | -0.101 | 1 | 0.627 |
PKCB |
0.825 | 0.061 | 2 | 0.741 |
MLK1 |
0.825 | -0.079 | 2 | 0.808 |
GRK7 |
0.824 | 0.107 | 1 | 0.690 |
PAK1 |
0.824 | 0.036 | -2 | 0.766 |
TSSK1 |
0.824 | 0.068 | -3 | 0.849 |
CAMK2G |
0.824 | -0.122 | 2 | 0.781 |
IKKA |
0.823 | -0.008 | -2 | 0.686 |
CDK6 |
0.823 | 0.392 | 1 | 0.850 |
PKCA |
0.823 | 0.073 | 2 | 0.735 |
MASTL |
0.823 | -0.116 | -2 | 0.765 |
AKT2 |
0.822 | 0.118 | -3 | 0.697 |
PKG2 |
0.822 | 0.082 | -2 | 0.643 |
MLK3 |
0.822 | 0.024 | 2 | 0.746 |
PIM2 |
0.822 | 0.133 | -3 | 0.738 |
DLK |
0.822 | -0.079 | 1 | 0.724 |
PRKX |
0.822 | 0.139 | -3 | 0.718 |
PRKD3 |
0.821 | 0.082 | -3 | 0.732 |
BMPR1B |
0.821 | 0.064 | 1 | 0.717 |
CAMK2A |
0.821 | 0.081 | 2 | 0.765 |
MNK1 |
0.821 | 0.071 | -2 | 0.756 |
PKCZ |
0.821 | 0.037 | 2 | 0.783 |
CK1E |
0.821 | 0.138 | -3 | 0.617 |
TGFBR2 |
0.821 | -0.089 | -2 | 0.680 |
PASK |
0.821 | 0.194 | -3 | 0.852 |
IRE1 |
0.820 | -0.038 | 1 | 0.707 |
PKCG |
0.820 | 0.034 | 2 | 0.739 |
GSK3A |
0.820 | 0.204 | 4 | 0.496 |
CDK4 |
0.820 | 0.395 | 1 | 0.835 |
MNK2 |
0.820 | 0.030 | -2 | 0.749 |
SGK3 |
0.820 | 0.085 | -3 | 0.765 |
GCN2 |
0.820 | -0.227 | 2 | 0.791 |
TSSK2 |
0.820 | 0.004 | -5 | 0.815 |
PAK3 |
0.819 | -0.004 | -2 | 0.757 |
AURB |
0.819 | 0.057 | -2 | 0.627 |
QSK |
0.819 | 0.061 | 4 | 0.809 |
MSK1 |
0.819 | 0.089 | -3 | 0.756 |
ULK2 |
0.819 | -0.242 | 2 | 0.780 |
VRK2 |
0.818 | 0.026 | 1 | 0.795 |
GRK6 |
0.818 | -0.059 | 1 | 0.730 |
RIPK1 |
0.818 | -0.140 | 1 | 0.715 |
PKR |
0.818 | -0.014 | 1 | 0.744 |
PDHK1 |
0.818 | -0.264 | 1 | 0.737 |
HUNK |
0.817 | -0.147 | 2 | 0.806 |
DSTYK |
0.817 | -0.202 | 2 | 0.870 |
MSK2 |
0.817 | 0.037 | -3 | 0.756 |
MELK |
0.817 | 0.002 | -3 | 0.786 |
PHKG1 |
0.816 | 0.002 | -3 | 0.817 |
MST3 |
0.816 | 0.063 | 2 | 0.844 |
CK1D |
0.816 | 0.149 | -3 | 0.576 |
MYLK4 |
0.816 | 0.038 | -2 | 0.735 |
CAMK2B |
0.816 | 0.020 | 2 | 0.744 |
ERK7 |
0.816 | 0.175 | 2 | 0.562 |
NIM1 |
0.815 | -0.070 | 3 | 0.735 |
NEK6 |
0.815 | -0.137 | -2 | 0.750 |
CAMK4 |
0.814 | -0.065 | -3 | 0.793 |
ANKRD3 |
0.814 | -0.189 | 1 | 0.751 |
NEK9 |
0.814 | -0.192 | 2 | 0.835 |
WNK3 |
0.813 | -0.243 | 1 | 0.701 |
ALK4 |
0.813 | -0.057 | -2 | 0.738 |
DCAMKL1 |
0.813 | 0.039 | -3 | 0.788 |
YSK4 |
0.812 | -0.098 | 1 | 0.668 |
PAK2 |
0.811 | -0.025 | -2 | 0.746 |
QIK |
0.811 | -0.072 | -3 | 0.794 |
PKCH |
0.811 | -0.014 | 2 | 0.720 |
SMG1 |
0.811 | -0.040 | 1 | 0.687 |
GSK3B |
0.811 | 0.103 | 4 | 0.489 |
NEK7 |
0.811 | -0.272 | -3 | 0.764 |
CK1A2 |
0.811 | 0.123 | -3 | 0.577 |
CHAK1 |
0.810 | -0.093 | 2 | 0.788 |
MEK1 |
0.810 | -0.154 | 2 | 0.836 |
SIK |
0.810 | 0.023 | -3 | 0.751 |
PAK6 |
0.810 | 0.040 | -2 | 0.678 |
TTBK2 |
0.810 | -0.157 | 2 | 0.715 |
TGFBR1 |
0.810 | -0.043 | -2 | 0.710 |
MARK3 |
0.810 | 0.028 | 4 | 0.772 |
MLK4 |
0.809 | -0.073 | 2 | 0.725 |
BCKDK |
0.809 | -0.210 | -1 | 0.728 |
AKT1 |
0.809 | 0.088 | -3 | 0.720 |
NUAK1 |
0.809 | -0.006 | -3 | 0.766 |
BUB1 |
0.809 | 0.213 | -5 | 0.775 |
PKACA |
0.809 | 0.086 | -2 | 0.594 |
GRK4 |
0.809 | -0.133 | -2 | 0.766 |
IRE2 |
0.808 | -0.066 | 2 | 0.740 |
GAK |
0.808 | 0.113 | 1 | 0.788 |
CAMK1G |
0.807 | 0.010 | -3 | 0.737 |
TAO3 |
0.807 | -0.001 | 1 | 0.704 |
BRSK1 |
0.806 | -0.009 | -3 | 0.780 |
AURA |
0.805 | 0.019 | -2 | 0.602 |
ULK1 |
0.805 | -0.270 | -3 | 0.716 |
GRK2 |
0.805 | -0.027 | -2 | 0.665 |
BRSK2 |
0.805 | -0.040 | -3 | 0.789 |
MEK5 |
0.804 | -0.163 | 2 | 0.818 |
NEK2 |
0.804 | -0.151 | 2 | 0.818 |
DNAPK |
0.804 | -0.035 | 1 | 0.626 |
CHK1 |
0.804 | -0.026 | -3 | 0.802 |
GCK |
0.804 | 0.065 | 1 | 0.710 |
PKCE |
0.803 | 0.059 | 2 | 0.727 |
TLK2 |
0.803 | -0.111 | 1 | 0.678 |
NEK5 |
0.803 | -0.093 | 1 | 0.721 |
ACVR2B |
0.803 | -0.067 | -2 | 0.684 |
ATM |
0.803 | -0.108 | 1 | 0.670 |
DRAK1 |
0.803 | -0.072 | 1 | 0.685 |
MARK2 |
0.803 | -0.021 | 4 | 0.735 |
IRAK4 |
0.803 | -0.083 | 1 | 0.698 |
LKB1 |
0.803 | 0.045 | -3 | 0.782 |
SSTK |
0.802 | 0.022 | 4 | 0.788 |
ROCK2 |
0.802 | 0.110 | -3 | 0.788 |
AKT3 |
0.802 | 0.110 | -3 | 0.661 |
PKCT |
0.802 | -0.012 | 2 | 0.730 |
CK1G1 |
0.802 | 0.067 | -3 | 0.597 |
SGK1 |
0.801 | 0.111 | -3 | 0.641 |
SMMLCK |
0.801 | -0.004 | -3 | 0.779 |
MEKK2 |
0.801 | -0.113 | 2 | 0.799 |
ACVR2A |
0.801 | -0.090 | -2 | 0.667 |
DAPK3 |
0.800 | 0.052 | -3 | 0.794 |
WNK4 |
0.800 | -0.120 | -2 | 0.842 |
ALK2 |
0.800 | -0.088 | -2 | 0.721 |
MEKK3 |
0.800 | -0.154 | 1 | 0.704 |
P70S6K |
0.800 | 0.035 | -3 | 0.695 |
PDK1 |
0.800 | -0.014 | 1 | 0.707 |
PKCI |
0.799 | -0.011 | 2 | 0.751 |
DCAMKL2 |
0.799 | -0.029 | -3 | 0.784 |
NEK11 |
0.799 | -0.091 | 1 | 0.707 |
HPK1 |
0.799 | 0.023 | 1 | 0.703 |
PLK1 |
0.799 | -0.208 | -2 | 0.674 |
ZAK |
0.799 | -0.156 | 1 | 0.679 |
MEKK1 |
0.798 | -0.167 | 1 | 0.704 |
MAPKAPK5 |
0.798 | -0.067 | -3 | 0.712 |
CAMK1D |
0.797 | 0.030 | -3 | 0.696 |
PBK |
0.797 | 0.103 | 1 | 0.720 |
FAM20C |
0.797 | -0.040 | 2 | 0.571 |
MARK1 |
0.797 | -0.056 | 4 | 0.783 |
MAP3K15 |
0.797 | -0.004 | 1 | 0.669 |
KHS1 |
0.796 | 0.059 | 1 | 0.686 |
MEKK6 |
0.796 | -0.048 | 1 | 0.698 |
TNIK |
0.796 | 0.012 | 3 | 0.846 |
DAPK1 |
0.795 | 0.049 | -3 | 0.778 |
PINK1 |
0.795 | -0.097 | 1 | 0.828 |
PERK |
0.795 | -0.202 | -2 | 0.735 |
KHS2 |
0.795 | 0.057 | 1 | 0.704 |
BRAF |
0.794 | -0.202 | -4 | 0.811 |
MRCKB |
0.794 | 0.061 | -3 | 0.727 |
SNRK |
0.794 | -0.187 | 2 | 0.662 |
TAO2 |
0.794 | -0.096 | 2 | 0.842 |
DMPK1 |
0.793 | 0.115 | -3 | 0.748 |
BMPR1A |
0.793 | -0.032 | 1 | 0.686 |
LRRK2 |
0.793 | -0.041 | 2 | 0.838 |
CAMKK2 |
0.793 | -0.089 | -2 | 0.728 |
HGK |
0.793 | -0.037 | 3 | 0.836 |
PAK5 |
0.793 | -0.002 | -2 | 0.630 |
MRCKA |
0.793 | 0.057 | -3 | 0.743 |
GRK3 |
0.792 | -0.022 | -2 | 0.628 |
PLK4 |
0.792 | -0.171 | 2 | 0.612 |
MINK |
0.792 | -0.057 | 1 | 0.689 |
CHK2 |
0.792 | 0.046 | -3 | 0.647 |
LOK |
0.792 | -0.034 | -2 | 0.717 |
SBK |
0.791 | 0.125 | -3 | 0.594 |
SLK |
0.790 | -0.032 | -2 | 0.668 |
PAK4 |
0.790 | 0.011 | -2 | 0.636 |
PHKG2 |
0.789 | -0.071 | -3 | 0.759 |
PLK3 |
0.789 | -0.202 | 2 | 0.744 |
TAK1 |
0.789 | -0.103 | 1 | 0.706 |
PKN1 |
0.788 | 0.007 | -3 | 0.711 |
NEK4 |
0.788 | -0.138 | 1 | 0.686 |
CAMKK1 |
0.788 | -0.195 | -2 | 0.723 |
CAMK1A |
0.788 | 0.045 | -3 | 0.663 |
NEK1 |
0.788 | -0.084 | 1 | 0.694 |
HRI |
0.787 | -0.291 | -2 | 0.740 |
VRK1 |
0.787 | -0.106 | 2 | 0.827 |
NEK8 |
0.787 | -0.201 | 2 | 0.811 |
HASPIN |
0.787 | 0.043 | -1 | 0.681 |
CRIK |
0.787 | 0.114 | -3 | 0.723 |
EEF2K |
0.787 | -0.069 | 3 | 0.794 |
MST2 |
0.787 | -0.131 | 1 | 0.700 |
TLK1 |
0.785 | -0.224 | -2 | 0.730 |
ROCK1 |
0.783 | 0.055 | -3 | 0.746 |
PDHK3_TYR |
0.782 | 0.299 | 4 | 0.860 |
IRAK1 |
0.780 | -0.294 | -1 | 0.714 |
MST1 |
0.780 | -0.131 | 1 | 0.681 |
TTBK1 |
0.780 | -0.193 | 2 | 0.628 |
YSK1 |
0.779 | -0.105 | 2 | 0.812 |
STK33 |
0.777 | -0.150 | 2 | 0.615 |
CK2A2 |
0.777 | -0.047 | 1 | 0.617 |
CK1A |
0.777 | 0.101 | -3 | 0.499 |
BIKE |
0.776 | 0.056 | 1 | 0.707 |
PDHK4_TYR |
0.775 | 0.175 | 2 | 0.858 |
PKG1 |
0.775 | 0.001 | -2 | 0.567 |
OSR1 |
0.774 | -0.072 | 2 | 0.806 |
LIMK2_TYR |
0.774 | 0.176 | -3 | 0.832 |
MYO3B |
0.773 | -0.038 | 2 | 0.829 |
YANK3 |
0.773 | -0.010 | 2 | 0.406 |
TESK1_TYR |
0.773 | 0.095 | 3 | 0.856 |
PKMYT1_TYR |
0.771 | 0.107 | 3 | 0.820 |
CK2A1 |
0.770 | -0.038 | 1 | 0.598 |
MAP2K4_TYR |
0.769 | 0.060 | -1 | 0.806 |
AAK1 |
0.769 | 0.124 | 1 | 0.640 |
ASK1 |
0.769 | -0.104 | 1 | 0.658 |
TTK |
0.769 | -0.103 | -2 | 0.703 |
PLK2 |
0.769 | -0.113 | -3 | 0.677 |
MAP2K6_TYR |
0.768 | 0.048 | -1 | 0.806 |
MEK2 |
0.767 | -0.306 | 2 | 0.807 |
BMPR2_TYR |
0.765 | 0.018 | -1 | 0.804 |
MYO3A |
0.765 | -0.100 | 1 | 0.691 |
NEK3 |
0.765 | -0.201 | 1 | 0.662 |
MAP2K7_TYR |
0.765 | -0.117 | 2 | 0.840 |
PDHK1_TYR |
0.764 | -0.001 | -1 | 0.812 |
TAO1 |
0.762 | -0.122 | 1 | 0.630 |
RIPK2 |
0.762 | -0.324 | 1 | 0.634 |
ALPHAK3 |
0.760 | -0.100 | -1 | 0.695 |
PINK1_TYR |
0.759 | -0.191 | 1 | 0.750 |
LIMK1_TYR |
0.757 | -0.097 | 2 | 0.841 |
RET |
0.756 | -0.118 | 1 | 0.701 |
TNK2 |
0.755 | 0.009 | 3 | 0.722 |
EPHA6 |
0.755 | -0.046 | -1 | 0.782 |
ABL2 |
0.755 | 0.004 | -1 | 0.737 |
TXK |
0.754 | 0.035 | 1 | 0.717 |
EPHB4 |
0.753 | -0.052 | -1 | 0.754 |
FGR |
0.753 | -0.019 | 1 | 0.741 |
MST1R |
0.752 | -0.128 | 3 | 0.777 |
ABL1 |
0.752 | -0.006 | -1 | 0.735 |
TYRO3 |
0.752 | -0.134 | 3 | 0.754 |
CSF1R |
0.752 | -0.075 | 3 | 0.746 |
ROS1 |
0.751 | -0.099 | 3 | 0.719 |
LCK |
0.750 | 0.010 | -1 | 0.802 |
JAK2 |
0.750 | -0.126 | 1 | 0.698 |
YES1 |
0.749 | -0.060 | -1 | 0.815 |
TNK1 |
0.749 | -0.028 | 3 | 0.741 |
CK1G3 |
0.749 | 0.046 | -3 | 0.459 |
TYK2 |
0.749 | -0.217 | 1 | 0.694 |
STLK3 |
0.748 | -0.224 | 1 | 0.638 |
DDR1 |
0.746 | -0.187 | 4 | 0.761 |
ITK |
0.746 | -0.075 | -1 | 0.759 |
BLK |
0.745 | 0.007 | -1 | 0.789 |
HCK |
0.745 | -0.089 | -1 | 0.794 |
JAK3 |
0.743 | -0.161 | 1 | 0.680 |
JAK1 |
0.743 | -0.043 | 1 | 0.644 |
TNNI3K_TYR |
0.743 | -0.042 | 1 | 0.715 |
KDR |
0.742 | -0.111 | 3 | 0.714 |
NEK10_TYR |
0.742 | -0.111 | 1 | 0.597 |
FER |
0.742 | -0.182 | 1 | 0.738 |
SRMS |
0.741 | -0.122 | 1 | 0.721 |
YANK2 |
0.741 | -0.041 | 2 | 0.420 |
MET |
0.740 | -0.085 | 3 | 0.754 |
EPHA4 |
0.740 | -0.092 | 2 | 0.749 |
KIT |
0.740 | -0.145 | 3 | 0.748 |
FYN |
0.739 | -0.005 | -1 | 0.795 |
WEE1_TYR |
0.739 | -0.105 | -1 | 0.712 |
MERTK |
0.739 | -0.112 | 3 | 0.737 |
INSRR |
0.739 | -0.178 | 3 | 0.694 |
FGFR2 |
0.738 | -0.175 | 3 | 0.753 |
AXL |
0.738 | -0.154 | 3 | 0.733 |
BMX |
0.738 | -0.080 | -1 | 0.684 |
EPHB1 |
0.737 | -0.155 | 1 | 0.717 |
PDGFRB |
0.736 | -0.242 | 3 | 0.759 |
DDR2 |
0.735 | -0.034 | 3 | 0.679 |
EPHB3 |
0.735 | -0.150 | -1 | 0.740 |
TEK |
0.734 | -0.173 | 3 | 0.680 |
CK1G2 |
0.733 | 0.038 | -3 | 0.532 |
EPHB2 |
0.733 | -0.152 | -1 | 0.729 |
FLT3 |
0.732 | -0.245 | 3 | 0.749 |
FGFR1 |
0.732 | -0.195 | 3 | 0.713 |
TEC |
0.732 | -0.152 | -1 | 0.695 |
PTK2B |
0.730 | -0.064 | -1 | 0.730 |
FLT1 |
0.730 | -0.158 | -1 | 0.740 |
BTK |
0.730 | -0.244 | -1 | 0.739 |
PDGFRA |
0.729 | -0.267 | 3 | 0.756 |
ALK |
0.729 | -0.195 | 3 | 0.656 |
PTK6 |
0.729 | -0.234 | -1 | 0.698 |
EPHA7 |
0.728 | -0.132 | 2 | 0.752 |
FGFR3 |
0.728 | -0.177 | 3 | 0.724 |
EPHA1 |
0.727 | -0.167 | 3 | 0.730 |
LTK |
0.726 | -0.206 | 3 | 0.686 |
LYN |
0.726 | -0.131 | 3 | 0.667 |
SRC |
0.726 | -0.090 | -1 | 0.782 |
EPHA3 |
0.726 | -0.174 | 2 | 0.722 |
PTK2 |
0.726 | -0.002 | -1 | 0.734 |
FRK |
0.725 | -0.170 | -1 | 0.776 |
ERBB2 |
0.724 | -0.226 | 1 | 0.651 |
NTRK1 |
0.723 | -0.282 | -1 | 0.739 |
SYK |
0.722 | -0.020 | -1 | 0.704 |
MATK |
0.722 | -0.157 | -1 | 0.655 |
INSR |
0.721 | -0.225 | 3 | 0.677 |
NTRK3 |
0.721 | -0.189 | -1 | 0.697 |
NTRK2 |
0.718 | -0.305 | 3 | 0.706 |
FLT4 |
0.718 | -0.278 | 3 | 0.705 |
EPHA8 |
0.718 | -0.150 | -1 | 0.730 |
EPHA5 |
0.717 | -0.173 | 2 | 0.726 |
CSK |
0.716 | -0.199 | 2 | 0.757 |
EGFR |
0.715 | -0.160 | 1 | 0.568 |
FGFR4 |
0.714 | -0.165 | -1 | 0.682 |
ZAP70 |
0.713 | -0.006 | -1 | 0.641 |
ERBB4 |
0.709 | -0.103 | 1 | 0.591 |
EPHA2 |
0.708 | -0.155 | -1 | 0.691 |
MUSK |
0.705 | -0.219 | 1 | 0.563 |
IGF1R |
0.703 | -0.224 | 3 | 0.614 |
FES |
0.696 | -0.189 | -1 | 0.664 |